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Abstract 
Lysyl oxidase (E.G. 1.4.3.13) is a copper dependent enzyme of 
connective tissue that initiates cross -linking in collagens and elastin by 
oxidative deamination of certain lysine (or hydroxylysine) residues. The 
enzyme can be purified from 6M i.irea extracts of porcine skin. Tyrosine -rich 
acidic matrix protein (TRAMP) is a protein that co- purifies with lysyl oxidase 
and is the porcine equivalent of the human protein 'dermatopontin' and a 
protein (Mr = 22K) that co- purifies with dermatan sulphate proteoglycans 
from bovine skin. Polyclonal anti -serum was raised to purified TRAMP, and 
Western blotting showed that TRAMP is a widespread protein in murine 
tissues. Enzymatic studies showed that TRAMP is capable of releasing 
tritium labelled, low molecular weight material ( <10 kDa) from [4,5 -3H] 
lysine -labelled collagen, but not from [4,5 -3H] lysine -labelled elastin, and 
that collagen 1312 components were increased in the presence of TRAMP. 
TRAMP may therefore be a collagen specific lysyl oxidase. 
In an attempt to remove the necessity for 6M urea during the 
purification of lysyl oxidase, and to allow genetic manipulation of the 
enzyme, work was undertaken to produce active mature lysyl oxidase 
using recombinant DNA technology. The cDNA sequence of the rat aorta 
lysyl oxidase precursor was used to design primers for amplification of a 
DNA fragment by the polymerase chain reaction (PCR), which was then 
radiolabelled and used to probe a human placental cDNA library for the 
human lysyl oxidase sequence. During the project, the cDNA sequence of 
the human placental lysyl oxidase precursor was published, and primers 
were then designed to amplify directly, a region of the human lysyl oxidase 
precursor cDNA, from the codon for Asp 169 to the termination codon. This 
sequence is thought to encode mature lysyl oxidase. The cDNA was 
obtained and sequenced. The amplified DNA was cloned into a yeast 
shuttle vector (pDP315), which was then used to transfect a strain of S. 
cerevisiae (JRY188) and attempts were made to express mature lysyl 
oxidase. Only one protein band of approximately 90 kDa was observed in 
the yeast cell culture after running concentrated extracts on 12% SDS- 
PAGE. 
Extracts of 6M urea from porcine skin were found that contained no 
endogenous lysyl oxidase activity, but were able to enhance lysyl oxidase 
catalysed tritium release from a [4,5 -3H] lysine -labelled elastin substrate. 
All activity was abolished in the presence of 2mM (3- aminopropionitrile, a 
specific inhibitor of lysyl oxidase. Investigations were carried out on this 
material to determine its identity as a protein, its molecular weight was and 
its substrate specificity. The enhancer bound CM- Sepharose pre - 
equilibrated in 6M urea at pH 7.8, and could be eluted in 6M urea, 0.5 M 
NaCI pH 7.8. No enhancement was detected on lysyl oxidase activity when 
1,5- diaminopentane or [4,5 -3H] lysine -labelled collagen were used as 
substrates. Enhancement was found to be greatest at low concentrations of 
radiolabelled elastin and the material responsible was inactivated by 
treatment with trypsin. The enhancer was stable at temperatures up to 
800C, but was inactivated by boiling at 1000C or by freezing. 
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1.1 Extracellular matrix 
The extracellular matrix is a composite material of higher, multi -cellular 
organisms with major roles in the provision of tissue mechanical integrity, 
cell migration and cell differentiation (Brown et al., 1991; Hay, 1991). 
Extracellular matrix proteins include collagens (Hulmes, 1992), elastin 
(Mecham and Heuser, 1991), proteoglycans (Oldberg et al., 1990; Kjelllen 
and Lindahl, 1991) and structural glycoproteins (Yamada, 1991). 
Collagens are a family of relatively rigid proteins characterised by the 
presence of a unique triple helical conformation. Elastin facilitates stretch 
and recoil and is therefore important for tissue flexibility. 
The functions of both collagens and elastin are strongly dependent on 
the formation of lysine (or hydroxylysine) derived intra and inter -molecular 
crosslinks. The extracellular enzyme that initiates cross -linking, in both 
collagens and elastin, is lysyl oxidase (Pinnell and Martin, 1968). 
1.2 Elastin 
Elastin is a fibrous protein, present in most vertebrates, whose major 
function is to provide tissue elasticity and strength (Mecham and Heuser, 
1991). Elastin is abundant in mammalian nuchal ligament and aorta 
(Davidson and Sephel, 1987), whereas relatively low levels are found in 
tissues such as foetal lung parenchyma (Rosenbloom, 1987) 
1.2.1 Tropoelastin 
The soluble precursor of mature elastin is tropoelastin (molecular mass 
2 
72 -74 kDa; Rosenbloom, 1987). The structure of tropoelastin is unusual, 
consisting of hydrophobic stretches (which account for about 40 % of the 
molecule) interspersed with hydrophilic regions which contain potential 
cross -linking sites. These cross -linking sites are polyalanine sequences 
containing pairs of lysine residues (Hay, 1991) set two or three amino 
acids apart. In an a- helical conformation these lysine residues would be 
orientated on the same side of the helix, and hence be available for 
formation of multi -functional, interchain cross -linking. In contrast, the 
hydrophobic stretches are thought to form a random coil structure that 
gives rise to the elasticity of the molecule (section 1.2.3). Some 
hydroxylation of proline residues occurs in tropoelastin (Uitto et al., 1976), 
although the significance of this is unknown. 
1.2.2 Mature elastin formation 
Newly secreted tropoelastin is targeted to specific sites on the 
extracellular surface of the plasma membrane where synthesis of mature, 
insoluble elastin occurs (Hinek et al., 1988; Mecham et al., 1989a). The 
assembly is thought to be regulated by specific elastin receptors that 
recognise the hydrophobic elastin sequence Val -Gly- Val -Ala- Pro -Gly 
(Mecham, 1991). The elastin receptor (molecular mass 67kDa) contains a 
cell binding component and an elastin / carbohydrate binding subunit 
(Mecham et al., 1989a). This receptor is functionally and immunologically 
similar to the 67 kDa laminin receptor found in some tumour cells (Mecham 
et al,. 1989b). 
Mature elastic fibres consist of a microfibrillar mass which surrounds an 
inner elastin core. The secretion of the microfibrillar component precedes 
3 
that of elastin (Farenbach et al.,1966), which suggests that the microfibrils 
create a scaffold on which the mature elastin fibres are formed. Maturation 
of elastin occurs by spontaneous inter- and intra- molecular cross -linking 
following oxidative deamination of specific lysine residues by the enzyme 
lysyl oxidase (E.C.1.4.3.13), to form a- aminoadipic- s- semialdehyde 
(allysine). This aldehyde group is the functional precursor to the covalent 
cross -links desmosine and isodesmosine (Fig 1.1; section 1.4.3). 
1.2.3 Elastin function 
Elastin provides both structural integrity and ability to stretch and recoil 
without deformation. Elasticity is possible because of the unique 
hydrophobic structure of elastin. In mature elastin, the molecules are held 
together by stable cross -links. On stretching, the hydrophobic groups are 
exposed, leading to a loss of entropy (including that of the solvent), which 
raises the Gibbs free energy, and hence elastic recoil (Wainright et al., 
1976). 
1.2.4 Elastin gene structure 
The human tropoelastin gene is approximately 45 kilobase pairs (kbp) 
in length, containing 34 exons, and with an intron : exon ratio of 19:1 
(011iver et al., 1987). Tropoelastin mRNA is 3.5 kbp in length, coding for 
786 amino acids (Deak et al., 1987). The hydrophobic and cross -linking 
domains of the elastin molecule are encoded by separate exons within the 
gene, which indicates that the gene structure is compartmentalised into 
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Figure 1.1. Stable cross -link formation in elastin. Desmosine is 
formed when allysine residues spontaneously condense with other 
allysine or lysine residues to form a pyridinium ring. (Adapted from 
,Sandberg et al., 1981) 
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functional areas. In human elastin, alternative mRNA splicing leads to 
tissue specific differences in the structure of the elastin molecule (Indik, 
1988).Tissue specific differences in transcriptional control occur during 
development, as shown by the simultaneous decrease and increase in 
levels of aortic and skin elastin mRNA, respectively (Tokimitsu et al., 1987). 
1.3 Collagen 
Vertebrate collagens (currently 18 different genetic types; Table 1.1) are 
a diverse family of proteins which can be sub -divided broadly into fibrillar 
and non -fibrillar categories. All collagen molecules are characterised by 
the presence of a unique triple -helical conformation. Formation of the triple 
helix requires the presence of a repeating primary structural motif, (Gly - X - 
Y)n, where X and Y residues can be any amino acid, often proline (X 
position) or hydroxyproline (Y position). The helical structure is stabilised 
by extensive intermolecular hydrogen bonding (Berg and Prockop, 1973). 
Hydroxyproline and hydroxylysine are post -translationally modified 
amino acids almost unique to collagen, and are derived from proline and 
lysine, respectively. Hydroxylysine is formed from lysine residues (in the Y 
position of the Gly -X -Y triplet) by the enzyme lysyl hydroxylase (Kivirikko 
and Myllyla, 1985). In fibrillar collagens, approximately half of the proline 
residues (i.e. those in the Y position of the Gly -X -Y triplet) are converted 
into 4- hydroxyproline by the enzyme prolyl hydroxylase (Grant and 
Prockop, 1972; Prockop et al., 1979). The presence of 4- hydroxyproline 
increases the stability of the collagen triple helix by increasing hydrogen 
bonding through water molecules. Hydroxylysine is required for collagen 
specific 0- linked glycosylation (Kivirikko and Myllyla, 1984) and the 
6 
Table 1.1 : Vertebrate collagens 
Type a chains Most common 
molecular form 
Tissue distribution 
1 al (I), a2(I) 
I al (II) 
III ai(III) 
IV al (IV), a2(IV), a3(IV) 
a4(IV), a5(IV) 
V al (V), a2(V), a3(V) 
VI al (VI), a2(VI), a3(VI) 
VII al (VII) 
VIII al(VIII), a2(VIII) 
[al (1)12 a2(I) 
[a1(II)]3 
[al (III)]3 
[al (IV)]2 a2(IV) 
[al (V)]2 a2(V) 
al (VI)a2(VI)a3(VI) 
[a1(VII)]3 
[al (VIII)]2 a2(VIII)]? 
IX al (IX), a2(IX), a3(IX) ai(IX)a2(IX)a3(IX) 
X al(X) 
XI al (XI), a2(XI), a3(XI) 
XII al (XI I) 















Bone, skin, cornea, lung 
Cartilage, vitreous humour 
Skin, lung, vascular system 
Basement membrane 
Collagen I containing tissue 





Collagen II containing tissue 
Hypertrophic zone of cartilage 
Collagen II containing tissue 
Collagen I containing tissue 
Endothelial cells? 
Collagen I containing tissue 
Human placenta (from cDNA) 
Human fibroblasts (from cDNA) 
Human skin (from cDNA) 
Mouse kidney, lung and liver 
References: Types 1 -XIV (Hulmes, 1992), Types XV -XVIII (Mayne and Brewton, 1993). 
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formation of stable, pyridinium cross -links (Reiser et al., 1992). 
1.3.1 Fibrillar collagens 
The fibrillar collagens ( types I, II, III, V and XI) are characterised by a 
molecular packing arrangement in which neighbouring collagen molecules 
are staggered along the length of the fibril by integral multiples of 67 nm, a 
distance (D) slightly less than the molecular length (300 nm; Hulmes, 
1992). Gaps that appear as a result of this packing arrangement are called 
`hole zones', and these give rise to the characteristic banding pattern that 
is seen when fibrils are stained and observed in the electron microscope. 
Type I is the most abundant collagen, present in tendon, cornea, skin, 
bone and the vascular system. Each type I molecule is a heterotrimer of 
two al (I) chains and one a2 (I) chain, both containing approximately 1000 
amino acids. The a chains are each encoded by separate genes. 
Type II collagen can be found in cartilage, embryonic cornea, and 
vitreous humour. Unlike type I collagen, type II collagen is a homotrimer, 
consisting of three al (II) chains (Miller and Matukas, 1969). Type III 
collagen is also a homotrimer (Miller et al., 1971) with glycine residues 
occupying some of the X or Y positions of the triplet repeat, leading to a 
more flexible molecular structure than other fibrillar collagens. Type Ill 
collagen is present in tissues that are relatively extensible e.g. skin and 
lung. 
Types V and XI collagen are closely related to each other, and are 
associated with tissues containing types I and II collagens, respectively. 
Fibrillar collagens are secreted into the extracellular matrix as 
procollagen molecules, with propeptides at both the NH3 and COON 
8 
termini. The propeptides must be removed before the collagen molecules 
can assemble. Detailed understanding of the proteolytic processing 
mechanism comes from the conversion of procollagen I to collagen I, by 
specific procollagen proteinases (Turderman et al., 1977).The N- 
propeptide is removed by procollagen N- proteinase to give pC- collagen 
while the C- terminal propeptide is processed to pN- collagen by 
procollagen C- proteinase (Prockop and Kivirikko, 1984). 
The mature collagen molecule consists of a central, triple -helical core 
flanked by two short non -helical telopeptides at the C- terminus (25 amino 
acids) and the N- terminus (16 -18 amino acids). The telopeptides contain 
the lysine and hydroxylysine residues that are oxidatively deaminated by 
the action of lysyl oxidase (section 1.4.2) to produce allysine and 
hydroxyallysine respectively. These modified residues spontaneously form 
bifunctional cross -links with lysine and hydroxlysine residues from the 
helical regions of other collagen molecules, leading eventually to the 
formation of stable tri- functional cross -links (Reiser et al., 1992). 
1.3.2 Non -fibrillar collagens 
The non -fibrillar group of collagens include the Fibril Associated 
Collagens with Interrupted Triple helices (FACIT). They include collagen 
types IX, XII and XIV and are found closely associated with fibrillar collagen 
fibrils, mediating interactions between fibrils and the rest of the 
extracellular matrix (Shaw and Olsen, 1991). 
Network forming collagens (types IV, VII and VIII) are present near or as 
part of basement membranes, which are extracellular sheet -like structures 
that underly epithelial and endothelial cells (and some mesenchymal cells) 
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with functions that include filtration (e.g. glomerulus) or the provision of 
morphogenetic tracks (e.g. neuromuscular junctions; van der Rest and 
Garrone, 1991; Burgeson et al., 1990). 
Beaded filament (type VI) collagen (Timpl and Engel, 1987) is present 
in most connective tissues, including cartilage and cornea, and appears to 
be necessary for the maintainence of integrity of some tissues (e.g. skin 
and blood vessels; Kielty et al., 1991). The protein has many cell adhesion 
(RGD) sites in its helical domain, and there are collagen binding domains 
contained in the extensive N and C- termini (Koller et al., 1989). 
Types VIII and X collagens are the so called short chain collagens, with 
molecular lengths approximately half the length of the fibrillar collagens. 
Type X collagen is specifically located in the hypertrophic zone during 
endochondral ossification (Schmid and Linsenmayer, 1987). Type VIII 
collagen is produced by endothelial cells (e.g. Descemet's membrane in 
the cornea) and by some transformed cell types (Sage and Bornstein, 
1987). Types VIII and X collagen are closely related, and both can form 
networks with molecules in hexagonal array. 
1.4 Lysyl oxidase 
Lysyl oxidase (E.C.1.4.3.13 ) is the enzyme that initiates the formation 
of covalent cross -links in mature collagens and elastin. Lysyl oxidase 
activity is widespread in vertebrate tissue. Reports of lysyl oxidase -like 
activities have also been observed in sea urchin (Lytechinus variegatus; 
Wessel and McClay, 1987) and the cell envelope of E. coli (Mirelman and 
Siegel, 1979). 
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1.4.1 Molecular mass 
Since Pinnell and Martin recognised the role of lysyl oxidase in the 
formation of cross -links (Pinnell and Martin, 1968), the molecular mass of 
the enzyme has been reported as 170 kDa in chick embryo cartilage 
(Seigel and Martin, 1974), 59 -61 kDa in immature chick aorta (Harris et al., 
1974) and 32 -33 kDa in bovine aorta (Kagan et aL, 1979 a), porcine skin 
(Shackleton et al., 1990 a), rat skin (Romero- Chapman et al., 1991) and 
human placenta (Kuivaniemi etaL, 1984). Multimers of lysyl oxidase have 
been observed up to 100 kDa (Kagan et al., 1979a). 
Recently, the cDNA coding for rat lung lysyl oxidase has been isolated 
from a 2,gt 11 library (Trackman et aí.,1990). It codes for a 48 kDa precursor 
form of lysyl oxidase, which presumably is processed to become the active, 
mature enzyme . 
1.4.2 Lysyl oxidase reaction 
Lysyl oxidase catalyses the conversion of specific lysine and 
hydroxylysine residues in collagens and elastin to a- aminoadipic -8- 
semialdehyde (allysine). The reaction requires molecular oxygen and 
releases H2O2 and NH3 (Fig. 1.2). The pattern of the reaction follows a 
ping -pong kinetic course (Williamson and Kagan, 1986) where the 
substrate is oxidized to an aldehyde by the passage of two electrons from 
11 
RCHiNH, RCHO O, H202 NH3 
Enz oz Enz _NH_ Enz =NH Enzox 
Figure 1.2. The proposed ping -pong kinetic course followed by 
lysyl oxidase. Peptidyl lysine is bound to the enzyme and becomes 
oxidatively deaminated. The reduced enzyme is reoxidised on binding of 
oxygen which receives two electrons and is released as hydrogen 
peroxide. Finally, the amine group is released as ammonia. Adapted from 
Kagan et al., (1991). 
12 
the a- carbon of the amine substrate to a carbonyl cofactor. The enzyme is 
then required to be reoxidized by oxygen before it returns to a catalytically 
competent form (Kilgore et al., 1989). These electrons are then released 
within hydrogen peroxide. Copper is also required for catalysis (Gaucheru 
et al., 1990), although its role is still undetermined (section 1.4.4.1). 
1.4.3 Cross -link formation 
Following the conversion of lysine to allysine, a spontaneous 
condensation takes place in which various forms of cross -links are formed 
(Foster et al., 1974; Davis, 1978; Eyre et al., 1984). Allysine can condense 
with another allysine to form an aldol condensation product (ACP) or with 
the e -amino group of an unoxidized lysine to form dehydrolysinonorleucine 
(LNL). In elastin, ACP is formed when the lysine residues involved are 
separated by three alanine residues, whereas LNL is formed when two 
alanines separate the lysines (Mecham and Heuser, 1991). These cross - 
links in turn condense to form stable pyridinium cross -links called 
desmosine and isodesmosine. ACP and LNL are common to both 
collagens and elastin. 
The presence of hydroxylysine in collagens leads to the formation of 
additional cross -links, not observed in elastin, called 
dehydrohydroxylysinonorleucine and dehydroxydihyroxylysinonorleucine. 
Hydroxylated cross -links are capable of forming keto- amines which 
provide more stability to collagen (Robins, 1982), and can exist in 
glycosylated forms. In collagen ACP is also able to react with histidine to 
form aldol histidine. In cartilage, pyridinolines are formed that covalently 
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link collagen IX molecules to collagen II molecules (Eyre etal., 1987). 
1.4.4 Cofactors 
1.4.4.1 Copper 
Lysyl oxidase requires copper, as first discovered by feeding animals 
on copper deficient diets, which resulted in lathyritic -like disorders 
including bone fragility, aortic rupture, osteoporosis and joint deformities 
(Shields et al., 1962; O'Dell et al., 1961). Upon examination of tissue from 
these animals, tendon allysine levels were found to be decreased 
(compared to controls) while soluble collagen levels had increased (Chou 
et al., 1969). In aorta and lung elastin, increased lysine and decreased 
desmosine levels were observed (Buckingham et al., 1981). In chicks there 
was a significant reduction in lysyl oxidase activity (Rayton and Harris, 
1979), and the observed effects were reversed when CuSO4 supplements 
or serum copper proteins supplied with copper were administered. Only 
lysyl oxidase made de novo was able to incorporate copper (Rayton and 
Harris, 1979). 
During the conversion of lysine to allysine, release of the aldehyde 
requires the presence of copper (Gaucheru et al., 1990). The precise role 
of copper here is still undetermined; however the following two possibilities 
have been put forward. The metal ion may be involved in creating a 
complex with a putative carbonyl cofactor to form a catalytic semiquinone 
intermediate after the oxidation of the amine residue. The complex formed 
could then react with oxygen (Dooley et al., 1991). Alternatively copper 
may stabilise a catalytic intermediate between the enzyme and its 
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substrate, necessary for this first stage of the reaction. 
Recent studies suggest that copper may be incorporated into a copper - 
talon complex encoded by residues 284- 301(in the human lysyl oxidase 
precursor) containing a single cupric ion (Krebs and Krawetz, 1993). A 
tyrosine residue at position 295 in this complex could be a candidate for 
modification to the putative carbonyl cofactor topaquinone (see 1.4.4.2) 
which would then be available for binding to the copper ion. 
1.4.4.2 Carbonyl cofactor 
Debate has surrounded the identity of the second cofactor of lysyl 
oxidase since copper amine oxidases were first shown to possess a 
carbonyl group capable of reacting with phenylhydrazine to form a 
chromophoric complex (Yasunobu et al., 1976). Initially pyridoxal 
phosphate had been considered to be this cofactor because of its ability to 
reverse the actions of certain lathyrogenic agents such as ureides, 
hydrazines and hydrazides (Levene, 1961). A diet deficient in pyrodoxine 
has been shown to lead to a decrease of elastin cross -links in chick aorta 
(Starcher, 1969). It was then observed that derivatization of lysyl oxidase 
with phenylhydrazine failed to produce a peak corresponding to the 
phenylhydrazone of pyridoxal phosphate when isolated by HPLC 
(Williamson et al .,1986a). Derivatization of purified human lysyl oxidase 
with 2,4- dinitrophenylhydrazine was found to yield a product that was 
spectrally and chromatographically identical with a hydrazone derivative of 
pyrroloquinolino quinone (PQQ; Van Der Meer and Duine, 1986). Further 
supporting evidence was supplied from absorption and resonance Raman 
spectroscopy studies of phenylhydrazones derived from bovine aortic lysyl 
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oxidase. These were thought to be similar to hydrazones of PQQ (Fig 1.3 
a), and therefore provided strong evidence that the carbonyl cofactor of 
lysyl oxidase was either PQQ or a similar molecule (Williamson et al., 
1986b). No direct structural evidence however has shown P00 to be 
present at the active site of any known amine oxidase. 
A recent study by Klinman et al. (1991) has implicated another carbonyl 
containing molecule as a possible cofactor. Topaquinone 
(trihydroxyphenylalanine quinone or 6- Hydroxydopa; Fig 1.3 b) has been 
isolated from a pentapeptide present at the active site of bovine serum 
amine oxidase, and identified by mass spectrometry, proton nuclear 
magnetic resonance and ultraviolet -visible spectroscopy (Janes et al., 
1990). 
The phenylhydrazone of topaquinone is highly reactive when it 
undergoes cyclization, and it is likely that a reaction with glutamate may 
occur to yield a product that would subsequently co -elute (on HPLC) with 
PQQ. This result could give rise to confusion over the exact nature of the 
cofactor (Janes et al., 1990). 
The mechanism by which topaquinone is synthesised is unknown. 
Evidence points to a post -translational modification of a tyrosine residue, 
since the codon UAC (which codes for tyrosine) has been found to 
correspond to the topaquinone incorporation position at the active site of 
yeast amine oxidase from Hansenula polymorpha (Mu et al., 1992) as 










Figure 1.3. The structure of the putative carbonyl containing 
cofactors of lysyl oxidase. a) Pyrroloquinoline quinone b) 
Topaquinone. 
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A consensus sequence for the incorporation of topaquinone at the active 
site of copper- dependent amine oxidases has been postulated (Janes et 
al., 1992). This sequence, Asn- Tyr- Asp /Gln, is present in bovine serum 
amine oxidase, porcine serum amine oxidase, pig kidney amine 
oxidase and pea seedling amine oxidase (Janes et al., 1992). The 
consensus sequence is absent in lysyl oxidase, but Asn- Tyr- Tyr -Asp is 
present (residues 185 -188) in the human lysyl oxidase precursor 
(Hamalainen et al., 1991), and is conserved in the chick (Wu et al., 1992), 
rat (Trackman et al., 1991) and pig (A.D.Cronshaw; personal 
communication) enzymes. 
1.4.5 Inhibition of lysyl oxidase 
Lysyl oxidase is inhibited by 0.2 mM 13- aminopropionitrile (BAPN), a 
naturally occurring lathyrogen found in Lathyratus odoratus (sweet pea). 
Other amine oxidases are inhibited by this reagent, though at much higher 
concentrations e.g. porcine plasma amine oxidase requires 5mM BAPN 
(Page and Benditt, 1967 ) for total inhibition. 
Though first noted by Pinnell and Martin (1968) to be an irreversible 
inhibitor of lysyl oxidase activity, the mechanisms of BAPN and other lysyl 
oxidase inhibitors are not fully understood. BAPN binds covalently to lysyl 
oxidase, as shown by addition of 14C -BAPN to the diet, and subsequent 
co- elution of lysyl oxidase and 14C -BAPN by gel exclusion chromatography 
(Narayanan et al., 1972). 
With elastin or alkyl amine substrates, the initial reaction between lysyl 
oxidase and BAPN is competitive. After further incubation with the enzyme, 
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the reaction becomes irreversible, in a time and temperature dependent 
manner. Studies using [1,2 -14 C] BAPN and [3 -14 C] BAPN were used to 
examine the mechanism of inhibition of lysyl oxidase (Tang et al., 1983). 
These studies suggested that BAPN is activiated by binding to the enzyme 
through Schiff base formation with a carbonyl group from the co- factor at 
the active site. An intermediate is then formed which becomes covalently 
attached to the enzyme, leading to inactivation (Tang et al., 1983; Fig 1.4). 
1.4.6 Lysyl oxidase purification 
Lysyl oxidase activity was first demonstrated in a PBS (100mM 
phosphate buffer, 0.16M NaCI pH 7.4) extract of embryonic chick bone 
(Pinnell and Martin, 1968). The enzyme was found to be stable in 4 -6M 
urea (Narayanan et al., 1974), and this finding led to the use of DEAE- 
cellulose ion exchange (where in the absence of urea all activity was 
permanently bound) to achieve 50 -100 fold purification of lysyl oxidase. 
Urea solubilisation of lysyl oxidase also allowed affinity chromatography 
on a collagen derivitized Sepharose 4B matrix, from which almost all 
activity was recovered (Narayanan et al., 1974). 
In the absence of urea, lysyl oxidase forms aggregates of up to 1000 
kDa and displays low solubility (Jordan et a/.,1977). The enzyme is only 
partially active in 6M urea, although activity is fully recovered after removal 
of urea by dialysis. Lysyl oxidase is stable in 6 M urea for several months at 
-20 °C. 
Modifications to the procedure of Narayanan et al. (1974), using 
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allowed purification of the embryonic chick cartilage enzyme to apparent 
homogeneity, with an estimated molecular mass of 28 kDa (Stassen, 1976) 
and 62 kDa (Siegel and Fu, 1976) respectively. Stassen (1976) resolved 
four peaks of lysyl oxidase activity on DEAE -cellulose which were Vater 
shown to be four distinct variants of lysyl oxidase (Kagan et al., 1979a). 
These variants were purified from 2 -6 week old bovine thoracic aorta using 
DEAE -cellulose ion exchange, denatured collagen -Sepharose affinity 
chromatography and Sephacryl S -200 gel permeation. The procedure 
yielded four different peaks of lysyl oxidase. When analysed by SDS -PAGE 
this yielded four enzyme peaks of molecular mass 31700 -33100 Da. 
The use of Sephacryl S -200 pre -equilibrated in the absence of urea 
and then eluted with 6M urea at low ionic strength gives an almost 140 fold 
purification of the enzyme from porcine skin (Shackleton and Hulmes, 
1990a). The 'selective interaction' that occurs between lysyl oxidase and 
Sephacryl S -200 may be due to aggreg.tion of lysyl oxidase in the 
absence of urea. In the presence of 6 M irea,, the aggregates would then 
dissociate, followed by elution of hiigh c r`''ed llysyl oxidase_ 
Other purification procedures have included the use of Cibacron -blue 
dye, which binds to lysyl oxidase (Williams and Kagan, 1985), affinity 
chromatography with lathyritic chick aorta elastin (Romero -Chapman et 
al., 1991) and hydroxyapatite chromatography (Almassiian etal., 1991)_ 
1.4.7 Variants of lysyl oxidase 
A number of studies have been undertaken to determine the 
differencies between the variants of lysyl oxidase. None of the variants 
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bind to concavalin -A Sepharose or stain with periodic acid / Schiff reagent 
(Kagan et al., 1979a). Furthermore treatment of the four variants with 
alkaline phosphatase or neuraminidase does not affect their elution 
position on ion -exchange chromatography (Sullivan and Kagan, 1982). 
These observations indicate that the variation is not due to glycosylation. 
Furthermore, the variants persist after reduction and alkylation (Williams 
and Kagan, 1985), showing that they are not disulphide isomers. 
Slight differences in amino acid composition, as well as small 
differences in the tryptic and S.aureus V8 protease digestion patterns, 
suggest that the primary sequence is the most likely source of the 
heterogeneity of these species (Sullivan and Kagan, 1982). 
1.4.8 Regulation of lysyl oxidase 
Regulation of the activity and expression of lysyl oxidase is of vital 
importance in connective tissue. Elastin and collagen synthesis, hence 
foundation and maintenance of the extracellular matrix is dependent on 
lysyl oxidase activity. 
Steroid hormones are lipid- soluble molecules that can freely travel 
through plasma membranes. Steroid hormones commonly interact with a 
specific receptor in the cytoplasm. The receptors have a hormone binding 
site and a DNA binding site. When bound, the hormone -receptor complex 
migrates to the nucleus where it binds to specific sites on DNA and 
stimulates transcription (Weinberger et al., 1986). 
Oestrogen has been found to influence lysyl oxidase activity in different 
murine tissues (Ozasa et aí.,1986). In mice, during pregnancy, lysyl 
oxidase activity was found to be high during oestrus and low during 
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dioestrus. An inverse relationship was also noted between the dilatability 
of the uterine cervix and the level of lysyl oxidase activity. Ovariectomy in 
these mice caused a decrease in lysyl oxidase activity of 75% after 3 days, 
which could be restored to levels observed at oestrus after injection of 1 mg 
ß- oestradiol (Ozasa et aL,1986). Skin collagen solubility is greatly reduced 
and lysyl oxidase activity significantly increased in bone and skin of 
gonadectomized 7 week old mice after treatment with 2mg oestrogen 
(Sanada et al., 1978). 
Testosterone (10- 100mM) in the growth medium of calf aortic smooth 
muscle cells has been observed to stimulate lysyl oxidase activity 2.5 fold 
in the medium, and 5.5 fold in the cell layer (Bronson et a1, 1987). 
Hypophysectomy in rats greatly reduces skin lysyl oxidase activity, 
which indicates an influence by hormones secreted by the pituitary 
(Shoshan and Finkelstein, 1976). 
It is interesting to note that an untranslated 3' 258 bp region of the lysyl 
oxidase gene is 93% identical to a region in the 3' untransllated sequence 
of the elastin gene. These regions usually determine the rate of production 
and stability of the mRNA transcripts synthesised which suggests that 
expression of the two genes may in some way be co- regulated (Trackman 
etal., 1990). Studies in chick aorta indicate that lysyl oxidase and collagen 
/ elastin expression are indeed co- ordinated, such that the mANA 
transcripts of lysyl oxidase peak at 12 days in chick aorta, followed by type 
collagen and tropoelastin mRNA, which peak 2 days later (Wu et al., 1992). 
It has been noted that after neoplastic transformation of rat fibroblasts, 
both collagen and ras- recision genes (a phenotypic suppressor of the ras 
oncogene; Contente et al., 1990) are down -regulated (Hajnal et al., 1993). 
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Reversion of rat H -ras transformed fibroblasts was found to induce both 
lysyl oxidase and type I collagen al chains, which also suggests co- 
regulation of expression (Hajnal etal., 1993). 
Finally, extracts of porcine skin have been found to enhance lysyl 
oxidase activity when elastin is used as substrate P.R. Shaclkleton, 
unpublished observation). This may indicate that a lysyl oxidase r tuIl.ni ng 
substance exists. 
1.4.9 Assay of lysyl oxidase 
For assay of lysyl oxidase activity on collagen i'r ellastin sun 1014.11 
conventional procedure depends on the formation of triitiiat ,. 
n the 
allllystine. 
When collagen or elastin is radiola.beledl "Of :," -= l or Q45--13iH111 Ihysiine 
tritiated protons released during the read,': - : -e iín aporTalt Ii 
tritiated water (Fig 1.5). This lis either directt from to 
position ([6 -3H] lysine), or occurs _ ylil tturtommeniismrn of allllysiinn 
((4,5 -3H1 lysine) which releases a pro: n :,nni the carbon ilia) the 55- votition. 
itmdto 
During the course of the reaction, tritial, alp ,Ill( r its rrell 
fashion over several hours (Pinnelll and LlIaatiiin,11 
.:%id finn a Ilimear 
)). The tuse off [[4,5-311-Ig 
lysine label is not ideal in collagen, since the c nmertion of I4siine tto 
hydroxylysine leads to the loss of ' ne tritium atom on the 5-positmion 
(Popenoe et al., 1965). 
An alternative assay procedure measures ,.;Illlysiinn.' diirect fy ((Pinnellll arnd 
Martin, 1968). [14C]lysine labelled collagen or Ilasthin stubs-rat ils 
converted to [14C]allysine and then s bs-quentlly oxciidiisedl rtormiicc 
acid t become aminoadipic acid which is then firydrolloed tw 72 Items iin X11 
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Figure 1.5. Lysyl oxidase assay using [4,5 -3H] lysine labelled 
elastin as substrate. Lysine is oxidatively deaminated to a- 
aminoadipic-s- semialdehyde (allysine) which then undergoes keto -enol 
tautomerisation to release a tritum atom from the 5- position which is 
incorporated into water. 
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HCI at 107 °C. 
Amino acid analysis of the hydrolysate is then used to separate and 
quantify the [14C] aminoadipic acid. 
The above reactions require long incubation periods of several hours 
and must be terminated before analysis can take place. They are therefore 
discontinuous and can provide no information about the kinetics of lysyl 
oxidase activity. In contrast, measuring H2O2 release using the artificial 
substrate 1,5- diaminopentane gives a continuous measurement of enzyme 
activity for up to 300 turnovers of the enzyme at 55 °C (the optimal 
temperature for lysyl oxidase activity; Trackman et al., 1981). In the assay 
developed by Trackman et al. (1981) horse radish peroxidase catalyses 
the reaction between H2O2 and homovanillate to produce a molecule that 
fluoresces at excitation and emission wavelengths of 315 and 425nm 
respectively. 
1.4.10 Localisation of lysyl oxidase 
Lysyl oxidase is secreted by cells in culture. In cultured human 
fibroblasts, the cell medium was found to contain almost all of the lysyl 
oxidase activity (Layman et al., 1972). In rabbit aorta smooth muscle cell 
cultures, approximately 40 % of the lysyl oxidase activity was found to be in 
the medium (Gonnerman et al., 1981). Subsequent immunolocalisation 
techniques have established that lysyl oxidase is present in the 
extracellular matrix of connective tissue septa from fibrotic rat liver and 
tendon sheaths of 17 day -old chick (Siegel et al., 1978). 
Two studies using polyclonal, anti -lysyl oxidase antibodies provide 
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apparently conflicting results (Kagan et al., 1986; Baccarani -Contri et al., 
1989). Chicken anti -lysyl oxidase polyclonal antibodies, in association with 
gold conjugated rabbit anti -chicken immunoglobulin G, labelled the 
amorphous elastin / microfibril interface in calf aorta and newborn rat aorta 
(Kagan et al., 1986). The gold label was absent from both the microfibrils 
and the amorphous elastin distal to this interface.This supports the 
hypothesis that the microfibrils are used as a scaffold around which the 
mature elastic fibres are formed. Cross -linking of tropoelastin molecules to 
produce mature elastin would therefore presumably occur at the elastin / 
microfibril interface.The antibodies utilized here did not cross -react with 
collagen bound lysyl oxidase, which may indicate possible substrate 
specificity of the enzyme. In contrast to the results with antibodies against 
bovine lysyl oxidase, anti -human placental lysyl oxidase polyclonal 
antisera reacted against elastin fibres outside the region of the elastin / 
microfibril interface, and also cross -reacted with collagen in all the human 
tissues tested (Baccarani -Contri et al., 1989). 
The anti -human placental lysyl oxidase antiserum cross -reacted with a 
24 kDa protein that co- purifies with lysyl oxidase (Kuivanemi etal., 1984 ). 
Furthermore, four monoclonal antibodies against human lysyl oxidase also 
cross - reacted with a similar 24kDa protein (Burbelo et al., 1986). 
1.4.11 Lysyl oxidase in embryogenesis 
Lysyl oxidase is required for cross -link formation in collagens from an 
early stage of vertebrate development. Type II collagen for example is 
widespread in embryonic chick at stages 14 -19, where it is present in the 
basement membrane of notochord, gut endoderm surface ectoderm and 
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auditory vesicle (Kosher and Solursh, 1989). In the adult chicken, type II 
collagen is restricted to cartilage, intervertebral discs and vitreous humour, 
perhaps indicating a more complex role for type II collagen than simply the 
provision of strength to the developing tissue. This is also suggested by the 
ability of types I and II collagens to promote embryonic cell differentiation 
and migration in chick embryo (Bilozur and Hay, 1988). 
Collagen involvement in invertebrate development has been observed 
in the sea urchin Lytechinus variegatus which requires the presence of 
cross -linked collagen before entering gastrulation (Wessel and McClay, 
1987). The specific inhibitor of lysyl oxidase, 13- aminopropionitrile (BAPN) 
can prevent this progression. Subsequent removal of BAPN by washing 
restores development (Wessel and McClay, 1987). Lysyl oxidase is 
therefore necessary for successful tissue development, the failure of which 
can have serious and widespread effects. 
1.4.12 Role of lysyl oxidase in disease 
1.4.12.1 Genetically inherited connective tissue disorders 
Several inherited diseases of connective tissue are associated with 
reduced levels of lysyl oxidase activity (Danks et al., 1983; Byers et al., 
1976; Kuivaniemi et al., 1982; Peltonen et al., 1983). These disorders are 
functionally and morphologically similar to lathyrism, a condition induced in 
by feeding animals the specific lysyl oxidase inhibitor BAPN. 
Two forms of human Ehlers -Danlos Syndrome (types V and IX) have 
been linked with functional lysyl oxidase deficiency as manifested by 
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hyperextensible skin, tissue fragility, joint laxity and cardiovascular 
disorder. Lysyl oxidase activity in cultured skin fibroblasts was found to be 
reduced in one study of patients with Ehlers -Danlos type V (Di Ferrante et 
aL, 1975), though skin biopsies from patients and control groups in another 
study contained similar lysyl oxidase activity and antigenicity (Siegel et al., 
1979). Equivalent numbers of reducible cross -links in skin collagen 
between the groups also confirmed that lysyl oxidase deficiency is not 
responsible for this disorder (Siegel et al., 1979). 
Ehlers -Danlos Syndrome type IX (X- linked cutis laxa or occipital horn 
syndrome) is a recessively inherited disease affecting copper metabolism. 
Skin fibroblast cultures from these patients display greatly reduced levels 
of lysyl oxidase activity and reduced conversion of soluble to insoluble 
collagen (Kuivaniemi et al., 1982). Concentrations of serum copper and 
ceruloplasmin (a copper transport protein) are reduced, whereas copper 
concentrations are increased within the skin fibroblasts (Kuivaniemi et al., 
1982). The metal ion within these cells does not appear to be available for 
incorporation into copper dependent enzymes such as lysyl oxidase. 
Abnormalities in cell copper metabolism may therefore be the primary 
defect responsible for the connective tissue disorders observed 
(Kuivaniemi et al., 1982). 
A similar inherited X- linked disease of human connective tissue, 
Menkes' syndrome, is associated with `kinked' hair, retarded growth, 
neurological degeneration and a lifespan of around 3 years (Royce and 
Steinman, 1990). Copper and ceruloplasmin levels in serum are also 
reduced and lysyl oxidase activity is 6 - 12 % of normal levels (Royce and 
Steinman, 1990). 
A parallel can be drawn here between occipital horn disease, Menkes' 
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syndrome and the "mottled" and "blotchy" phenotypes observed in mice. 
"Mottled" mice have around 50% of the normal lysyl oxidase activity in skin 
and die of cerebral abnormalities after about 14 days, while the connective 
tissue is morphologically normal. Subcutaneous injections of 50 mg 
copper in Cu+ form in an alkylpolyether / sebacic acid solution at 7 days 
increases lysyl oxidase activity to between 84 - 150% of normal mouse 
levels (Royce et al., 1982). Copper provided in the correct form seems 
necessary for incorporation into lysyl oxidase. "Blotchy" mice have lower 
lysyl oxidase activity than the wild -type (20 - 30% in skin) and die, at 
around 150 - 200 days, of aortic aneurysm. These two mouse disorders 
may be due either to defects in two separate genes positioned close to 
each other on the X - chromosome, or two different alleles of the same 
gene. Menkes' syndrome and occipital horn syndrome may be the human 
equivalents of "mottled" mouse and "blotchy" mouse genotypes, 
respectively. 
1.4.12.2 Fibrosis 
Fibrosis in rat lung can be induced with exposure to cadmium chloride 
(Almassian et al., 1991). Fibrosis is associated with an induction of 
collagen synthesis and a large increase in the synthesis and activity of 
lysyl oxidase (Counts et al., 1981). Carbon tetrachloride can similarly 
induce a fibrotic response in rat liver, with an accompanying four -fold rise 
in lysyl oxidase activity and three -fold rise of lysyl oxidase mRNAs present 
(48 Kbp; Wakasaki and Ooshima, 1990a). 
Oral administration of ß- aminopropionitrile and CdCl2 to Syrian 
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hamsters simultaneously induces an emphysema associated phenotype, 
suggesting that the amount of collagen deposition in the lung tissue after 
injury determines whether a fibrotic or emphysematous pathology occurs 
(Niewoehner and Hoidal, 1982). Lysyl oxidase may therefore play a key 
role in the development of these two diseases during the healing process 
which occurs after injury. 
1.4.12.3 Role of lysyl oxidase in cancer 
Many human neoplasms are associated with the presence of retroviral 
genes called oncogenes, which are believed to have evolved from human 
genes (Weinberg, 1983). The `ras' gene encodes the protein p21, which is 
a 21 kDa guanyl- nucleotide binding protein. The retroviral equivalents of 
this gene contain mutations which inhibit the GTPase activity of p21, as a 
result of which the GTP form is constantly active. The specific effect of this 
on the cell is unknown. 
There are several examples of the mutations in oncogenes that lead to 
cell transformation i.e. in the lung carcinoma cell line (HS - 242), Ha -ras 
gene encodes leu instead of glu at position 61 and in lung cell line (Calu- 
1) Ki -ras oncogene encodes cys instead of gly at position 12 (Tanaka et 
al., 1986). 
Kuivaniemi et al., (1986) have shown that lysyl oxidase activity is 
greatly reduced in a number of human sarcoma cell lines (fibrosarcoma, 
embryonal rhabdomyosarcoma) and other tumour cell lines such as 
trophoblastic choriocarcinoma and melanoma. 
Rat lysyl oxidase cDNA has been sequenced, and found to have 89 
identity with a murine protein termed ras - recision gene (rrg; Kenyon et 
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al., 1991), which is a putative tumour suppressor gene or anti -oncogene of 
ras. The expression of rrg is greatly reduced after transformation of mouse 
NIH 3T3 cells with activated long terminal repeat (LTR) c -H -ras ( Contente 
et al., 1990). Treatment of these transformed cells with interferon reverted 
them to phenotypically non -transformed and non -tumorogenic cells which 
retained high levels of ras mRNA and p21 expression. Ras -recision gene 
expression levels were between 35 and 200% of normal NIH 3T3 cells 
(Contente etal., 1990). 
The blocking of rrg expression in itself is not enough to induce cell 
transformation (Contente et al., 1990). It is therefore possible that 
transformation of cells induced by ras may require the down regulation of 
the rrg gene product, and therefore lysyl oxidase expression. 
1.4.13 Lysyl oxidase precursor cDNA 
Rat aorta lysyl oxidase cDNA has been cloned and sequenced 
(Trackman et aL, 1990). This was carried out by screening a neonatal rat 
aorta cDNA library in ?gt 11 with anti -bovine lysyl oxidase polyclonal 
antiserum. The open reading frame of this sequence is 1227 bp, which 
corresponds to a calculated prepro- enzyme mass of 45,979 Da, consistent 
with reports of a 48,000 Da lysyl oxidase precursor in fibrotic liver cells 
(Wakasaki and Ooshima, 1990a). 
The cDNA sequences of human chick and murine lysyl oxidase have 
also been determined. The human placental sequence has an open 
reading frame of 1215 bp and is 78% identical to the rat sequence at the 
DNA level, and 84% identical at the amino acid level (Hamalainen et al., 
1991).This sequence is also 89% identical to the murine ras- recision gene 
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(Kenyon et al., 1991). 
Chick aorta lysyl oxidase has an open reading frame of 1260 bp, giving 
a calculated prepro- enzyme molecular mass of 48,150 Da. This sequence 
is only 60% identical, in the first 150 amino acids, with the rat sequence; 
however, the latter 270 amino acids have 92% identity. This strongly 
conserved part of the sequence would be expected to code only for the 
mature enzyme (Wu et al., 1992). 
Rat, human and chick lysyl oxidase cDNA sequences contain a 
putative metal binding consensus sequence His -X4- Cys -X5- Cys -X4 -His. 
This sequence is not totally conserved in chick aorta where the final 
histidine is absent (Wu etaL, 1992). Copper binding consensus sequences 
YGYHRRFAC and YTGHHAY are conserved in rat, human and murine 
sequences but only partially conserved in chick. 
1.4.14 The lysyl oxidase gene and its expression 
The lysyl oxidase gene has been characterised from several sources 
(Contente et al., 1993; Kenyon et al., 1993; Csiszar et al., 1993; Mock et 
al., 1992; Svinarichv et al., 1992). The gene coding for murine lysyl 
oxidase is split into seven exons and six introns which span around 14 kbp 
of the mouse genome (Contente et al., 1993). Two different sizes of mRNA 
transcript encode the enzyme. These are 4.8kb and 3.8kb in size, which 
differ in the length of their 3' non -coding regions through the use of 
separate poly A tracts (Contente et al., 1993).The length of these mRNAs 
are consistent with human lysyl oxidase from one study which also 
displays a 2.0 kb transcript present in low abundance (Mariani et al., 1992). 
In a separate study of the human gene however, transcripts were observed 
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at 4.3 kb, 2.5 kb and 2.0 kb (Svinarichv et al., 1992). 
Murine and human genes for lysyl oxidase have been mapped to 
chromosomes 18 and 5 respectively. A 1770bp cDNA fragment of human 
lysyl oxidase co- segregated with chromosome 5 when screening human x 
hamster somatic cell hybrids. Further in situ hybridization revealed that this 
fragment mapped to 5q 23.3 -31.2 (Hamalainen et al., 1991). Murine lysyl 
oxidase cDNA co- segregates with chromosome 18 in Chinese Hamster x 
Mouse somatic cell hybrids (Mock et al., 1992). 
A restriction fragment length polymorphism (RFLP) has been discovered 
within the coding sequence of the human lysyl oxidase gene. This 
mutation, a G to A transition, results in the appearance of a Pst 1 site into 
the sequence and results in arginine being replaced by a glutamine at 
codon 158. The RFLP occurred in one -third of a large population of 
apparently healthy, normal individuals (Csiszar etal., 1993). 
1.4.15 Lysyl oxidase post -translational modifications 
Lysyl oxidase appears to be synthesised as a 47 -50 kDa precursor 
protein which is N- glycosylated. Pulse -chase experiments with rat aortic 
smooth muscle cells have established that the 50 kDa precursor protein is 
processed to the mature 32 kDa form by removal of an N- terminal 
propeptide (Trackman et al., 1992). There is also a putative, 21 residue, N- 
terminal signal peptide (Trackman et al., 1992). The putative cleavage site 
for removal of the propeptide has been predicted to be between Arg 134 
and Arg 135 in the rat sequence, based on the calculated mass of the 
mature protein (Trackman et al., 1990). However this predicted position of 
the proteolytic site is not consistent with laser desorption mass 
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spectrometry and amino acid sequencing data, which indicate that the site 
in human lysyl oxidase is between Gly 168 and Asp 169 (A.D. Cronshaw, 
personal communication). 
Potential glycosylation sites within the lysyl oxidase sequence (Asn- 
Arg-Thr) occur at positions 91 -93 and 138 -140 in the rat sequence and 
position 97 -99 in human lysyl oxidase. Incubation of the 50 kDa precursor 
form of rat lysyl oxidase with glycopeptidase F reduced its molecular mass 
to 45 kDa (Trackman et al., 1992), while similar incubation of 
glycopeptidase F with the 32 kDa form had no effect on molecular mass. 
This indicated that only the 50 kDa precursor form was N- glycosylated 
even though the second potential glycosylation site lies beyond the 
processing site of the mature sequence as predicted by Trackman et al., 
(1990; Arg 134 -Arg 135). 
1.5 Tyrosine rich acidic matrix protein 
A protein that co- purifies with porcine skin lysyl oxidase has recently 
been isolated that has a molecular mass of 22kDa, and contains an 
abundance of tyrosine residues (11%; Cronshaw et al., 1993). This protein, 
named Tyrosine Rich Acidic Matrix Protein (TRAMP), is the same as a 
protein isolated from bovine skin that co- purifies with dermatan sulphate 
proteoglycans (Neame et al., 1989), and the human equivalent has 
recently been named Dermatopontin' (Superti -Furga et al., 1993). 
Other proteins about the same size as TRAMP have previously been 
observed to co- purify with lysyl oxidase. Sullivan and Kagan, (1982) 
observed a 24 kDa protein in extracts of bovine aorta. Proteolytic digests of 
this protein showed it to be very similar to lysyl oxidase, and the amounts of 
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the protein increased during storage of the enzyme. Lysyl oxidase from 
human placenta is also contaminated by a similar 23 kDa protein that 
cross -reacts with polyclonal antisera raised against the pure enzyme. The 
quantity of this protein also increased during storage of lysyl oxidase 
(Kuivaniemi et al., 1984). Furthermore, a monoclonal antibody raised 
against bovine aortic lysyl oxidase has also been shown to cross -react with 
a 24 kDa protein (Burbelo et al., 1986). Wakasaki and Ooshima, (1990b) 
also observed a 24 kDa protein that co- purified with lysyl oxidase from 
human umbilical cord. Amino acid analysis and peptide maps produced 
using S. aureus V8 protease showed that this protein closely resembled 
lysyl oxidase. TRAMP however has recently been found to contain no 
sequence homology with lysyl oxidase and is therefore a distinct protein 
(Cronshaw et al., 1993). 
TRAMP contains three large homologous domains, each with the 
repeating sequence Asp- Arg- Glx- Trp -Asn / Gln / Lys -Phe / Tyr. A scheme 
put forward by Neame et al. (1989), in which the disulphide bridge 
arrangement within TRAMP places one of these repeats in each of three 
loop structures, raises the possibility that these motifs interact with other 
molecules within the extracellular matrix. 
Five variants of TRAMP have been resolved by mono Q ion- exchange 
FPLC (Cronshaw et al., 1993). The five types have distinct isoelectric 
points, ranging from pl 4.1 -4.4, but have identical electrophoretic mobility 
on SDS -PAGE and reverse -phase chromatography elution. TRAMP 
appears to be sulphated since it stains with Alcian blue, and sulphatase 
treatment reduces this staining significantly. The sulphation is probably 
associated with the tyrosine residues because acid hydrolysis reduces the 
staining, consistent with the susceptibility of the tyrosine ester bond to acid 
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hydrolysis (J.R.E. MacBeath, personal communication). 
The biological significance of TRAMP is currently under investigation. It 
has been found to accelerate the formation of type I collagen fibril 
formation in vitro by reconstituting fibrils of lathyritic rats in warm start 
conditions (MacBeath et al., 1993). This acceleration was observed at low 
concentrations of TRAMP, a molar ratio of 1 : 20 (TRAMP : Type I collagen). 
All the TRAMP variants were found to accelerate the fibril formation. 
TRAMP contains the putative topaquinone incorporation consensus 
sequence Asn- Tyr -Asp, associated with copper dependent amine 
oxidases. The sequence Tyr -Asn- Tyr- Asp -Tyr incorporating the consensus 
sequence in TRAMP is the same as that in pig kidney amine oxidase 
(Janes et al., 1992). 
1.6 Aims of the present study 
In the first part of the project, the aims were to determine whether 
TRAMP is a degradative product of lysyl oxidase, since proteins (22 -24 
kDa) that co- purified with lysyl oxidase in human umbilical cord were found 
to closely resemble the enzyme (Burbelo et al., 1986; Wakasaki and 
Ooshima, 1990b); to find out how widespread TRAMP is in different tissues, 
and to discover whether TRAMP had any enzymatic activity on collagen, 
since previous studies had shown that TRAMP accelerates collagen fibril 
formation in vitro (MacBeath et al., 1993). 
A further aim of the project was to produce a radiolabeled fragment of 
rat aorta lysyl oxidase cDNA, which could be used to probe a human 
placental cDNA library, and obtain the sequence of human lysyl oxidase 
precursor DNA. Mature human placental lysyl oxidase could then be 
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amplified using PCR and cloned into a yeast shuttle vector for production 
and secretion of mature lysyl oxidase in S. cerevisiae. This work would 
remove the necessity for 6M urea during the purification of lysyl oxidase, 
and would allow genetic manipulation of the enzyme using recombinant 
DNA technology. 
Finally, an investigation was to be undertaken of urea extracts from 
porcine skin that had been found to contain no endogenous lysyl oxidase, 
but were able to enhance lysyl oxidase catalysed tritium release from [4,5- 




Materials and Methods 
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2.1 Preparation of Lysyl oxidase and TRAMP 
2.1.1 Materials 
Stillborn piglets were obtained from the Animal Breeding Research 
Organisation, Dryden -Montmarle Field Laboratory, Roslin, Midlothian. 
Materials for chromatography, including columns and media were from 
Pharmacia ,/ LKB, Milton Keynes. AG 501- X8 mixed bed resin was from 
Bio -Rad, Hemel Hempstead. All other chemicals (analytical grade), unless 
otherwise stated, were from BDH, Poole, Dorset. 
2.1.2 Procedure 
All the following steps were performed at 0 -4 °C. Lysyl oxidase was 
purified from the skins of stillborn piglets using a modification of the method 
of Shackleton and Hulmes (1990a). 
The skins from five fresh stillborn piglets (wet weight 450g) were 
washed with water then minced with a hand mincer and homogenised into 
500mis of 0.15 M NaCI, 1mM PMSF, 10mM sodium phosphate, pH 7.8 
(PBS) using a 4 litre Waring blender. The homogenate was centrifuged in 
six 250m1 Nalgene centrifuge tubes at 12400g for 20 minutes. Fatty 
deposits were removed, and the pellets were rehomogenised and 
centrifuged again. 
The pellets were washed twice in 10mM sodium phosphate, pH 7.8 
(PB) containing 1mM PMSF, and homogenised into 6M Urea, 10mM 
sodium phosphate, pH 7.8 (PBU) containing 1mM PMSF. Lysyl oxidase is 
40 
soluble only in the presence of high concentrations of urea (Narayanan et 
al., 1974; to remove traces of cyanate, urea stock solutions were passed 
through a column of AG 501- X8 mixed bed resin (1.6cm x 15cm) 
immediately prior to buffer preparation). Three sequential extracts in PBU 
were made, over 16 hrs, 8 hrs and 16 hrs. Homogenates were centrifuged 
as above and the supernatants were pooled. After filtering twice through 
Whatman No.1 paper, the pooled extracts were loaded onto a DEAE- 
Sepharose Fast flow ion exchange column (2.6 x 40 cm), pre -equilibrated 
with PBU, at a flow rate of 30 mis / minute, followed by washing in PBU. 
Elution of the protein containing fractions with PBU containing 0.5 M NaCI 
at a flow rate of 25 mis / minute was monitored by absorbance at 280 nm 
on an LKB Ultraspec II spectrophotometer. Protein containing fractions 
were pooled and dialysed exhaustively against PB. The small precipitate 
formed during dialysis was removed by centifugation at 12400 g for 20 
minutes and the remaining solution was loaded onto a Sephacryl S -400 
column (2.6 x 40 cm) pre -equilibrated with PB. When run in these buffer 
conditions, the Sephacryl S -400 acts as an "affinity" column, giving 
purification of almost 140 fold (Shackleton and Hulmes, 1990a). The 
column was loaded at 10 mis / minute, washed in PB and eluted with PBU 
at a flow rate of 10 mis / minute. 
The fractions produced from this step were then run on SDS -PAGE to 
identify lysyl oxidase and TRAMP. Protein containing fractions were 
assayed for lysyl oxidase activity. The protein concentration in the fractions 
was measured using the Bradford (1976) assay. Lysyl oxidase and TRAMP 
samples were stored at -20 °C. 
This purification procedure produced lysyl oxidase fractions 
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contaminated by large quantities of TRAMP. Improvements in the 
procedure to separate these proteins are described in section 5.1. 
2.2 Protein assay 
Protein concentrations of each sample were determined using the 
Bradford assay (Bradford, 1976). A standard curve of protein 
concentrations was set up using 10 -1001.1g of bovine serum albumin (BSA; 
Sigma) diluted in 0.15 M NaCI. To each protein sample (100 µl), 1 ml of 
Bradford reagent (0.01% (w /v) Coomassie Brilliant Blue G -250, 4.7% (v /v) 
ethanol; 8.5% (v /v) phosphoric acid) was added, mixed and incubated at 
room temperature for 30 minutes. Absorbance at 595nm was then 
recorded using an LKB Ultraspec II spectrophotometer. Protein 
concentrations of samples were determined by comparing absorbance at 
595nm with the BSA samples on the standard curve. 
2.3 Preparation of [4,5 -3H] lysine labelled elastin substrate 
2.3.1 Materials 
Seventeen day old chicks were supplied by Ross Breeders, 
Newbridge, Midlothian. MEM Select -amine kits were from GIBCO, Paisley, 
Srathclyde. BAPN (fumarate salt) was from Sigma Chemical Co., Poole, 
Dorset. All other reagents (analytical grade), unless otherwise stated, were 
from BDH, Poole, Dorset. 
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2.3.2 Elastìn purification procedure 
The [4,5 -3H] lysine labeled elastin was prepared essentially as 
described (Pinnell and Martin, 1968). Modified -MEM was prepared without 
lysine, but supplemented with 50µg / ml ascorbic acid, glycine, alanine, 
valine and proline to increase the yield of elastin (Shackleton and 
Hulmes,1990b).The lathyrogen ß- aminopropionitrile (0.2mM) was also 
added to the incubation medium to inhibit endogenous lysyl oxidase 
activity. 
2.3.2.1 Dissection and radiolabeling 
The thoracic arteries from 10 dozen 17 -day chick embryos were 
removed and placed into petri- dishes containing incubation medium. The 
arteries were washed twice in fresh medium, then placed in 300 ml of 
modified MEM using a 500 ml autoclaved Erlenmayer flask (Nalgene). The 
flask was gassed for 1 min with 5% CO2 / 95% air and then incubated (at 
100 rpm in a Labtherm orbital shaker) for 1 hour to deplete the tissues of 
lysine. The arteries were then transferred to fresh medium containing 55 
MBq [4,5 -3H] lysine per 100 mis. The arteries were then re- gassed and 
incubated overnight. 
2.3.2.2. Extraction of elastin 
The thoracic arteries were drained and washed with several changes 
of cold distilled water. They were then homogenised in 50 ml of 150 mM 
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NaCI on ice and centrifuged at 10,000g for 5 minutes at 2 °C. The 
supernatant was discarded and the pellet re- homogenised as before. The 
pellet was then homogenised in 1N HCI, and centrifuged as before. This 
step was repeated. Finally, the pellet was homogenised in 150 mM NaCI, 
100 mM sodium borate pH 8.0 (assay buffer) and centrifuged. This step 
was repeated. 
A 1000 sample of the elastin produced was added to 9000 Ultima Gold 
liquid scintillation cocktail (Packard), and 3H counts were determined using 
a Packard 1900 CA liquid scintillation analyzer, assuming 60 % counting 
efficiency. The concentration of the labeled elastin was adjusted with assay 
buffer to give 3 x 105 dpm per 1004 
During storage at -20 °C, the elastin became increasingly insoluble and 
therefore it was re- homogenised in assay buffer immediately before use. 
2.4.1 Preparation of [4,5 -3H] lysine labelled collagen substrate 
The [4,5 -3H] lysine labeled collagen was prepared essentially as 
described (Siegel, 1974). Calvaria from 10 dozen 17 day old chick 
embryos were removed and incubated in lysine -free MEM supplemented 
with glycine, alanine, valine, proline, ascorbate and ß- aminopropionitrile 
as above. The calvaria were washed in fresh medium, then pre- incubated 
and labelled with [4,5 -3H] lysine as above (section 2.3.2.1). 
2.4.2 Extraction of collagen 
The calvaria were washed three times in Hanks' balanced salt solution 
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(HBSS; GIBCO), and then homogenised with a Polytron homogeniser in 
20 ml of 1M NaCI, 20mM EDTA, 10mM NEM, 1mM PMSF, 50 mM Tris, pH 
7.5. The homogenate was then diluted to a total volume of 200 ml with 
water and extracted at 4 °C overnight, followed by centrifugation at 28,000g 
for 10 minutes. The supernatant was precipitated overnight after the 
addition of 3.5 M NaCI, and this was centrifuged at 28,000g for 10 minutes. 
The pellet was then washed in 200m1 of 3.5 M NaCI, 50 mM tris, 20mM 
EDTA, 10mM NEM, 1mM PMSF, pH 7.5 and centrifuged at 28,000g for 10 
minutes and then resuspended overnight in 10 ml of PBS (100 mM 
NaH2PO4, 0.15 M NaCI, pH 7.8), with continuous rotation. The solution was 
dialysed against PBS exhaustively, and finally centrifuged at 37,000g for 
20 minutes. The concentration of the labeled collagen was adjusted with 
PBS to give 342,000 cpm per 100µI. The radiolabelled collagen was then 
aliquoted, and stored at -30 °C. 
2.5 Lysyl oxidase assay 
2.5.1 Introduction 
The method used to assay lysyl oxidase is a modification of the 
procedure developed by Pinnell and Martin (1968). Lysyl oxidase activity 
is measured by the release of tritium from allysine, which is formed by lysyl 
oxidase catalysed oxidation of the [4,5 -3H] labeled lysine in the elastin 
substrate. The keto form of allysine produced during the reaction 
undergoes keto -enol tautomerism, with the result that a tritium atom is 
released from the 5- position to become incorporated into water. Tritiated 
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water is subsequently isolated and measured for radioactivity. 
2.5.2 Lysyl oxidase reaction 
Lysyl oxidase assays were routinely performed in duplicate (protocols 
1 a and 1 b). Prior to each assay, the [4,5- 3H]lysine labeled elastin was 
homogenised in assay buffer. Aliquots of 100 µI of elastin substrate with a 
specific activity of 3000 dpm / pi were added to 70011I assay buffer in 1.5 ml 
Eppendorf plastic tubes. Typically, 2µg of lysyl oxidase were added to the 
assay mixture and the total reaction volume was always adjusted to 900µI 
with PBU. Control assays were performed without enzyme to allow 
calculation of basal tritium release. The contents of the Eppendorf tube 
were mixed by vortexing, then incubated at 37 °C for 16 hours. 
Trichloroacetic acid (50 % w /v) was then added to each tube to a final 
concentration of 5% (w /v), to precipitate high molecular weight, tritium 
labelled protein. The reactants were then centrifuged at 15400g for 5 
minutes. 
2.5.3 Isolation of tritiated water by ultrafiltration and 
microdistillation 
Following centrifugation, two methods for isolation of tritiated water 
were utilized. The first method, ultrafiltration, is based on the filtration of 
tritiated water through the membrane of a Millipore Ultrafree -MC filter unit 
with a cut off point of 10,000 Da (Shackleton and Hulmes, 1990b; protocol 
la). The pore size of this filter also allows small, labelled peptides to pass 
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To a 1.5 ml Eppendorf tube, add: 
Elastin: 100µI (3000dpm / µl) of [4,5-3H] lysine labelled elastin. 
Lysyl oxidase: 100111 
Assay buffer: 700µI 
1. Vortex mix the reactants, and incubate for 16 hours at 37 °C. 
Add trichloroacetic acid 50% (w /v) to each tube to give a final volume of 
5% (w /v). 
2. Centrifuge the sample tubes at 15400g for 5 minutes. Transfer 4000 of the 
supernatant into a Millipore Ultrafree -MC filter unit (10,00 kDa cut off 
point), and centrifuge in a Beckman JA 18.1 rotor at 5000g for 90 minutes at 40C. 
3. Remove 300µI of the filtrate from each filter unit and add 2.7 ml Ultima Gold 
liquid scintillation cocktail (Packard). 
4. Count 3H in a Packard 1900 CA liquid scintillation counter. 
Protocol la. Lysyl oxidase assay using ultrafiltration (Shackleton and Hulmes, 1990b). 
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To a 1.5 ml Eppendorf tube, add: 
Elastin: 10011I (3000dpm / µl) of [4,5 -3H] lysine labelled elastin. 
Lysyl oxidase: 2µg 
Assay buffer: 7000 
1. Vortex mix the reactants, and incubate for 16 hours at 37 °C. 
Add trichloroacetic acid 50% (w /v) to each tube to give a final volume of 
5% (w /v). 
2. Centrifuge the sample tubes at 15400g for 5 minutes. Transfer 800µI of the 
supernatant into a pyrex boiling tube with 5 -10 anti -bumping granules 
(BDH). 
3. Set up the microdistillation apparatus is set up as below under vacuum . 
I vacuum 
37c 
16 hrs 100.c 70c 
4. Heat the boiling tube at 1000C for 5 minutes, and then seal the cooled collecting 
tube with Nescofilm until the distillate has thawed. 
5. Take 300µI of the distillate and add 2.7 ml of Ultima Gold 
liquid scintillation cocktail (Packard). 
4. Count 3H in a Packard 1900 CA liquid scintillation counter. 
Protocol 1b. Lysyl oxidase assay using microdistillation (Pinnell and Martin, 1968). 
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through, which may raise the radioactive background in the filtrate. This 
method is convenient however, and it was used when a large number of 
samples required to be assayed rapidly. 
The second method of isolation involves evaporation of tritiated water 
in a microdistillation apparatus (Pinnell and Martin, 1968; protocol 1 b). The 
reactants are heated to 100 °C under vacuum in the presence of anti - 
bumping granules. The tritiated water then condenses in a separate part of 
the apparatus cooled to -700C. Theoretically only tritiated water should be 
collected using this procedure leading to a lower background level of 
radioactivity. The lathyrogen BAPN (0.2 mM), which inhibits the activity of 
lysyl oxidase completely, was routinely included in separate assays as a 
control. 
2.6 Peroxidase coupled lysyl oxidase assay 
2.6.1 Introduction 
Lysyl oxidase was also assayed by measuring the hydrogen peroxide 
released during oxidation of the artificial substrate 1,5- diaminopentane 
(Trackman et al., 1981). The reaction was coupled to the peroxidase 
catalysed oxidation of homovanillate to a molecule that fluoresces at 
excitation and emission wavelengths of 315nm and 425nm, respectively. A 
Perkin -Elmer LS -3B fluorimeter was fitted with a heating block apparatus 




To calibrate the fluorimeter, horse radish peroxidase type VI A (204) 
and homovanillate (12511g; both obtained from Sigma) were heated to 
52 00 in 1 ml assay buffer (section 2.4.2) in a cuvette. Aliquots of 0.2 
nmoles H2O2 were then added to the reactants to obtain a standard plot 
relating fluoresence to the amount of H2O2. 
2.6.3 Determination of activity 
The lysyl oxidase substrate 1,5- diaminopentane (175µg) and lysyl 
oxidase (typically 24) were added to the reactants, and a fluoresence 
reading was recorded every three minutes. The baseline fluoresence in the 
absence of lysyl oxidase was also monitored and subtracted from the final 
activity curve obtained. 
2.7 Preparation of polyclonal antibodies against TRAMP 
TRAMP was purified by the procedure above (section 2.1) and by anion 
exchange Mono Q FPLC to separate the protein from lysyl oxidase (This 
final purification step and antibody preparation were done in collaboration 
with Mr J.R.E. MacBeath). Two female New Zealand white rabbits were 
obtained (City Farms, West Calder) and a sample of pre- immune serum 
was taken from each rabbit. Polyclonal antibodies were raised by the 
methods described by Harlow and Lane, (1988). Intradermal injection of a 
1:1 mixture of 2004 purified TRAMP in 0.15 M NaCI and complete 
Freund's adjuvant (Sigma) was followed up four weeks later by a boost of 
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100µg of TRAMP mixed with incomplete Freund's adjuvant also in a 1:1 
ratio. Thereafter, four, six week booster injections of 50µg of TRAMP mixed 
with incomplete Freund's adjuvant were administered. 
Blood samples (10 mis) were taken from the rabbits at intervals of 10 
days after each injection and screened for anti -TRAMP polyclonal 
antibodies. Exsanguination of the rabbits two weeks after the final boost, 
produced around 30 mis of serum from each rabbit. Blood was clotted at 
37 °C for 30 minutes, stored overnight at 4 °C and centrifuged at 10,000g for 
10 minutes. Serum was collected from this, and 1001.I aliquots were stored 
at -30 °C until required. 
2.8 Preparation of crude samples for blotting 
For the detection of TRAMP in tissue extracts by Western blotting, 
tissues were dissected from 21 day mice and stillborn piglets, and 
weighed. Approximately 1.0g of each tissue was homogenised into 2ml of 
PBU and extracted at 4 °C for 24 hours. Bone tissue was pre- frozen in 
liquid N2 and shattered into fine pieces using an impact pulverising device. 
The extracts was then centrifuged at 12400g for 20 minutes, then the 
supernatant was collected and measured for protein content in a 
spectrophotometer at 280 nm. Approximately 100 µg of protein from each 
sample was run on a discontinuous 12% SDS -PAGE gel before western 
blotting. 
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2.9 Western blotting 
Rabbit antiserum was tested for its reactivity against TRAMP by 
Western blotting. Samples of pure TRAMP and crude extracts from porcine 
skin, and various murine tissues (described above) were run on SDS- 
PAGE. Proteins were then transferred to nitrocellulose by immunoblotting 
(Towbin et al., 1979) . 
The gel was sandwiched between Whatman chromatography paper 
and a nitrocellulose sheet (pore size 0.45µm ; Sartorius) in a Bio -Rad 
Trans -blot cell which allows complete immersion of both gel and 
nitrocellulose during protein transfer. The blotting apparatus was set up as 
follows. A locking gel holder was opened, and submerged flat in a tray 
containing blotting buffer. A Scotch brite porous fibre pad was placed on 
this and air bubbles were expelled. Whatman chromatography paper with 
slightly larger dimensions than the protein gel (15 cm x 18 cm) was placed 
on top. The protein gel was laid on top of this carefully avoiding any air 
bubbles. The nitrocellulose sheet was carefully positioned on the protein 
gel and a further sheet of chromatography paper and Scotch brite were 
laid on top before closing the gel holder. The trans -blot cell tank was filled 
with blotting buffer (0.16 M sodium phosphate, 20% methanol (v /v) pH 9.4) 
and the gel holder was locked into position inside. A constant current of 
250mA was applied, and proteins were transferred to the nitrocellulose 
(negative to positive) over 16 hours. 
Detection of the immobilized protein was carried out using an 
Amersham ECL kit and protocol. ECL detection relies on the oxidation of 
luminol (a cyclic diacylhydrazide) by H2O2, catalysed by horseradish 
peroxidase (attached to the second antibody). Light is emitted during the 
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reaction and in the presence of enhancers contained in the kit, the light 
output is increased up to 1000 fold and light decay is reduced substantially. 
The nitrocellulose was removed from the tank after transfer, and 
subjected to temporary staining with 0.4% (w /v) Ponceau S, 3% TCA (w /v). 
Ponceau S allows confirmation of successful transfer, and can be removed 
by washing with several changes of TBS (137mM NaCI, 20mM Tris -HCI, 
pH7.6). The destained nitrocellulose sheet was blocked with TBS -T (TBS, 
0.2% Tween 20 (v /v) ) and 5% Marvel (w /v), for 1 hour. The nitrocellulose 
was then washed in TBS -T, once for 15 minutes and then twice for 5 
minutes. The antiserum from the final rabbit bleed was diluted typically 
1:10000 in TBS -T and the nitrocellulose was incubated in this for 1 hour. 
Pre -immune serum taken from the animals before immunization was used 
as a control. Three washing steps in TBS -T were followed by incubation 
with the second antibody, horseradish peroxidase coupled anti -rabbit IgG 
(Scottish Antibody Production Unit, Law hospital, Carluke, Lanarkshire) for 
20 minutes. After washing again as before, the ECL reagents were mixed 
in a 1 : 1 ratio and a volume equal to 0.125 ml / cm2 of nitrocellulose was 
added to the blot for exactly 1 minute. ECL mix was then allowed to drip off 
the blot before it was laid down on Saran wrap inside a Kodak X- Omatic 
cassette, and then covered with more Saran wrap being careful to exclude 
air bubbles. Care was also be taken to avoid letting the blot dry. Exposure 
was for 30 seconds (or more) to pre -flashed X -ray film (Amersham) which 
was developed in an X- Ograph Compact X2 film processor. 
53 
2.10 SDS -PAGE 
2.10.1 Introduction 
Protein separation and visualization is possible using discontinuous 
sodium dodecyl sulphate -polyacrylamide gel electrophoresis (SDS -PAGE) 
as first described by Laemmli (1970). This technique separates protein 
molecules by size alone, as SDS binds to and denatures proteins causing 
them to migrate with a constant charge /mass ratio. Mercaptoethanol is 
used in the procedure to cleave disulphide bonds. SDS -PAGE is calibrated 
by running standards of known molecular weight, and plotting migration 
distance versus log molecular mass. 
2.10.2 Procedure 
Throughout the study 12% polyacrylamide gels were used, unless 
stated otherwise. This concentration of acrylamide is effective for the 
separation of proteins with molecular masses between 90 kDa- 15kDa. 
Gels were prepared as described in protocol 2. 
Reducing sample buffer (5x) was added to the protein samples giving a 
final concentration of 25mM Tris -HCI, 2% SDS (w /v), 0.01% bromophenol 
blue (w /v), 10% glycerol (v /v), 3% ß- mercaptoethanol (v /v) pH 6.8. These 
samples were boiled for 3 minutes and loaded on to the polyacrylamide 
gel, which was run in a water cooled LKB vertical gel electrophoresis 
apparatus at a constant current of 40 mA per gel, with an LKB 2002 power 
supply. Each gel was run for 3 hours or until the tracking dye front was 1 
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cm from the bottom of the gel. 
2.10.3 Gel staining 
Once run, gels were removed from the apparatus, fixed and stained 
with 0.25% (w /v) Coomassie Brilliant Blue -250, 50% (v /v) methanol, 10% 
(v /v) acetic acid for 12 hours, shaking slowly on a Denley reciprocal mixer. 
Unbound stain was removed with several changes of 7.5% (v /v) acetic 
acid, 5% (v /v) methanol over 12 hours. Coomassie blue stain was re -used 
several times. The lower limit of protein detection using this staining 
procedure is about 1µg of protein. 
Silver staining was used when greater detection sensitivity was 
required. Silver staining can detect about long of protein in a band 
(Andrews, 1986). The method is adapted from Morrissey (1981). Gels were 
fixed in three changes of 25% (v /v) methanol, 10% (v /v) acetic acid for 3 
hours and then washed in distilled water for 1 hour. The gel was then 
incubated in 0.1% (w /v) silver nitrate for 2 hours and washed twice in 
distilled water. The gel was developed in 200 ml of 0.02% (v /v) 
formaldehyde, 3% (w /v) sodium carbonate until the stained protein bands 
became visible. To stop the developing reaction, 2.3 M citric acid was 
added for 30 minutes, and finally, the gel was placed into 2% (v /v) glycerol 
for 2 hours before drying. 
2.11 TRAMP incubation with [4,5 -3H] lysine labelled collagen 
[4,5 -3H] lysine labelled collagen (12µg) labelled with (100µl) in PBS 
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1. Add 20% (w /v) SDS to each protein sample to give a final SDS concentration of 
2 %. 
2. Add 5x reducing sample buffer (50% (v /v) glycerol, 2% SDS, 15% (v /v) (- 
mercaptoethanol, 0.05% (w /v) bromophenol blue, 125 mM Tris -HCI, pH 6.8). 
3. Heat the samples to 100 0C for 3 minutes. 
4. Load samples on to a discontinuous gel consisting of a12% separating gel (12% 
(w /v) acrylamide, 0.32% (w /v) bis -acrylamide, 0.2% SDS, 0.05% (w /v) ammonium 
persulphate, 0.0005% (v /v) N, N, N ',N'- tetramethylethylenediamine (TEMED),125 
mM Tris -HCI, pH 8.8) and 4.5% stacking gels (4.5% (w/w) acrylamide, 0.12% (w /v) bis - 
acrylamide, 0.2% SDS, 0.05% (w /v) ammonium persulphate, 0.0005% (v /v) N,N,N',N'- 
tetramethylethylenediamine (TEMED),125 mM Tris -HCI, pH 6.8). 
5. Carry out electrophoresis with a water cooled vertical electrophoresis unit 
approximately 3 hours at a constant current of 40 mA per gel in running buffer 
(0.192 M glycine, 0.1% SDS, 0.025 Tris, pH 8.3). Turn the current off when the 
dye front is 1cm from the bottom. 
Protocol 2. SDS -polyacrylamide gel electrophoresis (Laemmli, 1970). 
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was incubated with TRAMP (2 N.g), in PBS pH 7.8 (final volume of 150 µl) 
overnight at 37 °C. A control sample without TRAMP was also incubated. 
Reducing sample buffer (5x) was then added to the reactants, followed by 
electrophoresis on a 6% SDS -PAGE gel. To visualise radiolabeled 
proteins by fluorography (Laskey and Mills, 1975), the gel was then soaked 
in 200 ml DMSO for 30 mins followed by a further 30 mins in fresh DMSO. 
The gel was then immersed in 200 ml of 20% (w /v) PPO in DMSO for 3 
hours. A wash in 200m1 of 10% methanol, 0.1% glycerol for 1 hour was 
followed by drying the gel under vacuum. Finally, the gel was placed in 
contact with Hyperfilm -MP pre -flashed X -ray film (Amersham) and exposed 
for 48 hours before being developed in an X- Ograph Compact X2 film 
processor. 
2.12 Trypsin digestion 
Lysyl oxidase stimulating fractions (each approximately 20 µg of 
protein) eluted from Sephacryl S -400 in 6M PBU were incubated with 25 
µg of bovine pancreatic trypsin (GIBCO) in a total volume of 1.0 ml for 6 
hours at 37 °C. After incubation, 200µg of Soybean trypsin inhibitor type I -S 
(Sigma) were added, and the incubation continued for 30 minutes to inhibit 
further trypsin activity. A control sample of PBU was also incubated with 
trypsin and Soybean trypsin inhibitor as above. Finally, trypsinized and 
non -trypsinized samples were assayed with lysyl oxidase to determine any 
activity change. 
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2.13 Preparation of the rat aorta lysyl oxidase cDNA probe 
LOF 1 
All reagents, media, solutions, pipette tips, centrifuge tubes and 
Eppendorf tubes were autoclaved for 15 minutes at 15 psi before use. 
2.13.1 Library titre determination 
A Sprague -Dawley neonatal rat Xgt11 cDNA library (Clontech) was 
obtained and titred. The manufacturer recommends that libraries are titred 
before use by infecting E.coli Y1090 cells (Clontech; Table 4.1) as follows 
(Manufacturers protocol). A streak culture of Y1090 was prepared on LB 
agar plates (1% (w /v) tryptone, 0.5% (w /v) yeast extract, 1% (w /v) sodium 
chloride and 2% (w /v) bacto agar) 2 -4 days old, and incubated overnight at 
37 °C. One cell colony was used to inoculate 50 ml of LB -broth (1% (w /v) 
tryptone, 0.5 %(w /v) yeast extract and 1%(w/v) sodium chloride) 
supplemented with 0.2% (w /v) maltose to induce the E.coli maltose operon 
which contains the lamB gene coding for the bacteriophage X receptor, 
therefore allowing more efficient adsorption of x. The inoculated LB -broth 
was shaken overnight at 370C to produce a cell culture which was then 
centrifuged at 4000g for 10 minutes and the pellet produced was 
resuspended in 10mM magnesium chloride, and vortex mixed. The cells 
were incubated for 1 hour at 37 °C. 
Cell dilutions of 102 -104 were set up in X dilution buffer (0.1 M NaCI, 
0.2% (w /v) MgSO4 -7 H2O, 2% (w /v) gelatin, 20mM Tris -HCI, pH 7.5). Top 
agar (1% (w /v) tryptone, 0.5% (w /v) yeast extract, 1% (w /v) sodium chloride 
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and 0.7 % (w /v) bacto agar) was prepared and incubated at 50 °C. Then 
350 of 5- bromo -4- chloro -3- indolyl -ß -D- galactopyranoside(X -Gal; 40mg /ml, 
dissolved in dimethylformamide) was added to 3ml of top agar, followed 
immediately by mixing with each cell dilution and pouring on to LB -agar 
plates. The plates were incubated at 37 °C for 12 -16 hours. 
2.13.2 cDNA library amplification 
Amplification of the cDNA library is necessary to maintain its stock 
(Sambrook et al., 1989). A quantity of cDNA library containing around 105 
bacteriophage (20) was mixed with 6000 of E.coli strain Y1090 in LB- 
broth. This was incubated for 20 minutes at 37 °C, and plated on to NZCYM 
agar (1% (w /v) casein enzymatic hydrolysate, 0.5% (w /v) bacto yeast, 0.5% 
(w /v) NaCI, 0.1% (w /v) MgSO4.H2O, 0.05% (w /v) casamino acids, pH7.0), 
which was incubated at 42 °C for 12 hours to prevent lysogeny (in this A. 
vector, the repressor for lytic growth is temperature sensitive). The 
bacteriophage were then collected by adding 15 ml of SM buffer (100mM 
NaCI, 0.2 % (w /v) MgSO4.H2O , 0.01% (w /v) Gelatin, 50mM Tris.HCI, pH 
7.5) on top of the agar and incubating this for 2 hours at room temperature. 
The SM buffer was then poured off and centrifuged at 7000g for 30 minutes 
to pellet the cell debris. The supernatant was collected, aliquoted and titred 
as before. 
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2.13.3 Polymerase chain reaction 
2.13.3.1 Introduction 
The polymerase chain reaction (PCR) is a method of quickly and 
efficiently amplifying a small amount of DNA, using a thermostable DNA 
polymerase (Saiki et al., 1985; Mullis et al., 1986; Faloona and Mullis, 
1987). Primers are designed that flank the two ends of the double stranded 
DNA, from which Taq polymerase (a thermostable DNA polymerase) 
synthesises new DNA. The template DNA is denatured at high temperature 
(92- 94 °C), and then cooled to allow annealing of the primers to each of the 
single strands produced (the annealing temperature is usually calculated 
as 5 °C lower than the melting temperature of the primers). The 
temperature is then raised to 72 °C to allow optimal conditions for DNA 
synthesis using the thermostable DNA polymerase, and finally the 
temperature is raised to 94 °C again and the cycle is repeated. After 30 -35 
cycles, the thermostable DNA polymerase eventually loses activity and the 
reaction stops. 
2.13.3.2 Procedure 
From the sequence of rat aorta lysyl oxidase cDNA (Trackman et al., 
1990, 1991), primers for the PCR reaction were designed with the aid of 
Gene Jockey software (Biosoft; L1 and L2, Fig 4.1). A BamHI restriction 
enzyme site was designed into the primers to flank the cDNA fragment 
produced. The melting temperature was calculated to be 68 °C and 56 °C 
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for the 5' and 3' primers respectively (from the formula, Tm = 4 x (C or G) + 
2 x (A or T) ; Innis, 1990) and the PCR reaction was carried out (protocol 3) 
by the method of Friedman et al. (1988) using 50 of neonatal rat xgt 11 
cDNA library (Clontech), previously disrupted by heating at 70 °C for 10 
minutes, as template DNA. 
2.13.4 DNA gel electrophoresis 
2.13.4.1 Introduction 
Separation, identification and purification of DNA fragments (200 bp - 
50 kbp) can be performed quickly and efficiently by electrophoresis in 
agarose gels (Aaij and Borst, 1972). Bands can be visualised by running 
the gels in the presence of ethidium bromide (141.g / ml), and exposure to 
ultraviolet light. 
2.13.4.2 Procedure 
For purification and separation of the lysyl oxidase cDNA fragment, 
0.8 %(w /v) agarose (ultrapure grade, BRL) supplemented with 1µg / ml of 
ethidium bromide was prepared in 50 ml TBE buffer (90 mM orthoboric 
acid, 2.5 mM EDTA, 90 mM Tris HCI, pH 8.0), melted in a microwave and 
poured in a Pharmacia LKB GNA 100 DNA electrophoresis apparatus. TBE 
was used as running buffer, supplemented with 11.ig / ml of ethidium 
bromide. Bacteriophage x DNA digested with BstEll restriction 
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To a 500µI Eppendorf tube, add : 
Template DNA: 51_1I (Xgt 11 cDNA library source, Clontech). 
Buffer : 1011I (500mM KCI, 1% Triton X -100, 100mM Tris -HCI, pH 9.0; Promega). 
Magnesium chloride: 10µI (25mM; Promega). 
Deoxynucleotide triphosphates: 14tI (2 mM; Promega). 
Primers: 1111 (700 µg /ml - 150014/ml; Oswel DNA service). 
DNA Taq polymerase: 1µl (5 units /µl; Promega). 
DNase and RNase free water: to 100µI total reaction volume (Sigma). 
Mineral oil : 100µI overlaying the reaction (Sigma). 
Temperature programme (Techne PHC -2 Dri -block cycler) 35 cycles: 
940C for 1 minute (to denature the double stranded cDNA). 
500C for 2 minutes (to anneal the primers to the denatured cDNA). 
720C for 3 minutes (to extend the primers). 
In the final cycle, increase extension time to 10 minutes. 
Protocol 3. Cold start PCR, adapted from Friedman et al. (1988) 
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endonuclease (GIBCO) was used for size determination of the sample 
DNA. The gel was run at a constant 100 volts for 90 minutes. 
2.13.5 Ligation of LOF 1 into the vector pK19 
The gel band corresponding to the lysyl oxidase cDNA fragment (LOF 
1) was excised from the agarose gel and isolated using a Geneclean kit 
(Bio 101 Inc; protocol 4) to remove contaminating DNA fragments smaller 
than 500 bp, e.g. PCR primers. The DNA was eluted in a final volume of 
200 TE buffer (1mM EDTA, 10mM Tris HCI, pH 8.0). All 200 of LOF1 was 
then subjected to a restriction digest with BamHI restriction endonuclease 
and incubation buffer B (both Boehringer Mannheim) in a 400 reaction 
(200 cDNA, 40 buffer B, 11.1l BamHI, 0.1 mg / ml RNase, 140 water; the 
RNase was supplied courtesy of Dr Alan Boyd, Biochemistry Dept., 
Edinburgh University). This was incubated for 90 minutes at 37°C. This 
cDNA was then purified with a Geneclean kit for the second time to allow 
ligation into a vector. 
The vector used was pK19 (Pridmore, 1987; supplied courtesy of Dr 
Alan Boyd) which is derived from pUC19 (Messing, 1983) and encodes 
kanamycin rather than ampicillin resistance. The pK19 was digested with 
BamHI (200 pK19, 200 buffer B, 1600 water, 10 BamHI, 0.1 mg / ml 
RNase), and incubated at 37 °C for 90 minutes. To remove contaminating 
protein this linearised vector DNA was then extracted in phenol : 
chloroform : isoamyl alcohol (25:24:1), and precipitated in ethanol (protocol 
5). Both LOF 1 and pK19 were run on an agarose electrophoresis gel 
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1. Excise the band of DNA from the agarose gel visualized under ultraviolet light using a 
plastic scalpel (long wave UV light should be used for as short a time as possible to 
avoid damage to the DNA). 
2. Weigh out the excised agarose slice in an eppendorf tube, and add 4.5 times the 
volume of the sodium iodide provided, and 0.5 times the volume of TBE modifier. 
3. Incubate at 45 -55 °C for 2 minutes, vortex mix and return to incubation for a further 5 
minutes or until the agarose has completely melted. 
4. Add 101.1.I of Glassmilk and vortex mix. Incubate on ice for 25 - 30 minutes, vortex mixing 
every 3 minutes. 
5. Centrifuge for 15 seconds at 15400g, and resuspend the pellet in 500µI of New Wash 
(stored at -20 °c) and centrifuge again. Repeat twice. 
6. Re- suspend the final pellet in 20µI of TE buffer pH 8.0 or water and incubate at 
45 -550C for 2 minutes. Centrifuge once more for 30 seconds, and collect the 
supernatant. 
Protocol 4. Purification of DNA using a Geneclean II kit (BIO 101 linc). 
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1. Vortex mix vector DNA with an equal volume of phenol : chloroform : isoamyl 
alcohol (25 : 24 : 1; Sigma) for at least 30 seconds. 
2. Centrifuge the mixture at 15400g for 3 minutes and collect the aqueous layer. 
3. Add volumes of cold ethanol and 3M sodium acetate pH 5.2 equal to 2.5 and 
one -tenth of the aqueous layer, respectively. 
4. Incubate at -70 0C for 20 minutes, then centrifuge at 15400g for 10 minutes. Dry 
the vector DNA in a rotary evaporator and resuspend in TE buffer pH 8.0. 
Protocol 5. Extraction and concentration of vector DNA. 
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to compare the concentrations of each. The ligation reaction was set up 
with 50 LOF 1 cDNA, 10 vector pK19, 10 T4 DNA ligase, 20 ligase buffer 
(Boehringer Mannheim) and 11 µl water, then incubated overnight at room 
temperature. 
2.13.6 Transformation of competent NM 522 E.co/icells 
E.coli cells can be transformed with plasmid DNA if treated with calcium 
chloride to produce a state of `competence' (Cohen et al., 1972). A strain 
of E.coli cells (NM 522; Table 4.1) were prepared for transformation 
(protocol 6) and incubated on ice for 2 hours before use. 
The transformation reaction was then set up using 1000 of competent 
cells added to the total volume of the ligation reaction (section 2.3.5 ). This 
was incubated on ice for 45 minutes, then heat shocked for 2 minutes at 
42 °C followed by addition of 1 ml of LB -broth and further incubation, on a 
shaker, at 37 °C for 1 hour. 
LB -Agar plates supplemented with 0.005% (w /v) X -Gal, 0.003% (w /v) 
IPTG and 0.001 % (w /v) kanamycin were prepared in advance, and 1000 of 
the transformed cells were then spread on to the plates using a sterile 
glass spreader. A concentrated sample of these cells was also plated by 
centrifuging the cells at 6500g for 2 minutes, and resuspending the cell 
pellet in 1000 of LB- broth. The plates were incubated at 37 °C overnight 
(upside down to prevent condensation building up on the plate surface). 
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1. Inoculate LB -broth (10 mis) with E.coli, and incubate overnight. On the 
following day inoculate 50 mis of LB -broth with 0.5 mis of the overnight culture 
and grow until the culture reaches an optical density of 0.4 -0.5 absorbance 
units at 600nm. Place the cells on ice. 
2. Centrifuge at 6000g for 5 minutes, discard supernatant , and re- suspend cells in 
20 mis of cold 100mM calcium chloride. 
3. Centrifuge cells as above and resuspend in 10 mis cold 100mM calcium 
chloride. Leave on ice for 30 minutes then centrifuge at 4000g for 5 minutes. 
4. Gently re- suspend in 1m1 of cold 100mM calcium chloride, and incubate on ice 
for at least 2 hours before use. Ideally, the cells should be left overnight to 
maximise their competence. 
Protocol 6. Preparation of competent E.colicells. 
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2.13.7 Screening cell colonies 
2.13.7.1 Introduction 
Cell colonies can be screened for successful transfection with vector 
incorporating an insert, as follows. pK19 vector carries the first 146 amino 
acids of the f3- galactosidase gene (lac Z), into which a polycloning site 
(including BamHI) is incorporated. When this vector is grown inside a host 
cell strain that carries only the carboxy terminal of ß- galactosidase, a- 
complementation results and functional ß- galactosidase is produced, 
giving blue coloured cell colonies on X -Gal / IPTG agar plates. If however 
a DNA insert is ligated into the polycloning site, the amino terminus of the 
enzyme will be disrupted, and cell colonies produced will be white in 
colour. 
2.13.7.2 Procedure 
White colonies were screened for the correct insert by harvesting and 
lysing the E.co/i cells in a minipreparation of vector DNA (protocol 7 ), and 
performing a restriction digest with BamHI (section 2.13.5), to excise the 
fragment of interest, followed by electrophoresis on a 0.8% (w /v) agarose 
electrophoresis gel. 
A large scale preparation of vector DNA was then carried out on the 
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1. Innoculate 5 mis of LB -broth with one cell colony, and incubate overnight at 
3700. 
2. Pipette 1.5 mis of the overnight culture into an Eppendorf tube and centrifuge at 
15400g for 3 minutes. 
3. Resuspend the pellet in 180pI of lysis solution 1 (50mM Glucose, 10 mM EDTA, 
0.2 %(w /v) lysozyme, 25mM Tris -HCI, pH 8.0) and add 400µI of lysis solution 2 
(0.2 N NaOH, 1% w/v SDS ). 
4. Vortex mix and leave on ice for 5 minutes. 
5. Add 300µI of 3M sodium acetate pH 5.2, mix and leave on ice for 10 minutes. 
6. Centrifuge at 15400g for 10 minutes and remove 750pI of the supernatant, to 
which 500µ.l of propan -2 -ol (isopropanol) is added and vortex mixed. 
7. Centrifuge at 15400g for 5 minutes and resuspend the pellet in 200µI of TE 
buffer pH 8.0. 
8. Add 400µI of phenol : chloroform : isoamyl alcohol (25:24:1), and vortex mix 
hard for at least 30 seconds. Centrifuge as before for 3 minutes and remove the 
aqueous layer which contains the DNA ( this is usually the upper layer) to 
another tube. Add one tenth its volume of 3M sodium acetate pH 5.2, and 2.5 
times volume of ice cold ethanol. 
9. Incubate at -70 °C for 20 minutes and then centrifuge at 15400g for 10 minutes. 
10. Freeze -dry the sample and resuspended in 20 µl TE buffer pH 8.0. 
Protocol 7. Miniprep of vector DNA (Sambrook et al., 1989; Birnboim and Doly 1979; Ish- 
Horowicz and Burke 1981). 
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cell colony containing the insert (protocol 8), to prepare sufficient vector 
DNA for sequence analysis. 
2.13.8 DNA sequence analysis 
The method of DNA sequencing utilized was the dideoxy- mediated 
chain termination method (protocol 9; Sanger et al., 1977; Hsiao, 1991) . 
When a DNA chain is being synthesised by DNA polymerase, the inclusion 
of 2',3' dideoxynucleoside triphosphate (ddNTP) terminates chain growth 
due to the lack of a hydroxyl residue at the 3' position of deoxyribose, and 
hence the inability to form the required phosphodiester bond to the next 
dNTP. This property of ddNTPs is exploited in the Sanger method by 
including a small concentration of one of each type (ddATP, ddGTP, ddTTP, 
ddCTP) in four separate DNA synthesis reactions. During the reactions, 
there is competition between the dNTPs and ddNTPs for inclusion into the 
growing chain, which results in terminations at each site of possible ddNTP 
incorporation along the chains produced. If the reactions are labelled with 
[35S] -d ATP then the different lengths of chain synthesised in each reaction 
can be visualized on a polyacrylamide gel after exposure for 48 hours to 
Hyperfilm MP pre -flashed X -ray film (Amersham), developed in an X -O 
graph Compact X2 film processor. 
DNA primers are required for the sequencing reactions to take place. 
When sequencing a vector insert, a universal primer is often used if the 
vector contains the corresponding sequence: 5'- GTAAAACGACGGCCAGT - 
3'. Although pK19 has the universal priming site, the PCR primer (L1) was 
utilized in the sequencing of pLOF 1. 
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1. Inoculate 100 mis of LB -broth with one cell colony, and incubate overnight at 
370C. 
2. Centrifuge the cells at 6000g for 10 minutes, and resuspend the pellet in 2 mis 
of lysis solution 1 (50mM glucose, 10 mM EDTA, 0.2 %(w /v) lysozyme, 25mM 
Tris -HCI, pH 8.0). Add 4 mis of lysis solution 2 (0.2 N NaOH, (1% w /v) SDS), 
mix by inversion and leave on ice for 10 minutes. 
3. Add 3 mis of ice cold 3M sodium acetate pH 5.2, vortex mix and leave on ice for 
a further 10 minutes. 
4. Centrifuge the cells at 6000g for 15 minutes, remove the supernatant to another 
tube, and to this add an equal volume of phenol : chloroform : isoamyl alcohol 
(25:24:1). Vortex and centrifuge again at 6000g for 10 minutes. 
5. Remove the aqueous layer which contains the DNA and add two volumes of 
ethanol. Leave this at room temperature for 5 minutes. 
6. Centrifuge at 6000g for 10 minutes and remove all supernatant. Resuspend 
the pellet in 5 mis of 70% ethanol, re -vortex and centrifuge again as above. 
7. Remove the supernatant, and dry the pellet in a freeze -drying apparatus. 
Re- suspend the pellet in 500µI TE buffer pH 8.0. 
Protocol 8. Midiprep of vector DNA (Sambrook etal., 1989; Birnhoim and Doly 1979; Ish- 
Horowicz and Burke 1981). 
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Polyacrylamide gel preparation 
1. Prepare a 7M Urea, 5 % polyacrylamide gel solution in 150 ml TBE buffer (90 
mM Tris, 90 mM Orthoboric acid, 2.5 mM EDTA). Degas the solution under 
vacuum for 20 minutes. 
2. To seal the underside of the Bio -Rad IPC gel assembly, combinel0m1 of the gel 
solution with 50µI of 25% (w /v) ammonium persulphate, and 50µI of 0.005% 
(v /v) N,N,N',N' - tetramethylethylenediamine (TEMED). Pour this solution on to a 
sealing strip, and clamp the IPC assembly to this. Let the sealing strip set (2 
minutes). 
3. To prepare the polyacrylamide gel, combine 60 ml of gel solution with 601.1I of 
25% (w /v) ammonium persulphate, and 0.001% (v /v) TEMED. Pour into the IPC 
assembly, leave to set for 60 minutes and then pre -run at 2300 volts (40 Watts) 
for at least an hour before loading samples. 
DNA sample denaturation: 
1. Adjust a sample of 1 -3ng of double stranded DNA from a midi -prep to a final 
volume of 10 µl with TE buffer pH 8.0 
2. Add 21112M ammonium acetate pH 4.5 and 55µI of cold ethanol. Centrifuge for 
5 minutes at 15400g. 
3. Re- suspend the pellet in 200µI of cold 70% ethanol, centrifuge again for 2 
minutes, dry the pellet in a rotary evaporator and then resuspend in 7µI TE pH 
8.0. 
Protocol 9 (part 1). Sequence analysis of double stranded DNA using a Bst DNA 
sequencing kit (BioRad). 
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Primer annealing: 
1. In an Eppendorf tube, mix 2111 5x reaction buffer (100mM MgCl2, 100mM Tris - 
HCI, pH 8.5), 7µI denatured DNA (from above) and 1µI of universal primer (5'- 
GTAAAACGACGGCCAGT-3'; 2.5 ng /µl) and incubate at 75 °C for 5 minutes. 
Allow the mixture to cool. 
2. Add 1.5 pi [a35S] dATP and 1µI Bst DNA polymerase (1 unit / pi) , vortex and 
centrifuge for 2 - 3 seconds. 
Sequencing: 
1. Label four eppendorf tubes A, G, C, T , and add 2µI of one of the pre -mixed 
nucleotide solutions to each tube i.e. A mix contains 620 nM dATP, 62 µM dCTP, 
62 µM dGTP, 62 µM dTTP, 25 µM ddATP in 0.15 mM EDTA, 1.5 mM Tris, pH 8.0). 
2. Add 2.5 µl of the annealing mix from above to each and incubate for 2 minutes 
at 65 °C. 
3. Add 2 pi of chase solution (1 mM each dNTP) to each and continue incubation 
at 65 °C for 2 minutes 
4. Add 4 pi of stop solution (95% deionised formamide, 10 mM EDTA, 0.05% 
xylene cyanole FF, 0.05% bromophenol blue) to the side of the Eppendorf, and 
centrifuge to stop the reaction. 
5. Prior to loading onto the polyacrylamide gel, heat the samples to 900C for 2 
minutes. 
Protocol 9 (part 2). Sequence analysis of double stranded DNA using a Bst DNA 
Sequencing kit (Bio -Rad). 
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2.13.9 LOF 1 labelling 
Approximately 8µg (visually determined) of LOF 1 was cut from pK19 
using BamHI as described (section 2.13.5). LOF 1 (0.1µg) was heated to 
100 °C for 3 minutes and then labelled by the method of Feinberg et al. 
(1983) in a reaction with 2µg BSA (Sigma), 2 units of Klenow DNA 
polymerase (Boehringer Mannheim), 2 units a [32P] -dATP (Amersham), 50 
oligo- labelling buffer (0.11 mM dATP, dTTP, dGTP, 30mM MgCl2, 1M Hepes, 
121.IM EDTA, 280 mM Tris -HCI, pH 8.0). The reaction was incubated 
overnight at room temperature, and desalted in a 1m1 column of Sephadex 
G -50 pre -equilibrated in STE buffer (1 mM EDTA, 100mM NaCI, 10mM Tris- 
HCI, pH 8.0). The column was centrifuged at 1000g for 90 seconds to elute 
the labelled DNA, which was then heated to100° C for 7 minutes. 
2.13.10 Human placental cDNA library plating and screening 
A human placental 34 week cDNA library in bacteriophage 
(Clontech) was obtained and used to transfect Y1090 cells. LB -agar plates 
were innoculated with the Y1090 cells, and one colony from this plate was 
used to innoculate LB -media supplemented with 0.2% maltose and 10mM 
MgSO4 and this was cultured overnight. Cells were collected by 
centrifuging at 3000g for 10 minutes and were then resuspended in 5 ml of 
10mM MgSO4. The human placental cDNA library was then diluted in ?, 
dilution buffer 1:10 and 100 of this was added to 1 ml of the cells and 35 ml 
of molten top agarose (1%(w/v) tryptone, 0.5 %(w /v) yeast extract, 1% (w /v) 
sodium chloride and 2% bacto agar) which was then poured onto petri- 
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dishes (30 cm x 30cm) containing L- bottom agar (1% (w /v) tryptone, 
0.5 %(w /v) yeast extract, 1% (w /v) NaCI, 1.5% (w /v) agar) and these plates 
were incubated overnight at 37 °C. 
Nitrocellulose (Sartorious) cut into sheets (30cm x 30cm) were placed 
on top of the plates for 1 minute, and the corners of the filter were marked 
asymetrically with a syringe needle allow later identification of orientation. 
Duplicate plaque lifts for 2 minutes were also taken . The sheets were lifted 
off the plates and placed into denaturing solution (1.5 M NaCI, 0.5 M 
NaOH) DNA side up for 1 minute, then placed into neutralising solution 
(1.5 M NaCI, 0.5 M Tris -HCI pH 7.5) for 5 minutes and lastly, washing 
solution (0.3 M NaCI, 20mM NaH2PO4, 2 mM EDTA pH 7.4) for 5 minutes. 
The DNA was cross -linked to the nitrocellulose using ultra -violet light in a 
Stratagene UV Stratalinker 2400 at full power for 30 seconds. 
The filters were placed into a revolving cylinder in an oven with 50 ml of 
pre- hybridisation solution (0.9 M NaCI, 90mM tri -sodium citrate, 0.25% 
(w /v) bovine serum albumin, 0.25% (w /v) Ficoll, 0.25% (w /v) polyvinyl 
pyrrolidone, 0.5 mM EDTA, 10% SDS) for 50 minutes at 65 °C with 2 mg / 
ml boiled herring sperm DNA and then add the probe DNA and continuing 
the incubation overnight. 
The pre- hybridisation solution was poured off and the filters were 
washed twice in SSC solution (0.9 M NaCI, 90mM tri -sodium citrate, pH 
7.4) for 30 seconds. The filters were then wrapped in cling film and 
developed using Hyperfilm MP X -ray film (Amersham) and processed in a 
X- Ograph compact X2 film processor. 
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2.14 Production of human placental cDNA lysyl oxidase clone 
VLO1 
2.14.1 Introduction 
From the published sequence of human placental lysyl oxidase 
(Hamalainen et al., 1991) new primers (V1 and V2; Fig 4.6) were designed 
to clone human lysyl oxidase using the polymerase chain reaction 
(protocol 3) from valine 167 to the termination codon at position 418. 
2.14.2 Hot start PCR 
`Hot start' (D'Aquila et al., 1991; protocol 10) is a modification to the 
PCR procedure that was used to reduce the amount of spurious DNA 
appearing in some amplifications. According to this procedure, the PCR 
reactants (except for the Taq DNA polymerase) are pre- heated to 95 00 for 
5 minutes to completely denature the double stranded cDNA template, 
before the reactants are cooled to the annealing temperature of the 
reaction and Taq DNA polymerase is added. The reactants are then heated 
to the denaturing temperature again, and the reaction continues as for 
`cold start' PCR. 
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To a 500 µl Eppendorf tube, add: 
Template DNA: 1µI (0.3ng /µ1; human placental Quickclone cDNA, Clontech). 
Buffer : 3µI (500mM KCI, 1% Triton X -100, 100mM Tris -HCI, pH 9.0; Promega). 
Magnesium chloride: 311I (25mM; Promega). 
Deoxynucleotide triphosphates: 311I (2 mM; Promega). 
Primers: 1µI (700 µg/m1- 1500µg /ml; Oswel DNA service) 
DNase and RNase free water: to 30µI total reaction volume (Sigma). 
Mineral oil : 40gI overlaying the reaction (Sigma). 
Temperature programme (Techne PHC -2 Dri -block cycler) 
1 cycle of; 
95 °C for 5 minutes (to completely denature all cDNA) 
60 °C for 2 minutes (add 1µl DNA Taq polymerase; (5units / µl; Promega) 
then 35 cycles of : 
94 °C for 1 minute (to denature the double stranded cDNA) 
600C for 2 minutes (to anneal the primers to the denatured cDNA) 
72 °C for 3 minutes (to extend the primers). 
After 15 cycles, add a further 1µI of Taq DNA polymerase to each tube. 
In the final cycle, increase the extension time to 10 minutes. 
Protocol 10. Hot start PCR (D'Aquila et al., 1991). 
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2.15 Production of VLO 2 
2.15.1 Introduction 
New primers were designed (V3 and V4) to amplify lysyl oxidase from 
valine 167 to beyond the termination codon TAG at position 418 (Fig 4.10). 
The template cDNA used was human placental Quickclone cDNA 
(Clontech) which is more suitable for use with polymerase chain reactions 
than cDNA libraries because there is less non -specific DNA to cause 
unwanted amplifications, and the cDNA included is selected to contain 
more full length cDNAs, therefore reducing amplifications of partial cDNA. 
The primers were flanked by restriction enzyme sites Bbrl (5') and Hindlll 
(3') to allow directional cloning into a vector. 
2.15.2 Procedure 
The reaction was carried out as described (protocol 10) in a total 
volume of 300, using 10 of Human placental Quickclone cDNA (Clontech) 
as template, diluted 1 in 3 with TE buffer pH 8.0, giving approximately 300 
pg / µl of cDNA per reaction. 
The mineral oil was removed from the reactants and 20 µl of the PCR 
reaction was run on a 0.8% agarose gel. The 750 bp DNA produced was 
excised from the gel and purified using a Geneclean kit (protocol 4). 
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2.15.3 Ligation of VLO 2 into pGEM -T 
2.15.3.1 Introduction 
For more efficient cloning of the lysyl oxidase cDNA, a vector 
specifically designed for incorporation of PCR products was used. pGEM -T 
is an ampicillin resistance carrying Promega vector based on pGEM -5Zf 
(Promega), but modified by cutting with EcoR V restriction endonuclease 
and adding a terminal thymidine to the two ends. PCR amplified DNA 
produced by Taq polymerase always contains an extra adenosine base at 
each end not specified by the template, which means that these products 
can be directly cloned into the pGEM -T vector without the use of restriction 
endonucleases. 
2.15.3.2 Procedure 
The amplified PCR DNA was purified with a Geneclean kit (protocol 4), 
and 70 (10 ng) was added to 111l pGEM -T (50 ng) in a standard ligation 
reaction (section 2.12.5). This was incubated at 15 °C for 3 hours and then 
heated to 72 °C for 10 minutes. 
2.15.4 Cell transformation 
Competent cells (JM109; Table 4.1) supplied by Promega were 
transformed by the total volume of ligated PCR product. The competent 
cells were thawed from -70 °C (storage temperature), and 1000 were 
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added to the ligation reaction. The cells were gently mixed and put on ice 
for 20 minutes, heat shocked at 42 °C for 45 seconds and returned to ice for 
2 minutes, before adding 9000 of LB -broth and shaking at 37 °C for 1 hour. 
The cells were then spread on LB -agar plates supplemented with 0.005% 
(w /v) X -Gal, 0.003% (w /v) IPTG and 0.001% (w /v) ampicillin. White 
recombinant colonies were screened for the lysyl oxidase cDNA by making 
a mini -preprep of DNA, and then performing restriction digests (section 
2.13.5) with BbrP1 and HindlIl, to check for insert DNA. Finally, partial DNA 
sequence analysis was obtained to confirm that the insert obtained coded 
for the mature lysyl oxidase cDNA (protocol 9). 
2.16 ALO 1 production 
2.16.1 Introduction 
Two further primers were designed to produce a lysyl oxidase 
sequence from Asp 169 to the termination codon 418 (ALO 1). A 
polymerase chain reaction was set up (protocol 10) using 1 µl of a midi -prep 
of VLO2 as template, 60 of deoxynucleotide triphosphates (2 mM), and 
0.50 of Vent DNA polymerase (Promega; Vent DNA polymerase does not 
add extra adenosine bases to the amplified DNA). 
DNA from this reaction was purified using a Geneclean kit (protocol 4) 
and ligated into the ampicillin resistant vector pUC18 (section 2.13.5), then 
transformed into JM109 competent cells (Promega), and the colonies 
produced were screened for insert DNA. Two colonies which contained 
inserts the correct size were subjected to restriction digests with Scal and 
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Kpnl, which occur within the human lysyl oxidase coding region 
(Hamalainen et al., 1991), Hincll and Sphl, which are contained within the 
5' and 3' primers respectively, and BamHI, EcoRI and PvuII, which occur 
in the polycloning site of pUC18. 
2.17 ALO 2 production 
2.17.1 Introduction 
A further set of primers were designed with restriction sites 
incorporated that would allow cloning of ALO 2 directly into the yeast 
expression vector pDP315 (kindly donated by Dr. D. Pioli, Zeneca 
Pharmaceuticals, Macclesfield; Fig 4.19). The 5' primer contained a Hincll 
site and the 3' primer contained a BamHI site. A polymerase chain rection 
was carried out as before (protocol 10), and the DNA produced was 
purified using a Geneclean kit (protocol 4). Digestion of pDP315 with Stul 
and the BamHI restriction endonucleases was used to excise a segment of 
DNA from the vector. To prevent possible re- ligation of the restricted ends 
of pDP315, alkaline phosphatase was used. pDP315 (11.1g) was incubated 
with 1 unit of alkaline phosphatase (Boehringer mannheim) and 11.Ll of 
phosphatase buffer at 37 °c for 30 minutes in a total volume of 100. The 
reaction temperature was then raised to 65 00 for 10 minutes. A phenol / 
chloroform extraction was performed to remove phosphatase and the DNA 
was concentrated by ethanol precipitation (protocol 5). ALO 2 was 
restricted with Hincll and BamHI, and ligated into the vector, and this was 
then used to transform JM 109 high efficiency competent cells (Promega). 
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The cells were plated onto LB -agar plates supplemented with 0.001% (w /v) 
ampicillin. 
2.18 Transformation of yeast cells 
2.18.1 Introduction 
The construct (ALO 2 / pDP315) was used to transform the 
S.cerevisiae strain JRY188 (kindly donated by Dr. A Boyd; Table 4.1) by the 
method of Gietz et al. (1992) as follows. YEPD medium (1% (w /v) yeast 
extract, 2% bacto -peptone, 2% glucose; 5ml) was innoculated with JRY 
188 and cultured overnight at 30 0C, 1 mll of this was used to ïïnnoculate 
50m1 of YEPD, cultured at 30°C until the optical density of the cell's at 
600nm reached 0.8. The cells were then centrifuged at 5000g for 5 
minutes, and the cell pellet was washed in TE buffer (10 mM EDTA, 0.1M 
Tris -HCI, pH 7.5; 8 ml). The cells were centrifuged again at 5000g for 5 
minutes and the cell pellet was re- suspended in 100mM lithium acetate. 
Approximately 0.5 gig (visually determined) of the construct (ALO 2 / pDP 
315) was incubated with 300g1 of the cells, 6000 of 50% (w/v) polyethylene 
glycol 400 and 50 gg of single stranded carrier DNA (herring sperm; 
donated by Dr. A Boyd) for 30 loinutes at 300'C. The cells were then heat 
shocked at 42°C for 15 minutes, centrifuged at 6500g for 2 minutes and the 
pellet was re- suspended in 1500 TE butler. The cells were plated an to 
HUB! plates (2% agar, 2% glucose, 0.65% nitrogen base, 0..002% histidine, 
0.002% uracil, 0.002% tryptophan) and incubated for 5 days at 30 °C. 
82 
2.19 Yeast lysyl oxidase cDNA expression 
Colonies from the yeast transformation procedure were used to 
innoculate 100m1 of SD -HUW medium (2% glucose, 0.65% nitrogen base, 
0.002% histidine, 0.002% uracil, 0.002% tryptophan). The cells were 
grown to an optical density at 600nm of 2.0 and centrifuged at 3000g for 5 
minutes. To the supernatant ammonium sulphate was added to 80% 
saturation, followed by stirring overnight at 4 °C. The precipitated protein 
was collected by centrifugation at 12000g for 10 minutes and re- 
suspended in 1 ml of 2% SDS, 125 mM Tris -HCI, pH 6.8. Approximately 
20µg of protein was run on a 12% SDS -PAGE gel, under reducing 
conditions (protocol 2). To determine whether the protein contained lysyl 
oxidase activity, an assay using the ultrafiltration method was undertaken 
(section 2.5), with 1000 (0.2 mg / ml) of protein, 100p.1(1 mg / ml) of [4,5 -3H] 
lysine labelled elastin in assay buffer (100mM sodium borate, 0.15 M NaCI, 
pH 8.0) in a total volume of 9000. 
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Chapter 3 
Immunological and enzymatic : studies on 
TRAMP 
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3.1 Immunological studies of TRAMP 
3.1.1 Introduction 
Tyrosine rich acidic matrix protein (TRAMP) is a protein of molecular 
mass 22 kDa that co- purifies with lysyl oxidase (Cronshaw et al., 1993) 
from 6 M urea extracts of porcine skin, after DEAE -Sephacel ion -exchange 
chromatography and selective interaction with Sephacryl S -400 (section 
2.1). Under these conditions, TRAMP usually appears in great excess to 
lysyl oxidase (Fig. 3.1). 
Several reports have documented the existence of proteins of 
molecular mass 22 -24 kDa that are associated with lysyl oxidase. For 
example, Sullivan and Kagan, (1982) reported the gradual appearance of 
a 24 kDa protein in fractions of bovine aortic lysyl oxidase when stored for 
prolonged periods at 4 °C, and peptide mapping with S. aureus V8 
protease indicated that this was a likely degradation product of the 
functional enzyme. In addition, Burbelo et al. (1986) found that monoclonal 
antibodies raised against human umbilical cord lysyl oxidase cross - 
reacted with a 24 kDa protein that co- purified with lysyl oxidase. 
Kuivaniemi et al. (1984) also observed a contaminating 22 kDa protein on 
long term storage of human placental lysyl oxidase, though the nature of 
this protein was not explored. The same study revealed that a 23 kDa 
protein co- purified with lysyl oxidase on DEAE -cellulose ion -exchange 
chromatography. The amino acid composition of this 23 kDa contaminant 
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Figure 3.1. S D S -PAGE of partially purified TRAMP 6M PBU (6M 
urea, 9 mM Na2HPO4 / 1 mM NaH2PO4, pH 7.8) extracts from porcine skin 
were purified by DEAE -Sepharose ion exchange chromatography (eluted 
in 6M PBU, 0.5 M NaCI) followed by exhaustive dialysis against PB (9mM 
Na2HPO4 ,1 mM NaH2PO4, pH 7.8), and selective interaction with 
Sephacryl S -400. TRAMP and lysyl oxidase were then eluted with 6M PBU 
and analysed by discontinuous SDS -PAGE under reducing conditions with 
12% acrylamide, 0.32% bis- acrylamide in the separating gel, followed by 
staining with Coomassie Blue. 
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was found to be distinct from lysyl oxidase. Finally, Wakasaki and Ooshima. 
(1990b) found a 24 kDa protein that co- purified with lysyl oxidase from 
human umbilical cord. Peptide mapping with S. aureus V8 protease and 
amino acid analysis showed this protein to closely resemble lysyl' oxidase 
(Wakasaki and Ooshima, 1990b). 
In order to explore the relationship between lysyl oxidase and 
TRAMP, polyclonai antibodies were raised to highly purified TRAMP from 
porcine skin. 
3.1.2 Western blotting 
TRAMP was prepared from porcine skin (section 2.1), and further 
purified by fast protein liquid chromatography on a Pharrnacia Mona O 
columnand reverse phase chromatography (Cronshaw et al., 1993). This 
final purification step and antibody preparation were done in collaboration 
with J.R.E. MacBeath. Polyclonal antibodies were raised against TRAMP 
(Harlow et aL, 1988; section 2.6) by subcutaneous injection of New 
Zealand white rabbits with an initial 2004 dose of TRAMP diluted in 1 ml of 
0.15 M NaCI and emulsified in complete Freund's adjuvant (Sigma), in a 
1:1 ratio, followed by a 1004 boost (emulsified in 1 :1 Freund's incomplete 
adjuvant) and then four further 504 boosts injected every six weeks. The 
rabbits were then sacrificed and exsanguinated. 
A crude, 6 M urea extract was prepared from 500g of porcine skin, as 
described in the lysyl oxidase purification procedure (section 2.1). TRAMP 
was purified from this extract by the method of Cronshaw et al. (1993). 
Briefly, 6M PBU (6M urea, PB) extracts were pooled and filtered through 
Whatman No.3 filters, then diluted with PB to give a concentration of 2M 
87 
PBU (2M urea, PB) and passed through a CM- Sepharose fast flow column 
(2.6 cm x 40 cm) pre -equilibrated in 2M PBU. The flow through material 
was then loaded onto a DEAE -Sepharose fast flow column (2.6 cm x 40 
cm), also pre -equilibrated in 2M PBU. After elution of the column in 3 M 
PBU, 0.3 M NaCI to remove lysyl oxidase and other contaminating 
proteins, TRAMP containing fractions were eluted in 6M PBU, 0.5 M NaCI. 
Urea and salt were removed from the eluent by gel permeation on a 
Sephadex G25 column (90cm x 5.6 cm), and finally the protein solution 
was loaded onto a Sephacryl S -400 column pre -equilibrated with PB, and 
TRAMP was eluted in 1.5 M PBU (1.5 M urea, PB). 
Samples of the crude skin extract (504) and purified TRAMP (54) 
were run on a discontinuous 12 % SDS -PAGE gel, transferred to 
nitrocellulose and probed with the polyclonal antiserum using enhanced 
chemiluminscence detection (ECL) (section 2.9). As shown in Fig. 3.2, the 
polyclonal antiserum reacted strongly with TRAMP. No reactivity was 
observed between pre- immune serum and either the crude extract or 
partially purified TRAMP. There is some evidence that the antiserum 
recognises a protein of higher molecular weight than TRAMP. 
Lysyl oxidase (prepared as described in section 2.1) did not cross - 
react with the TRAMP antiserum (or with the pre- immune rabbit serum) 
when run on SDS -PAGE and analysed by Western blotting (Fig. 3.3). 
Therefore lysyl oxidase does not contain epitopes that are recognized by 
the antiserum, which suggests that TRAMP and lysyl oxidase are 
unrelated. 
The amino acid sequence of porcine TRAMP (A.D. Cronshaw, 
personal communication) is over 96 % identical to the bovine form (Neame 
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TRAMP- 
1 2 3 4 5 6 
-22k 
Figure 3.2. Reactivity of anti -TRAMP polyclonal antiserum and 
pre- immune serum with purified porcine TRAMP and a crude 
6M urea extract of porcine skin. Samples were electrophoresed on a 
reducing 12 % SDS- polyacrylamide gel, Western blotted onto 
nitrocellulose and reacted with different concentrations of serum. 
Antibodies were detected by ECL, with a film exposure of 1 minute. Purified 
TRAMP (2 µg, lanes 1,3,5) and the crude urea extract (50 µg, lanes 2,4,6) 
were reacted against a 10,000 -fold dilution of the anti -TRAMP antiserum 
(lanes 1 and 2), a 20,000 -fold dilution of the anti -TRAMP antiseum (lanes 3 
and 4) and a 10,000 -fold dilution of pre- immune serum (lanes 5 and 6). 
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Lysyl oxidase - 
TRAMP - 
1 2 3 4 
-32k 
- 22k 
Figure 3.3. Lack of reactivity of anti -TRAMP antiserum against 
lysyl oxidase. Samples of partially purified lysyl oxidase (Fig 
3.1)containing TRAMP (24 ; lanes 1 and 2) and purified TRAMP (2µg ; 
lanes 2 and 4) were reacted with different concentrations of TRAMP 
antiserum and pre- immune serum. Antibodies were detected by ECL, with 
a film exposure of 1 minute. Lanes 1 and 2 : 20,000 -fold dilution of anti - 
TRAMP antiserum. Lanes 3 and 4 : 10,000 -fold dilution of pre- immune 
serum. 
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porcine TRAMP was used to screen skin extracts from human and other 
species. 6M PBU extracts of murine, avian and human skin were prepared 
(section 2.8) and blotted as above with the TRAMP antiserum (Fig. 3.4). 
Cross - reactivity occurred with extracts of both murine and human skin, at a 
single band co- migrating with porcine TRAMP. Extracts of avian skin did not 
cross -react with the antiserum indicating either an absence of TRAMP or 
(more likely) divergent primary structure. 
To investigate the tissue distribution of TRAMP, 6M PBU extracts were 
prepared from several porcine tissues (section 2.8) and blotted with the 
anti -TRAMP antiserum at a dilution of 1:1000. The antiserum recognised 
TRAMP in PBU extracts of skin, heart, skeletal muscle, lung, kidney, spleen, 
cartilage, ulna and calvaria (Fig. 3.5). In a separate blot, the antiserum also 
cross -reacted with PBU extracts of murine skin, skeletal muscle, heart, lung 
and cartilage at a dilution of 1:2000 (Fig. 3.6). TRAMP is not found in brain 
or liver and therefore TRAMP distribution appears to correlate with tissues 
that are rich in connective tissue. 
3.2 Enzymatic activity of TRAMP 
3.2.1 Introduction 
The wide distribution of TRAMP suggests that it may have a major 
structural or possibly catalytic role in tissue. The ability of TRAMP to 
accelerate collagen fibril formation in vitro has been demonstrated 
(MacBeath et al., 1993) and possible associations with extracellular matrix 
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TRAMP - 411111P 411110 
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-22k 
Figure 3.4. Reactivity of TRAMP polyclonal antiserum against 6 
M PBU extracts from different species. Skins were extracted in 6M 
PBU, then 100 µg of each extract was electrophoresed, blotted onto 
nitrocellulose and exposed to the TRAMP polyclonal antiserum diluted 
1:10000. Antibodies were detected by ECL with a film exposure time of 1 
minute. Lane 1, porcine; 2, murine; 3, chicken; 4, human; 5, purified 
TRAMP (3 µg). 
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Figure 3.5. Reactivity of TRAMP polyclonal antiserum against 
6M PBU extracts from different porcine tissues. Tissues were 
extracted in 6M PBU and 1004 of protein from each extract was run on a 
12 % SDS -PAGE gel, then blotted and exposed to a 1,000 dilution of the 
polyclonal antiserum. Antibodies were detected by ECL with a film 
exposure of 1 minute. Lane 1, purified TRAMP; 2, blank; 3, skin; 4, heart; 5, 
skeletal muscle; 6, lung; 7, liver; 8, brain; 9, kidney; 10, spleen; 11, 
cartilage; 12, ulna; 13, calvaria. 
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22k 
Figure 3.6. Reactivity of TRAMP polyclonal antiserum against PBU 
extracts from different murine tissues. Tissues were extracted in PBU and 
1004 of each sample was run on a 12 % SDS -PAGE gel, then blotted and cross - 
reacted to a 2,000 dilution of the polyclonal antiserum. Antibodies were detected by 
ECL with a film exposure of 1 minute. Lane 1, TRAMP; 2, blank; 3, skin; 4, skeletal 
muscle; 5, heart; 6, lung; 7, liver; 8, kidney; 9, spleen; 10, brain; 11, eye; 12, tendcn: 
13; bone; 14, cartilage; 15, hair. 
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components may occur through a hexamer consensus sequence (Asp - 
Arg - Glx - Trp - Asn /Gin /Lys - Phe/ Tyr) that occurs three times in TRAMP 
(Neame et al., 1989). Porcine, human and bovine TRAMP also include the 
sequence Tyr- Asn- Tyr- Asp- Tyr which is found in porcine kidney amine 
oxidase (Janes et al., 1992). It has been proposed that the sequence Asn - 
Tyr - Asp / Glu is a consensus sequence for the incorporation of tri -hydroxy 
phenylalanine quinone (topaquinone) in a variety of copper dependent 
amine oxidases (Janes et al., 1992 ; Table 3.1). 
The involvement of TRAMP in collagen fibril formation in vitro and the 
presence of the putative topaquinone incorporation consensus sequence 
led to the following investigation of TRAMP as a possible collagen amine 
oxidase. 
3.2.2. Determination of enzymatic activity 
Collagen I was prepared from 17 day, chick embryo calvaria cultured 
in the presence of [4,5 -3H] lysine (section 2.3). The purifed collagen (120 
µg / ml in PBS) had a specific activity of 28500 cpm / µg. Radiolabelled 
collagen (12 µg in 1000 of PBS), was incubated with 21ig TRAMP (in 1000 
6M PBU; Cronshaw et al., 1993), in assay buffer (0.1 M sodium borate, 
0.15 M NaCI, pH 8.0) in a final volume of 900 µI at 37 °C overnight. Using 
the ultrafiltration method (Shackleton and Hulmes 1990b; section 2.4), 
preliminary results (Table 3.2) showed that tritium labelled low molecular 
weight ( <10 kDa) material was released into the ultrafiltrate in the presence 
of TRAMP, when collagen was used as substrate. The presence of 0.2 mM 
ß- aminopropionitrile (BAPN), which completely inhibits lysyl oxidase 
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Table 3.1. Comparison of the known topaquinone 
incorporation sequences of four amine oxidases with porcine, 
bovine and human TRAMP. 
1 2 3 4 5 6 7 8 9 
Bovine Serum Ao T M L N X D Y V 
Porcine Serum Ao T M L N X D Y V 
Pea Seedling Ao V G N X D N V I 
Pig Kidney Ao T V Y N X D Y I 
Porcine TRAMP+ I S Y N Y D Y Y M 
Bovine TRAMP^ I S Y N Y D Y Y M 
Human TRAMP' I S Y N Y D Y Y I 
The following symbols are used: Ao= amine oxidase, X = observed site of topaquinone 
incorporation; denotes unknown amino acid. Bold letters represent the topaquinone 
incorporation consensus sequence as proposed by Janes et al., (1992). + Porcine TRAMP 
amino acid sequence (A.D.Cronshaw, personal communication). ^ Bovine TRAMP amino 
acid sequence (Neame et al., 1989). 
Human TRAMP (dermatopontin) sequence deduced from cDNA (Superti -Furga et al., 
1993). 
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Table 3.2. Release of 3H cpm by lysyl oxidase and TRAMP from 
radiolabelled collagen and elastin substrates. 
Addition to assay cpm 
± S.E. 
(n =2) 




Control 1559 + 15 100 + 1.0 
TRAMP 1735 + 0.0 111 + 0.0 
Lysyl oxidase 1312 ± 42 84 ± 3.0 
Collagen 
Control 1421 + N/A 100 ± N/A 
TRAMP 1602 ± 20 113 ± 1.2 
TRAMP (200mM BAPN) 1382 ± 39 97 ± 2.8 
Elastin 
Control 761 ± 26 100 ± 3.4 
TRAMP 782±14 103 ±1.8 
Lysyl oxidase 1152 ± 22 151 ± 1.9 
TRAMP (2 µg) was incubated with 12µg [4,5 -3H] lysine labelled collagen (342,000 cpm) or 
50µg [4,5- 3H] lysine labelled elastin (300,000 dpm) in assay buffer (900µI total volume) 
overnight at 37 °C. The effect of 200mM BAPN on tritium release is also shown. 
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activity on elastin (Siegel et al., 1970; Narayanan et al., 1972), partially 
reduced the activity of TRAMP on collagen (not shown), while complete 
inhibition was observed at 200 mM BAPN (Table 3.2). 
After incubation, a gel like structure was visible in the presence of 
TRAMP, in the presence and absence of 0.2mM BAPN, which was not 
observed in the absence of TRAMP. This observation is consistent with the 
known effect of TRAMP on collagen assembly (MacBeath et aL, 1993) and 
may reflect an increase in cross -linking between collagen molecules. 
Using the same assay, partially purified lysyl oxidase (2 µg; prepared by the 
method detailed in section 2.1), showed no activity on [4,5 -3H] lysine 
labeled collagen. 
Further to the above, TRAMP (2 µg in 300 PBS) was incubated with 
12 µg [4,5 -3H] lysine labeled collagen (in 5011I PBS) in assay buffer (final 
volume150µ1) at 37 °C for 16 hours. The entire volume was then run on 6% 
discontinuous SDS -PAGE, under reducing conditions, and detected by 
fluorography, as described (section 2.11; Fig. 3.7). The fluorograms were 
then analysed on a Joyce -Loebl Chromoscan 3 scanning densitometer 
(Fig. 3.8). The P12 components (Piez, 1967) are increased almost 1.9 fold 
in the presence of TRAMP compared with the control samples, while the 
[311 components are increased almost 1.3 fold in the presence of TRAMP. 
These preliminary results suggest that TRAMP may be involved in the 
cross -linking of collagen, and perhaps acts as a collagen specific lysyl 
oxidase'. 
98 
i 2 3 4 
Figure 3/. Effect of TRAMP on collagen cross -linking. Collagen 
labelled with [4,5 -3H] lysine (500 of 120µg / ml) with a specific activity of 
28500 cpm / µg, was incubated with TRAMP (2ig; 300) previously dialysed 
exhaustively against PBS (lanes 1 and 3), or with PBS (300) (lanes 2 and 
4) and700 of assay buffer at 37 °C overnight. The 1500 samples were run 
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Figure 3.8. Densitometric scans of cross -linked collagen ß 
components produced in the presence and absence of TRAMP. 
Collagen labelled with [4,5 -3H] lysine (500 at 1204 / ml) with a specific 
activity of 382500 cpm / (g, was incubated with 700 of assay buffer at 37 °C 
overnight and either (a) PBS (30µI) or (b) TRAMP (300 at 70µg / ml; section 
2.1) and dialysed exhaustively against PBS. The 15012I samples were run 
on a 6 % SDS -PAGE gel and detected by fluorography. The 13» and 1312 
bands were then scanned in a Joyce -Loebl Chromoscan 3 densitometer. 
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3.3 Discussion 
In the present study, polyclonal antibodies raised against purified 
porcine TRAMP were found not to cross -react with lysyl oxidase. TRAMP is 
therefore a distinct protein from lysyl oxidase. This result is consistent with 
the complete amino acid sequence of porcine TRAMP (A.D. Cronshaw, 
personal communication) which shows it to be unrelated to lysyl oxidase, 
but the same as a 22 kDa bovine skin extracellular matrix protein that 
purifies with dermatan sulphate proteoglycan (Neame et al., 1989) and the 
same as recently discovered human equivalent called `dermatopontin' 
(Superti -Furga et al., 1993). 
The polyclonal antiserum appeared to recognise a protein band with 
a higher molecular weight than TRAMP in Western blots of purified TRAMP 
(Fig 3.2). It is possible that this could represent a biosynthetic precursor of 
porcine TRAMP, although the cDNA of the human equivalent of TRAMP has 
been cloned and sequenced (Superti -Furga et al., 1993), and appears to 
contain only a putative 18 amino acid signal peptide immediately upstream 
of the first residue present in porcine and bovine TRAMP (Cronshaw et al., 
1993 ; Neame et al., 1989). It seems more likely therefore that this band is 
a contaminant of the purified TRAMP used to raise the rabbit anti -serum or 
a cross- linked multimer of TRAMP. 
The Western blotting results show that TRAMP is a widely distributed 
protein, present in tissues that are rich in connective tissue. The role of 
TRAMP in the extracellular matrix is not yet understood. It is probable that 
the functions of lysyl oxidase and TRAMP are connected, since the 
formation of collagen fibrils in vitro is accelerated in the presence of 
TRAMP (MacBeath et al., 1993) and collagen fibril cross -linking is initiated 
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by the action of lysyl oxidase on specific lysine residues. Preliminary 
studies here suggest that TRAMP may itself be involved in cross -link 
formation in type I collagen, but not in elastin. TRAMP also appears to 
influence the ratio of 311 and 312 components formed in collagen. These 
results raise the possibility that TRAMP is a collagen specific, lysyl oxidase- 
type enzyme. The activity demonstrated is not inhibitable by 0.2 mM BAPN, 
indicating that no contaminating lysyl oxidase is responsible for the activity 
observed. 
Polyclonal antibodies raised against bovine lysyl oxidase (Kagan et 
ai, 1986) failed to recognise lysyl oxidase associated with collagen. 
However, the same antibodies did react with lysyl oxidase- collagen 
complexes formed in vitro . Kagan et al. (1986) suggested that a collagen 
specific form of lysyl oxidase may exist in vivo that is not recognised by the 
antibodies raised to lysyl oxidase and which is capable of oxidizing both 
collagen and elastin substrates. 
TRAMP contains the sequence Asn- Tyr -Asp, the consensus 
sequence for the modification of tyrosine to topaquinone in copper 
dependent amine oxidases (Janes et al., 1992). This sequence is 
conserved in human, porcine and bovine TRAMP forms, however peptide 
sequencing of porcine TRAMP has indicated the presence of unmodified 
tyrosine at this position (Dr. A.D.Cronshaw, personal communication). Lysyl 
oxidase lacks the topaquinone incorporation consensus sequence. The 
incorporation site of the carbonyl cofactor in lysyl oxidase is still unknown, 
although Asn- Tyr- Tyr -Asp is present in the sequence. 
The bovine form of TRAMP co- purifies with dermatan sulphate 
proteoglycans (Neame et ai, 1989). The dermatan sulphate proteoglycan 
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decorin has previously been found to associate with specific sites on the 
collagen fibril (Scott et al., 1991) and has also been found to inhibit 
collagen fibrillogenesis in vitro (Vogel et al., 1984). Bovine TRAMP has the 
ability to adhere to particular cell types, e.g. 3T3 cells and dermal 
fibroblasts, in the absence of dermatan sulphate proteoglycans, which 
suggest that bovine TRAMP may have an important role in mediating cell 
adhesion in the extracellular matrix (Lewandowska et al., 1991). Inhibition 
of this adhesion activity by the integrin binding peptide Arg -Gly- Asp -Ser, 
and the presence of a potential integrin binding sequence Arg -Gly- Ala -Thr 
within the primary structure of bovine TRAMP, suggests that TRAMP binds 
to cell surface integrins. Dermatan sulphate chains have the ability to bind 
to bovine TRAMP and totally inhibit the binding activity (Lewandowska et 
al., 1991). 
It is possible that TRAMP is a multi -functional protein that serves in 
the communication between particular cells and their extracellular 
environment, and also performs a role in the development and 
maintenance of the matrix through interactions with forming collagen fibrils. 
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Chapter 4 
Expression of lysyl oxidase cDNA 
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4.1 Introduction 
In the original work on lysyl oxidase, enzyme activity was detected in 
a PBS extract of embryonic chick bone (Pinnell and Martin, 1968). 
Subsequently, it was discovered that much better yields of the enzyme 
could be obtained by extracting in 4 -6M urea (Narayanan et al, 1974). 
Lysyl oxidase remains partially active in urea and is stable for several 
months. Urea also improves the recovery of the enzyme from ion exchange 
chromatography (Narayanan et al., 1974). Subsequent removal of urea 
results in the formation of large aggregates (up to 1000 kDa) of enzyme 
(Jordan etal., 1977). Solubilisation of lysyl oxidase in solutions of urea has 
remained as the primary step in most purification procedures (section 
1.4.6). 
A disadvantage of urea in enzyme purification is the spontaneous 
formation of cyanate ions, especially at low pH (Hagel et al., 1971). Urea 
solutions containing cyanate can cause carbamylation of the a -amino 
group and of e -amino groups on the side chains of lysyl residues in 
proteins, which then become differently charged, with possible effects on 
enzyme structure and function (Cole et al., 1966). The presence of urea 
also causes proteins to unfold, and correct re- folding may not occur after 
the urea is removed. 
Recombinant DNA technology has been used to clone and express 
many proteins such as human insulin (Goeddal et al., 1979a) and human 
growth hormone (Goeddal et al., 1979b). At the start of the project, the 
cDNA for rat aorta lysyl oxidase had been cloned and sequenced 
(Trackman et al., 1990; 1991). This enabled the possible detection of lysyl 
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oxidase cDNA in a human placental cDNA library using a fragment of the 
rat sequence as a probe. The human cDNA sequence could then be 
cloned and sequenced. In addition to this the cDNA of the human enzyme 
could then be expressed in yeast, to produce lysyl oxidase without the 
requirement for the presence of urea, or the time -consuming purification 
procedure that is currently necessary (section 2.1). 
Cloning and expression of the human cDNA sequence will be useful 
for determining those regions of sequence that code for the active site of 
the enzyme, as well as cofactor binding sites, and inhibitor binding sites. 
Mutagenesis techniques will allow manipulation of the DNA to investigate 
how these sites function. These types of study may also be useful in 
probing the causes of genetic diseases such as Menkes' disease (Danks, 
1983), X- linked cutis laxa (Byers et al., 1976) and Ehlers -Danlos syndrome 
type IX (Kuivaniemi et al., 1982; Peltonen et al., 1983). Exploration of the 
link between lysyl oxidase and tumour supression may also be possible, 
since the rat cDNA sequence has been found to be 89% identical with 
murine ras- recision gene (Kenyon et al., 1991). Studies probing the 
molecular basis of the lysyl oxidase variants (Kagan et al., 1979a) could 
also be undertaken. The expression of a precursor form of the enzyme may 
also allow the ability to study proteolytic processing of the enzyme. 
The following attempts were undertaken to produce a DNA construct 
from which expression of recombinant human lysyl oxidase in the yeast 
S.cerevisiae could be achieved. 
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4.2 Production of a (rat aorta lysyl oxidase) cDNA fragment 
(LOF 1) to probe a human placental cDNA library 
4.2.1 Introduction 
From the sequence of the cDNA encoding rat aorta lysyl oxidase 
precursor (Trackman et al., 1990; 1991), two oligonucleotide primers were 
designed to produce a 532 bp fragment of rat lysyl oxidase cDNA using the 
polymerase chain reaction (section 2.13.3; protocol 3; Fig. 4.1). The cloned 
fragment could then be used to probe a human placental cDNA library. The 
primer design was aided by Gene Jockey software (Biosoft). A BamHI 
restriction endonuclease site was incorporated into both primers to allow 
for non -directional cloning of the DNA produced into the polylinker site of 
pK19 (kindly donated by Dr. A Boyd; Fig. 4.2). 
4.2.2 LOF 1 production using PCR 
The method of Friedman et al., (1988; section 2.13.3) was used for 
amplification of LOF 1 from a xgt11 library (Clontech), synthesised from 
Sprague -Dawley neonatal rat aorta cDNA. DNA was electrophoresed on a 
0.8% agarose gel (section 2.13.4) and visualized under ultra -violet light 
(Fig. 4.3). A fragment of approximately 530 bp was observed. 
4.2.3 LOF 1 ligation into pK19 
The DNA fragment produced was excised from the agarose gel, 
solubilized with sodium iodide and purified using a Geneclean Il kit (Bio 
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rigure oeyuence or rat aorta lysyl oxidase cDNA (Trackman et al.. 
1990,1991). 
ATG CGT TTC GCC TGG ACC GTG CTC TTT CTG GGA CAG CTG CAG TTC TGT CCC CTT C_C CGC TGC 
1 Met Arg Phe Ala Trp Thr Val Leu Phe Leu Gly Gin Leu Gin Phe Cys Pro _eu Leu Arg Cys 
GCC CCG CAG GCC CCG CGC GAG CCT CCC GCC GCC CCC GGT GCC TGG CGC CAG ACA ATC CAA TGG 
22 Ala Pro Gln Ala Pro Arg Gln Pro Pro Ala Ala Pro Gly Ala Trp Arg Gin Thr Ile Gin Trp 
GAG AAC AAC GGG CAG GTG TTC AGT CTG TTG AGC CTG GGG GCG CAG TAC CAG C._ CAG CGA CGC 
43 Glu Asn Asn Gly Gln Val Phe Ser Leu Leu Ser Leu Gly Ala Gin Tyr Gin Pro Gin Arg Arg 
CGC GAC TCC AGC GCC ACT GCC CCG AGA GCC GAC GGC AAC GCT GCA GCA CAG CCA C,.0 ACG CCC 
64 Arg Asp Ser Ser Ala Thr Ala Pro Arg Ala Asp Gly Asn Ala Ala Ala Gin ?ro Arg Thr Pro 
ATT CTG CTG 
85 Ile Leu Leu 
GTC GCC GCG 
106 Val Ala Ala 
GGG GCC GGC 
127 Gly Ala Gly 
CTC AGT AAT 
148 Leu Ser Asn 
TAC AAG TAC 
169 Tyr Lys Tyr 
GGG AGC AGG 
190 Gly Ser Arg 
CTG CGT GAC AAC CGC ACT GCC TCT GCC CGT GCG AGG ACT CCA AGC CCA TCT GS' 
Leu Arg Asp Asn Arg Thr Ala Ser Ala Arg Ala Arg Thr Pro Ser Pro Ser Gly 
GGT CGT CCC CGG CCC GCA GCC CGC CAC TGG TTC CAA GTT GGT TTC TCG CCG TCC 
Gly Arg Pro Arg Pro Ala Ala Arg His 'Trp Phe Gln Val Gly Phe Ser Pro Ser 
y 
GAT GGA GCC TCA AGG CGC GCA CCG AAC CGG ACT GCG TCG CCA CAG CCT CCG CAG 
Asp Gln Ala Ser Arg Arg Ala Ala Asn Arg Thr Ala Ser Pro Gin Pro Pro Gin 
CTG AGG CCA CCC AGC CAC GTA GAT CCC ATG GTG GGC GAC GAC CCC TAC AAT CCC 
Leu Arg Pro Pro Ser His Val Asp Arg Met Val Gly Asp Asp Pro Tyr Asn Pro 
TCC GAC GAC AAC CCC TAT TAT AAC TAC TAT GAC ACT TAT GAG AGA CCC CGG TCC 
Ser Asp Asp Asn Pro Tyr Tyr Asn Tyr Tyr Asp Thr Tyr Glu Arg Pro Arg Ser 
CAC CGA CCT GGA TAT GGC ACC GGT TAC TTC CAG TAC GGT CTC CCG GAC CTG GTA 
His Arg Pro Gly Tyr Gly Thr Gly Tyr Phe Gln Tyr Gly Leu Pro Asp Leu Val 
Primer L1 
Bam HI 
5'GCGGATCC TAC TAC ATC CAG GCA TCC ACG 3' 
CCC GAT CCC TAC TAC ATC CAG GCA TCC ACG TAC GTA CAA AAG ATG TCT ATG TAC AAC COG AG? 
211 Pro Asp Pro Tyr Tyr ile Gln Ala Ser Thr Tyr Val Gin Lys Met Ser Met Tyr Asn Leu A:': 
TGC GCT GCG GAA CAA AAC TGC CTG CCC ACT TCA CCA TAT AGG GCG GAT GTC AGA CAC TAT Ç 
23 Cys Ala Ala Glu Glu Asn Cys Leu Ala Ser Ser Ala Tyr Arg Ala Asp Val Arg Asp Tyr Asp 
CAC AGG GTA CTG CTA CGA TTT CCT CAG AGA GTG AAA AAC CAA GGG ACG TCT GAC TTC TTA CCA 
253 His Arg Val Leu Leu Arg Phe Pro Gln Arg Val Lys Asn Gin Gly Thr Ser Asp Phe Leu Pro 
AGC CGC CCC CGC TAC TCC TG_(; CAG TGG CAC AGC TGC CAC CAA CAT TAC CAC AGO ATG CAT GAA 
274 Ser Arg Pro Arg Tyr Ser Trp Glu Trp His Ser Cys His Gln His Tyr His Ser Met Asp Gìt 
TTC AGC CAC TAC GAC CTG CTG GAT GCC AGC ACA CAG AGG AGA COG GCC GAG GCC CAC AAA GCA 
295 Phe Ser His Tyr Asp Leu Leu Asp Ala Ser Thr Gin Arg Arg Val Ala Glu Giy His Lys Ala 
AGC TTC TGT CTC; GAG AAC ACT TCC TGT GAT TAT GGG TAC CAC PGA CCA T." CCC '"CT ACT G^P 
316 Ser Phe Cys Leu Glu Asp Thr Ser Cys Asp Tyr Gly Tyr His Arg Arg Phe Ala Cys Thr Ala 
T T T 
337 His Thr Gln Gly Leu Ser Pro Gly Cys Tyr Asp Thr Tyr Ala Ala Asp Ile Asp Cys Sin Tr., 
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ATT 3 °T ACA GAT GTA CAA CCC GGA AAT TAC ATT CTA AAG GTC AGC GTA AAC CCC AGC TAC 
358 11e Asp =_e Thr Asp Val Gln Pro Gly Asn Tyr Ile Leu Lys Val Ser Val Asn Pro Ser Tyr 
Primer L2 
3' GCG ATG TGT CCT GTA 
CTC GT:= CCT GAA TCA GAC TAC AGT AAC AAT GTC GTA CGC TGT GAA ATT CGS' TAC ACA CCA CA- 
379 Leu Val pro Glu Ser Asp Tyr Ser Asn Asn Val Val Arg Cys Glu Ile Arg Tyr Thr Gly cris 
Aazs H 
GTC CCTAGGCG 5' 
CAC GCC TAT GCC TCA GCC TGC ACC ATT TCA CCG TAT TAG 
400 His Ala Tyr Ala Ser Gly Cys Thr Ile Ser Pro Tyr END 
The position of the primers L1 and L2 used to amplify the LOF 1 cDNA (single 
underlined) are shown. Denotes the putative proteolytic processing site suggested 
by Trackman et al. (1990). 
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Asn II 





















Figure 4.3. Fragment LOF 1 amplified from a rat aorta cDNA 
library by the polymerase chain reaction. Lane 1, LOF 1; lane 2, 
molecular weight markers (X digested with BstEll restriction endonuclease). 
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101 Inc.) as described in section 2.13.5 (protocol 4). This procedure 
removes ethidium bromide, DNA fragments smaller than 500 bp (e.g. 
oligonucleotide primers), and contaminating proteins. After digestion with 
BamHI (section 2.13.5) a further Geneclean step was undertaken to 
remove this enzyme. LOF 1 was then ligated into the BamHl site of pK19 
(Pridmore, 1987) to produce pLOF 1. The plasmid pK19 is closely related 
to the ampicillin resistant pUC vectors, which have a very high copy 
number in bacterial cells (500 -700; Minton et al., 1988), though pK19 
encodes kanamycin resistance. These vectors encode the first 146 amino 
acids of the lac Z gene 03- galactosidase) which complements the partial lac 
Z gene in appropriate host cell strains, and allows blue / white screening 
for recombinant cell colonies when the cells are grown on LB -agar plates 
in the presence of X -gal and IPTG. 
4.2.4 pLOF 1 transformation of competent cells 
Competent NM522 E.coli cells (Table 4.1) were prepared by the 
method described in section 2.13.5 (protocol 6). pLOF 1 (10 µl) was then 
transfected into competent cells by the method described in section 2.13.6. 
The transformed cells (100 N.I) were plated out onto an LB -agar plate (plate 
1) supplemented with kanamycin (10 mg /ml), 10% X -gal and IPTG (200 mg 
/ ml). The remaining cells were resuspended into 1000 of LB- broth, and 
plated out on a similar plate (plate 2). 
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Table 4.1. Bacterial and yeast cell strains 





A (lac -pro AB) his 5 (rk -,mk +) 
thi sup E F1(pro AB lac Iq) 
ZA M15 
rec A1 supE44 endA1 hsdR17 
gyrA96 F' [tra D36 proAB+ laclq 
lac Z M 15] 
sup F hsdR araD139 Ion lac 
U16 rpsL trpC22 Tn i 0(tetr) 
pMC9 
S.cerevisiae strains 
Gough and Murray (1983) 
Gough and Murray (1983) 
Young and Davis (1983) 
J R Y 18 8 Mata leu 2 -3, 112 ura 3 -52 
trp 1 his 4 sir 3-8 rme GAL Brake et al. (1984) 
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4.2.5 Recombinant colony screening 
Colonies were screened for recombinant DNA after plasmid 
minipreps (section 2.13.7.2; protocol 7). Each colony was transferred into 
LB- broth, and grown overnight at 370C. The cells were then lysed with 
alkali, and the DNA was extracted in phenol / chloroform / isoamyl alcohol 
(25 : 24 : 1) and finally precipitated in ethanol. A restriction digest with 
BamHI was performed on each miniprep as described in section 2.13.3.2 . 
Approximately 60 colonies appeared on plate 2, of which one colony was 
found to contain an insert of approximately 530 bp (Fig. 4.4). A larger scale 
preparation of plasmid DNA (section 2.13.7.2; protocol 8) was then 
performed to obtain a sufficient quantity of the recombinant plasmid DNA 
for further manipulation. 
4.2.6 LOF1 DNA Sequencing 
To confirm its identity, the DNA fragment present in the plasmid 
(excised byBamHl) was sequenced using Sequenase version 2.0 DNA 
polymerase (USB) and 10 ng of PCR primer L1 (Fig. 4.1), according to the 
method of Sanger et al., (1977) and Hsiao, (1991), as described in section 
2.13.8 (protocol 9). The DNA sequence obtained (Fig. 4.5), allowed 97 
bases to be read, and confirmed that the fragment amplified and cloned 











Figure 4.4. Screening minipreps of colonies for pK19 
containing LOF1 with Barn Hl. LOF 1 was sub -cloned into pK19, and a 
mini -prep of this DNA was cut with Bam HI restriction endonuclease. Lane 
1, LOF 1; lane 2, molecular weight markers (a. DNA digested with Bst Eli). 
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Rat Aorta 5' 1067 AGT GGA TTG ATA TTA CAG ATG TAC AAC 
LOF 1 5' AGT GGA TTG ATA HA CAG ATG TAC AAC 
Rat Aorta 1094 CCG GAA ATT ACA TTC TAA AGG TCA GTG 
LOF 1 CCG GAA ATT ACA TTC TAA AGG TCA GTG 
Rat Aorta 1121 TAA ACC CCA GCT ACC TGG TGC CTG AAT 
LOF 1 TAA ACC CCA GCT ACC TGG TGC CTG AAT 
Rat Aorta 1148 CAG ACT ACA GTA ACA ATG TC 3' 
LOF 1 CAG ACT ACA GTA ACA ATG TC 3' 
Figure 4.5. Partial sequencing of the rat lysyl oxidase fragment 
LOF1, and comparison to the rat aorta cDNA sequence (Trackman 
et al., 1991). A 532bp fragment of rat lysyl oxidase cDNA (Fig 4.1) was 
amplified from a rat aorta cDNA library (Clontech), cloned into pK 19 and 
partially sequenced by the dideoxy -chain termination method (section 2.13.8; 
protocol 5). 
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4.2.7. LOF 1 labelling and use as a probe for human placental 
lysyl oxidase 
LOF 1 was radiolabelled as described in section 2.13.9, and used to 
probe a human placental cDNA library (Clontech), plated out on large LB- 
agar plates (30cm x 30cm) as described in section 2.13.10. Nitrocellulose 
filters were used to lift DNA from the plates in duplicate, and these were 
developed using Hyperfilm MP X -ray film (Amersham). No coincident spots 
of radioactivity could be found on the duplicate filters indicating that the 
radiolabelled probe did not hybridize to the lysyl oxidase cDNA in the 
library. This failure may have been due to very few or no complete lysyl 
oxidase cDNA clones being present in the human placental cDNA library. 
4.3 Cloning mature lysyl oxidase cDNA (VLO 1) from a human 
placental cDNA library. 
4.3.1 Introduction 
The cDNA sequence encoding the human placental cDNA lysyl oxidase 
precursor was published part way through the project (Hamalainen et al., 
1991). Hence an alternative strategy for cloning the cDNA encoding 
mature lysyl oxidase was undertaken. 
The precise N- terminus of mature lysyl oxidase was unknown during 
this part of the project, although Trackman etal., (1990) predicted that the 
site of proteolytic cleavage was likely to be between Arg 134 - Arg 135 in 
the rat aorta sequence, based on a calculation of the molecular mass C- 
terminal to this site (Fig. 4.1). The site is equivalent to Ser 140 - Arg 141 in 
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the human sequence (Hamalainen et al., 1991; Fig. 4.6). In contrast, 
analysis of porcine skin lysyl oxidase by amino acid sequencing and mass 
spectrometry (Dr. A.D. Cronshaw, personal communication) has indicated 
that the N- terminal amino acid is one of three consecutive amino acid 
residues equivalent to valine 167, glycine 168 or aspartic acid 169 in the 
human sequence. In the work described below, primers were designed to 
amplify lysyl oxidase cDNA corresponding to an N- terminus in the region of 
Val 167. 
4.3.2 PCR 
Two PCR primers were designed (V1 and V2; Fig. 4.6) to amplify a 
758 bp fragment of human lysyl oxidase cDNA from valine 167 to beyond 
the termination codon TAG at position 418. The 5' primer (V1) contained a 
Smal restriction site and the 3' primer (V2) contained a BamHI site. The 
use of different restriction sites allowed directional cloning of the DNA into 
a vector. 
The PCR was carried out as before (section 2.13.1; protocol 3) using 
511I of a 34 week, human placental cDNA library (Clontech) as template. 
Initially very poor yields of amplified DNA were produced. In an attempt to 
improve the yield, more cycles and more template DNA were introduced, 
and the MgCl2 concentration was altered from 1.5 mM to concentrations 
ranging from 0.5 mM to 2.5 mM, though without significant improvement. 
Instead, spurious DNA bands were observed (Fig. 4.7), so a `hot start' 
variation to the procedure was introduced to allow more specific annealing 
of the primers to the template. This procedure (D'Aquila et al., 1991) 
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Figure 4.6. Sequence of human placental lysyl oxidase cDNA 
(Hamalainen et al., 1991). 
1 ATG CGC TTC GCC TGG ACC GTG CTC CTG CTC GGG CCT TTG CAG CTC TGC GCG CTA GTG CAC 
1 Met Arg Phe Ala Trp Thr Val Leu Leu Leu Gly Pro Leu Gln Leu Cys Ala Leu Val His 
61 TGC GCC CCT CCC GCC GCC GGC CAA CAG CAG CCC CCG CGC GAG CCG CCG GCG GCT CCG GGC 
21 Cys Ala Pro Pro Ala Ala Gly Gln Gln Gln Pro Pro Arg Glu Pro Pro Ala Ala Pro Gly 
121 GCC TGG CGC CAG CAG ATC CAA TGG GAG AAC AAC GGG CAG GTG TTC AGC TTG CTG AGC CTG 
41 Ala Trp Arg Gln Gln Ile Gln Trp Glu Asn Asn Gly Gln Val Phe Ser Leu Leu Ser Leu 
181 GGC TCA CAG TAC CAG CCT CAG CGC CGC CGG GAC CCG GGC GCC GCC GTC CCT GGT GCA GCC 
61 Gly Ser Gln Tyr Gln Pro Gln Arg Arg Arg Asp Pro Gly Ala Ala Val Pro Gly Ala Ala 
241 AAC GCC TCC GCC CAG CAG CCC CGC ACT CCG ATC CTG CTG ATC CGC GAC AAC CGC ACC GCC 
81 Gln Ala Ser Ala Gln Gln Pro Arg Thr Pro Ile Leu Leu Ile Arg Asp Asn Arg Thr Ala 
301 GCG GGG CGA ACG CGG ACG GCC GGC TCA TCT GGA GTC ACC GCT GGC CGC CCC AGG CCC ACC 
101 Ala Gly Arg Thr Arg Thr Ala Gly Ser Ser Gly Val Thr Ala Gly Arg Pro Arg Pro Thr 
4 
361 GCC CGT CAC TGG TTC CAA GCT GGC TAC TCG ACA TCT AGA GCC CGC GAA GCT GGG CCC TCG 
121 Ala Arg His Trp Phe Gln Ala Gly Tyr Ser Thr Ser Arg Ala Arg Glu Ala Gly Pro Ser 
421 CGC GCG GAG AAC CAG ACA GCG CCG GGA GAA GTT CCT GCT CTC AGT AAC CTG CGG CCG CCC 
141 Arg Ala Glu Asn Gln Thr Ala Pro Gly Glu Val Pro Ala Leu Ser Asn Leu Arg Pro Pro 
Primer V1 
Sma I 
5' GTGCCCGGGTG GTG GGC GAC GAC CCT TAC AAC 3' 
481 AGC CGC GTG GAC GGC ATG 






181 Asn Pro Tyr Tyr Asn Tyr Tyr Asp Thr Tyr Glu Arg Pro Arg Pro Gly Gly Arg Tyr Arg 
601 CCC GGA TAC GG_C ACT GGC TAC TTC CAG TAC GGT CTC CCA GAC CTG GTG GCC GAC CCC TAC 
201 Pro Gly Tyr Gly Thr Gly Tyr Phe Gln Tyr Gly Leu Pro Asp Leu Val Ala Asp Pro Tyr 
661 TAC ATC CAG GCG TCC ACG TAC GTG CAG AAG ATG TCC ATG TAC AAC CTG AGA TGC GCG GCG 
221 Tyr Ile Gln Ala Ser Thr Tyr Val Gln Lys Met Ser Met Tyr Asn Leu Arg Cys Ala Ala 
721 44 44 
241 Glu Glu Asn Cys Leu Ala Ser Thr Ala Tyr Arg Ala Asp Val Arg Asp Tyr Asp His Arg 
781 GTG CTG CTC AGA TTT CCC CAA AGA GTG AAA AAC CAA GGG ACA TCA GAT TTC TTA CCC AGC 
261 Val Leu Leu Arg Phe Pro Gln Arg Val Lys Asn Gln Gly Thr Ser Asp Phe Leu Pro Ser 
841 CGA CCA AGA TAT TCC TGG GAA TGG CAC AGT TGT CAT CAA CAT TAC CAC AGT ATG GAT GAG 
281 Arg Pro Arg Tyr Ser Trp Glu Trp His Ser Cys His Gln His Tyr His Ser Met Asp Glu 
901 TTT AGC CAC TTG TAC CTG CTT GAT GCC AAC ACC CAG AGG AGA TGG GCT GAA GGC CAC AAA 
301 Phe Ser His Leu Tyr Leu Leu Asp Ala Asn Thr Gln Arg Arg Trp Ala Glu Gly His Lys 
961 
321 Ala Ser Phe Cys Leu Glu Asp Thr Ser Cys Asp Tyr Gly Tyr His Arg Arg Phe Ala Cys 
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1021 T 
mr,.r m . ^. A ̂' A 
341 Thr Ala His Thr Gln Gly Leu Ser Pro Gly Cys Tyr Asp Thr Tyr Gly Ala Asp Ile Asp 
1081 TGC CAG TGG ATT GAT ATT ACA GAT GTA AAA CCT GGA AAC TAT ATC CTA AAG GTC AGT GTA 
361 Cys Gln Trp =1e Asp Ile Thr Asp Val Lys Pro Gly Asn Tyr Ile Leu Lys Val Ser Val 
1141 AMC CCC AGC TAC CTG GIS CCT FAA TCI GAC TAT ACC AAC AAT GTT GTG CGC TGT GAC ATT 




3' CG TGT TAA AGT GGC ATA ATCTTCCTAGGGC 5' 
T T 4 14 444 
401 Arg Tyr Thr Gly His His Ala Tyr Ala Ser Gly Cys Thr Ile Ser Pro Tyr END 
The position of the primers V1 and V2 used to amplify the VLO 1 cDNA (single underlined) are 












Figure 4.7. Amplified DNA produced by the polymerase chain 
reaction using the VLO 1 primers (V1 and V2). 'Cold start' PCR 
using a human placental cDNA library (Clontech) as template. Lane 1, 
DNA produced from a PCR reaction using primers V1 and V2; lane 2, 
molecular weight markers (X DNA digested with BstEll restriction 
endonuclease). 
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involves an initial denaturation of the DNA at 94 -960C for four minutes 
before Taq DNA polymerase is added. At this temperature Taq polymerase 
has a half -life of about 6.5 hours. A reduction in spurious DNA bands was 
observed, though the DNA yields continued to be too low for further DNA 
manipulation (Fig. 4.8). 
A DNA band of approximately 750 bp was found to have been primed 
at both ends by primer V1 alone (Fig. 4.9). In order to overcome the poor 
quality of the PCR amplifications, and the possibility of further single - 
primer induced amplifications, the reaction was completely re- designed 
(section 2.13.1; protocol 10). The reaction volume was reduced from 1000 
to 300 to promote uniform temperature changes within the heating block. A 
human placental cDNA Quickclone kit (Clontech) i.e. purified double 
stranded DNA synthesised from placental poly A RNA, was used as 
template cDNA. Quickclone cDNA contains no vector DNA, leading to 
fewer unwanted amplifications during the reaction. 
4.4 Cloning mature lysyl oxidase cDNA (VLO 2) from a human 
placental cDNA Quickclone kit 
4.4.1 Introduction 
New PCR primers were obtained (V3 and V4; Fig. 4.10) to amplify a 
new 807 bp product VLO 2. The 5' primer (V3) was designed with a Bbri 
restriction enzyme site at the 5' end. In this primer, the Bbri site 
incorporates three bases that code for valine 167 and the DNA is cut blunt 
at the start of this codon. This allows Bbri restricted VLO 2 to be cloned into 









Figure 4.8. Amplified DNA produced by the polymerase chain 
reaction using the VLO 1 primers (V1 and V2). 'Hot start' PCR 
using a human placental cDNA library (Clontech) as template. Lane 1, 
DNA produced from a PCR reaction using primers V1 and V2,; lane 2, 









Figure 4.9. Amplified DNA produced by the polymerase chain 
reaction using the VLO 1 primer V1. 'Hot start' PCR using a human 
placental cDNA library (Clontech) as template. Lane 1, DNA produced from 
a PCR reaction using primer V1; Lane 2, molecular weight markers ( 4 DNA 




5' CAC GTG GGC GAC GAC CCT TAC AAC 3' 
490 GAC GGC ATG GTG GGC GAC GAC CCT TAC AAC CCC TAC AAG TAC TCT GAC GAC 
164 Asp Gly Met Val Gly Asp Asp Pro Tyr Asn Pro Tyr Lys Tyr Ser Asp Asp 
Primer V4 
Hind III 
3' TAGTCACGGACCACAAGACTTCATTCGAA 5' 
1217 TAT TAGAAGGCAAAGCAAAACTCCCAATGGATAAATCAGTGCCTGGTGTTCTGAAGT 
417 Tyr END 
Figure 4.10. The position of the primers V3 and V4 on the 
human placental lysyl oxidase precursor sequence 
(Hamalainen et al., 1991) used to amplify the VLO 2 cDNA. 
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Primer V4 contained a Hindlll site to allow directional cloning. DNA of the 
expected size (approximately 800 bp) was generated following PCR (Fig. 
4.11). 
4.4.2 VLO 2 ligation into pGEM -T 
Amplified DNA was excised from an agarose gel, solubilized and 
purified using a Geneclean II kit (protocol 4). This DNA was ligated into the 
linearised vector pGEM -T (Promega; Fig. 4.12), to produce pVLO2. pGEM- 
T is specifically designed for incorporation of POR products, and is 
compatible with blue / white screening. The vector is constructed from 
pGEM -5Zf and modified (by the manufacturer) by adding a terminal 
thymidine overhang to the two ends of an open EcoR V restriction site. By 
engineering the vector to contain these overhangs, the terminal transferase 
properties of many Taq DNA polymerases is exploited, where a non - 
specified adenosine residue is added by the Taq enzyme in the 3' position 
to each end of the DNA produced. This results in the ability to clone DNA 
directly into pGEM -T without the requirement for restriction digests. Another 
advantage of using pGEM -T is that this vector cannot re- ligate, leading to 
more efficient ligation between vector and PCR product. Cloning PCR 
products into pGEM -T is non-directional, though because restriction 
enzyme sites were incorporated at each end of VLO 2, the DNA could be 
excised and directionally cloned into an expression vector. 
High efficiency, competent JM109 cells (Promega; Table 4.1) were 
then transformed with pVLO 2. The transformed cells were plated onto LB- 
agar plates supplemented with ampicillin, X -Gal and IPTG, and these were 












Figure 4.11 : VLO 2. 'Hot start' PCR was used to ampify the DNA from 
human placental quickclone cDNA (Clontech) using primers V3 and V4 
(Fig 4.10). Lane 1, DNA produced from a PCR reaction using primers V3 
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Sca I 
Figure 4.12. Plasmid pGEM -T. 
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screened for recombinant DNA by restriction analysis of plasmid 
minipreps. Sixteen colonies were produced and one colony contained a 
DNA fragment of the expected size (800bp). 
VLO 2 was then sequenced (section 2.13.8 ; protocol 9) to further 
establish its identity. Using 17bp universal pUC / M13 sequencing primer, 
complementary to a region of pGEM -T starting 84bp upstream of the 
cloning site, it was possible to sequence 165 bp of VLO 2 in the forward 
direction (Fig. 4.13), for comparison with the human lysyl oxidase cDNA 
sequence (Hamalainen et al., 1991). In the forward direction, the 
sequences were identical, except for one G at position 610 of the human 
sequence which is unaccounted for in VLO 2, probably due to poor gel / 
film contact or uneven gel drying. 
4.5 Cloning mature lysyl oxidase cDNA (ALO 1) from VLO 2 
4.5.1 Introduction 
At this point in the project, analysis of mature porcine lysyl oxidase by 
cyanogen bromide digestion revealed that Asp 169 in the human 
sequence was likely to be the N- terminal amino acid of mature lysyl 
oxidase (Cronshaw et al., submitted for publication). Hence new primers 
were designed to amplify lysyl oxidase cDNA begining at Asp 169. 
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Hamalainen 5' 499 GTG GGC GAC GAC CCT TAC AAC CCC TAC 
VLO 2 5' 1 GTG GGC GAC GAC CCT TAC AAC CCC TAC 
V G D D P Y NP Y 
Hamalainen 526 AAG TAC TCT GAC GAC AAC CCT TAT TAC 
VLO 2 28 AAG TAC TCT GAC GAC AAC CCT TAT TAC KY S D D N P Y Y 
Hamalainen 553 AAC TAC TAC GAT ACT TAT GAA AGG CCC 
VLO 2 55 AAC TAC TAC GAT ACT TAT GAA AGG CCC NY Y D T Y E R P 
Hamalainen 580 AGA CCT GGG GGC AGG TAC CGG CCC GGA 
VLO 2 82 AGA CCT GGG GGC AGG TAC CGG CCC GGA 
R P G G R Y R PG 
Hamalainen 607 TAC GGC ACT GGC TAC TTC CAG TAC GGT 
VLO 2 109 TAC G_C ACT GGC TAC TTC CAG TAC GGT 
Y G T G Y F Q Y G 
Hamalainen 634 CTC CCA GAC CTG GTG GCC GAC CCC TAC 
VLO 2 136 OTC CCA GAC CTG GTG GCC GAC CCC TAC 
L P D L V AD P Y 
Hamalainen 661 TAC 3' 
VLO 2 163 TAC 3' 
Y 
Figure 4.13. Comparison of part of the VLO 2 sequence to 
bases 499 -661 of human lysyl oxidase (Hamalainen et 
a/.,1991). The DNA was sequenced using a universal M13 / pUC18 
forward primer. The partial sequence of VLO 2 from the 5' end is shown. 
The corresponding positions of the human cDNA bases (Hamalainen et 
a/., 1991; Fig 4.6) are also shown. Denotes undetermined base. 
(Sequencing performed by Mr J Mackrill, NIMR, London). 
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4.5.2 PCR 
Primers were designed to amplify cDNA from Asp169 in the human 
sequence to the termination codon TAG at residue 418 (Al and A2; Fig. 
4.14) in a PCR using VLO 2 as template (section 2.13.3; protocol 10). This 
amplification product was named ALO 1. The 5' primer (Al) contained a 
Hincll restriction site and the 3' primer (A2) contained a Sphl site to allow 
directional sub -cloning into the polycloning site of the pUC 18 vector (Fig. 
4.15). 
Vent DNA polymerase (New England Biolabs) was used for the PCR. 
Taq DNA polymerase incorporates an incorrect base approximately every 
3500 bases (Tindall et al., 1988), whereas Vent DNA polymerase 
incorporates around five -fold fewer incorrect bases (Mattila et al., 1991). 
Vent DNA polymerase also has 3' - 5' exonuclease activity, is more heat 
stable than Taq polymerase, and does not display terminal transferase 
activity. 
ALO 1 was amplified (Fig. 4.16), and blunt end cloned into the Smal 
restriction site in the polycloning site of pUC18. The DNA produced during 
Vent polymerase PCR reactions are blunt ended, and it is possible to ligate 
these products (without restriction digest) directly into a blunt ended 
restriction site such as Smal. Analysis with the restriction enzyme Scal 
revealed that the construct produced two DNA fragments of approximately 
1825 bp and 1615 bp (Fig. 4.17). This is consistent with a Scal site 22 bp 
downstream of the 5' end of ALO1, which is present in the human lysyl 
oxidase sequence at position 527 -532 (Hamalainen et al., 1991; Fig. 4.6). 




5'GTT GAC GAC CCT TAC AAC CCC TAC 3' 
493 GGC ATG GTG GGC GAC GAC CCT TAC AAC CCC TAC AAG TAC TCT GAC GAC 
165 Gly Met Val Gly Asp Asp Pro Tyr Asn Pro Tyr Lys Tyr Ser Asp Asp 
Primer A2 
Sph I 
3' CG ACG TGT TAA AGT GGC ATA ATCGTACG 
1210 GGA CAT CAT GCG TAT GCC TCA GGC TGC ACA ATT TCA CCG TAT TAG 
404 Gly His His Ala Tyr Ala Ser Gly Cys Thr Ile Ser Pro Tyr END 
5' 
Figure 4.14. The position of the primers Al and A2 on the 
human placental lysyl oxidase precursor sequence 
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Figure 4.16. ALO 1. `Hot start' PCR was used to amplify the DNA 
using VLO 2 as template and primers Al and A2 (Fig. 4.14). Lane 1, 
molecular weight markers (X. DNA, digested with BstEll restriction 
endonuclease); lane 2, DNA produced from a PCR reaction using primers 
















Figure 4.17. Restriction digest of the ALO 1 / pUC 18 construct 
with Scal. (Above) Map of the ALO 1 / pUC 18 construct. (Below) Lane 1, 
molecular weight markers (a, DNA digested with BstEII restriction 
endonuclease); lane 2, restriction digest of the construct with Scal 
restriction endonuclease. 
135 
functional (not shown). Two clones of ALO 1 contained non -functional 
Hindi sites and since this site was incorporated within the 5' primer, it is 
therefore possible that primer Al was synthesised incorrectly by the 
manufacturer. 
4.6 Cloning mature lysyl oxidase cDNA (ALO 2) from VLO 2 
4.6.1 Introduction 
New primers were designed to produce a partial VLO 2 sequence 
from Asp169 to the termination codon at position 418 (A3 and A4; Fig. 
4.18). This time the primers were designed to allow the DNA to be 
directionally cloned directly into the yeast expression vector pDP315 
(kindly donated by Dr D. Pioli, Zeneca Pharmaceuticals, Macclesfield ; Fig. 
4.19) using a Hindi site in primer A3 and a BamHI site in primer A4. In 
primer A3, the Hindi site incorporates three bases that code for aspartate 
169 and the DNA is cut blunt at the start of this codon. Both primers 
contained blunt cutting restriction sites which allows ligation into other 
blunt cutting sites, such as the Stu I site of pDP315. 
pDP315 is a shuttle vector which is able to replicate in both yeast and 
bacteria (Sikorski and Hiefer, 1989). This vector contains the gene coding 
for ampicillin resistance and LEU2, which are selectable markers for E.coli 
and yeast respectively. The LEU2 gene encodes 3- isopropylmalate 
dehydrogenase which allows yeast to synthesize leucine. Yeast leu2 
mutants require complementation with plasmids carrying the LEU2 wild - 
type gene for growth in media lacking leucine. 




5' GCGGTT GAC GAC CCT TAC AAC CCC TAC 3' 
165 GGC ATG GTG GGC GAC GAC CCT TAC AAC CCC TAC AAG TAC TCT GAC GAC 
493 Gly Met Val Gly Asp Asp Pro Tyr Asn Pro Tyr Lys Tyr Ser Asp Asp 
Primer A4 
Bam HI 
3' GT TAA AGT GGC ATA ATCCCTAGGGCG 5' 
1216 CAT GCG TAT GCC TCA GGC TGC ACA ATT TCA CCG TAT TAGAAGGCAAA 
406 His Ala Tyr Ala Ser Gly Cys Thr Ile Ser Pro Tyr END 
Figure 4.18. The position of the primers A3 and A4 on the 
human placental lysyl oxidase precursor sequence 
(Hamalainen et al., 1991) used to amplify the ALO 2 cDNA. 
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Stu I 
Pst Sal I ma Ill 
Pst I 
Xba I 
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a fusion between the gene coding for yeast pre pro -a- factor (80 amino 
acids) and ALO2, separated by DNA coding for the sequence Lys -Arg 
immediately upstream of ALO 2. When expressed, the Kex2 
endopeptidase cleaves after this sequence (Julius et al., 1984) in a late 
Golgi compartment of yeast cells (Graham and Emr, 1991) leading to 
secretion of the complete lysyl oxidase protein. 
4.6.2 PCR 
PCR was performed as described (section 2.13.3; protocol 10), using 
VLO 2 as template and Vent DNA polymerase. PDP315 was cut with Stul 
and the BamHI restriction endonucleases and then treated with alkaline 
phosphatase to prevent re- ligation of the cut ends. pDP315 (approximately 
1µg) was incubated with 1 unit of alkaline phosphatase and 10 of 10 x 
alkaline phosphatase buffer (Boehringer Mannheim) in a volume of 10µI at 
37 °C for 30 minutes. The reaction was then heated to 65 °C for 10 minutes 
before a phenol / chloroform extraction was carried out (section 2.13.5; 
protocol 5). The fragment was digested with Hindi and BamHI, and ligated 
into the vector, which was then used to transform JM109 high efficiency 
competent cells (Table 4.1). These cells were plated onto LB -agar plates 
supplemented with ampicillin. Transformants were analysed by screening 
for the presence of plasmids which generated the pattern of fragment 
expected following digestion with EcoRI nad Xhol. Of approximately 100 
colonies checked, 8 were found to contain the insert and were subjected to 
a plasmid midiprep. Reaction with Scal and Kpnl ( positions shown in Fig. 
4.6) indicated that two of these colonies (C1 and C2) contained the mature 
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lysyl oxidase clone ALO 2 (Fig. 4.20). The construct from Cl was then 
sequenced (Fig. 4.21), and was found to contain a sequence that 
corresponded to human lysyl oxidase (Hamalainen et al., 1991) from the 
codon for Asp 169 to the termination codon 418, except for the absence of 
one A at position 1207, which may have been caused by Vent DNA 
polymerase amplification of ALO2 or Taq DNA amplification of VLO2 . 
4.6.3 Transformation of S.cerevisiae with the ALO 2 construct 
The construct from Cl was used to transform the S.cerevisiae strain 
JRY 188 (kindly donated by Dr. A Boyd; Table 4.1). The method for 
transformation was adapted from Gietz et al. (1992) and is described in 
section 2.18.1. The transformed yeast were grown for 5 days on SD -HUW 
plates (0.65% (w /v) yeast nitrogen base, 2% (w /v) glucose, 2% (w /v) agar, 
20 mg / ml histidine, 20 mg / ml uracil, 20 mg / ml tryptophan), which do not 
contain leucine to select for transformed yeast cells. 
Approximately 80 colonies grew on the the plates which were then used to 
innoculate 400 ml of SD -HUW media. The cells were each grown to an 
optical density of 2.0 units at 600nm, and then centrifuged at 3000 g for 5 
minutes. The volumes of the supernatants were measured and ammonium 
sulphate was added to 80% saturation, followed by mixing overnight at 
4 °C. The suspension was then centrifuged at 12000g for 10 minutes and 
the pellet was resuspended in 2% SDS, 0.5 M NaCI, 0.125 M Tris -HCI, pH 
6.8. Approximately 40 µg of protein from each culture was run on a 12% 
discontinuous SDS -PAGE gel in reducing conditions. Only one very high 
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Sca 1 















1 2 3 4 5 
Sca I 
3600 bp 
Figure 4.20: Restriction digests of the pDP 315 / ALO 2 
construct. ALO 2 was amplified using VLO 2 as template, sub -cloned into 
the shuttle vector pDP 315 and digested with Scal and Kpnl. (Above) Map 
of pDP 315 / ALO 2 construct, showing Scal and Kpnl sites. (Below) Lane 
1, molecular weight markers (X. DNA digested with BstEll restriction 
endonuclease); lanes 2 +4, pDP 315 digested with Scal and Kpnl, 




505 pDp 315 GAC GAC CCT TAC AAC CCC TAC AAG TAC TCT GAC GAC AAC CCT TAT TAC AAC 
Stu I 
GAT AAA AGG GAC GAC CCT TAC AAC CCC TAC AAG TAC TCT GAC GAC AAC CCT TAT TAC AAC 
565 TAC TAC GAT ACT TAT GAA AGG CCC AGA CCT GGG GGC AGG TAC CGG CCC GGA TAC GGC ACT 
TAC TAC GAT ACT TAT GAA AGG CCC AGA CCT GGG GGC AGG TAC CGG CCC GGA TAC GGC ACT 
625 GGC TAC TTC CAG TAC GGT CTC CCA GAC CTG GTG GCC GAC CCC TAC TAC ATC CAG GCG TCC 
GGC TAC TTC CAG TAC GGT CTC CCA GAC CTG GTG GCC GAC CCC TAC TAC ATC CAG GCG TCC 
685 ACG TAC GTG CAG AAG ATG TCC ATG TAC AAC CTG AGA TGC GCG GCG GAG GAA AAC TGT CTG 
ACG TAC GTG CAG AAG ATG TCC ATG TAC AAC CTG AGA TGC GCG GCG GAG GAA AAC TOT CTG 
745 GCC AGT ACA GCA TAC AGG GCA GAT GTC AGA GAT TAT GAT CAC AGG GTG CTG CTC AGA TTT 
GCC AGT ACA GCA TAC AGG GCA GAT GTC AGA GAT TAT GAT CAC AGG GTG CTG CTC AGA TTT 
805 CCC CAA AGA GTG AAA AAC CAA GGG ACA TCA GAT TTC TTA CCC AGC CGA CCA AGA TAT TCC 
44 44 
865 TGG GAA TGG CAC AGT TGT CAT CAA CAT TAC CAC AGT ATG GAT GAG TTT AGC CAC TTG TAC 
TGG GAA TGG CAC AGT TGT CAT CAA CAT TAC CAC AGT ATG GAT GAG TTT AGC CAC TTG TAC 
925 CTG CTT GAT GCC AAC ACC CAG AGG AGA TGG GCT GAA GGC CAC AAA GCA AGT TTC TGT CTT 
CTG CTT GAT GCC AAC ACC CAG AGG AGA TGG GCT GAA GGC CAC AAA GCA AGT TTC TGT CTT 
985 GAA GAC ACA TCC TGT GAC TAT GGC TAC CAC AGG CGA TTT GCA TGT ACT GCA CAC ACA CAG 
GAA GAC ACA TCC TGT GAC TAT GGC TAC CAC *GG CGA TTT GCA TGT ACT GCA CAC ACA CAG 
1045 GGA TTG AGT CCT GGC TGT TAT GAT ACC TAT GGT GCA GAC ATA GAC TGC CAG TGG ATT GAT 
SOA TTC ACT CCT CCC TGT TAT GAT ACC TAT GGT GCA GAC ATA GAC TGC CAG TGG ATT GAT 
1105 ATT ACA GAT GTA AAA CCT GGA AAC TAT ATC CTA AAG GTC AGT GTA AAC CCC AGC TAC CTG 
ATT ACA GAT GTA AAA CCT GGA AAC TAT ATC CTA AAG GTC AGT GTA AAC CCC AGC TAC CTG 
1165 GTT CCT GAA TCT GAC TAT ACC AAC AAT GTT GTG CGC TGT GAC ATT CGC TAC ACA GGA CAT 
STT CCT CAA TCT CAC TAT ACC AAC AAT OTT CTC CGC TOT GAC ATT CGC TAC ACA GGA CAT 
1225 CAT GCG TAT GCC TCA GGC TGC ACA ATT TCA CCG TAT TAG Bam HI 
CAT GCG TAT GCC TCA GGC TGC ACA ATT TCA CCG TAT TAGGGATCCC 
Figure 4.21. Sequence of A 
oxidase cDNA (Hamalainen 
Hamalainen et al., 1991 is shown 
Denotes missing base. 
LO 2 vs human placental lysyl 
et al., 1991). The sequence of 
in comparison with ALO 2 (underlined).* 
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3, 
molecular weight band (90 kDa) was observed on the gels (not shown), 
and no lysyl oxidase activity was observed when 1000 (0.2 mg / ml) of 
protein was assayed with 10011I (1 mg / ml) of [4,5 -3H] lysine labelled elastin 
in assay buffer (100mM sodium borate, 0.15 M NaCI, pH 8.0) in a total 
volume of 900µI (section 2.18.2; not shown). 
4.7 Discussion 
The position of the N- terminus of lysyl oxidase is likely to be Asp 169 
(Cronshaw et al., submitted for publication). Previously, Trackman et al. 
(1990) predicted the site of proteolytic cleavage to be Arg 134 -Arg 135 in 
the rat aorta lysyl oxidase precursor. Indirect evidence also suggests that 
the N- terminus is downstream of this site. The sequence Arg -Arg is not 
conserved at the corresponding position in the human and chick 
sequences (Hamalainen et al., 1991; Wu et al., 1992), while the sequence 
Met -Gly- Asp- Asp- Pro -Tyr (166 -172 human) is conserved in chick, human 
and rat lysyl oxidase. From cyanogen bromide and endoproteinase -Asp -N 
digests of porcine lysyl oxidase (Cronshaw et al., submitted for 
publication), Asp- Asp- Pro -Tyr is also conserved at the N- terminus of the 
mature enzyme. There are two potential glycosylation sites in the rat 
precursor sequence, at positions 91 -93 and 138 -140. Glycosylation has 
been detected only in the precursor form and not the mature form 
(Trackman et aí.,1992), which suggests that the enzyme is processed 
downstream of residue 140 in rat. In the chick lysyl oxidase sequence, the 
first 168 amino acids are poorly conserved with rat (37.5 %). After the 
sequence Met -Gly- Asp- Asp- Pro -Tyr, the extent of conservation becomes 
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very high (94 %), which suggests that the coding sequence for mature lysyl 
oxidase is contained within the well conserved region (Wu et al., 1992). 
Finally, a restriction fragment length polymorphism (RFLP) that causes a 
G -A transition has been discovered within the first exon of the human lysyl 
oxidase gene (Csiszar et al., 1993). This transition creates a novel Pst I 
restriction site which has been detected in 36% of the healthy patients 
screened during a study, and should result in a glutamine being encoded 
instead of arginine at position 158 (arginine at this position is conserved in 
the chick, rat and human sequence). If the processing site of lysyl oxidase 
was upstream of this amino acid substitution as suggested by Trackman et 
al. (1991), the effect (if any) of this substitution would be more likely to 
cause disruption to the enzyme function than if it was within the precursor 
region. 
A yeast expression vector construct has been prepared that contains 
the cDNA sequence of human placental lysyl oxidase from the codon for 
Asp 169 to the termination codon at position 418 (Hamalainen et al., 1991). 
The vector has been used to transform JRY 188 S. cerevisiae, and the 
medium precipitated with ammonium sulphate. No lysyl oxidase activity 
could be detected in the medium and only one high molecular weight 
protein band (90 kDa) was present when a fraction of concentrated 
medium was run on 12% SDS -PAGE in reducing conditions. This result is 
consistent with the base omission at position 1207, which would cause a 
frame shift, leading to incorrect translation of the last 16 codons in the 
sequence and incorrect termination. To overcome the problem of the 
missing base in the sequence, site -directed mutagenesis may be used to 
insert an adenine at position 1207. 
Successful expression and secretion of lysyl oxidase may depend on 
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optimizing cell density, medium composition and temperature. Alternative 
yeast strains may also be tried to optimize secretion. The extraction 
procedure for the secreted enzyme from the medium may require 
manipulation since the SD -HUW medium is highly viscous after 
concentration in ammonium sulphate and centrifugation, leading to 
difficulty in re- suspension of the pellet. A less viscous medium may be 
useful to ensure a high recovery of protein. 
It is unknown whether yeast cells are capable of producing active 
lysyl oxidase. Lysyl oxidase contains an unidentified carbonyl containing 
co- factor (topaquinone or PQQ; Kagan et al., 1986). The yeast amine 
oxidase gene from Hansenula polymorpha contains topaquinone (Mu et 
al., 1992), however it is unknown whether S.cerevisiae is capable of 
modifying such proteins with topaquinone. The E.coli strain K -12 has been 
shown to produce an amine oxidase which contains topaquinone and 
copper (Cooper et al., 1992). Since lysyl oxidase contains no detectable 
glycosylation, it may be possible to produce active lysyl oxidase from this 
K -12 strain of E.coli. 
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Chapter 5 
Studies on an enhancing protein of lysyl oxidase 
146 
5.1 Introduction 
Lysyl oxidase acts extracellularly to initiate cross -linking in collagens 
and elastin. To date, the regulation of lysyl oxidase activity has only been 
studied at the hormonal level (1.4.8). Other control mechanisms such as 
processing of the 50kDa precursor (Trackman et al., 1992) are yet to be 
studied. 
Stimulation of lysyl oxidase by cationic amphiphiles such as 
dodecylamine hydrochloride has been demonstrated by Kagan et al. 
(1981). Lysyl oxidase activity can be stimulated up to four times in the 
presence of these molecules. Lysyl oxidase is a highly acidic protein with 
an isoelectric point of pl = 5 (J.R.E MacBeath, personal communication), 
whereas elastin is largely hydrophobic. It has been suggested that cationic 
amphiphiles help provide favourable electrostatic interactions between 
lysyl oxidase and elastin (Kagan et al., 1981). 
to the present study, partially porcine 
skin (with little or no endogenous lysyl oxidase activity) were found to 
stimulate lysyl oxidase up to four fold using an elastin substrate (Dr D.R. 
Shackleton, personal communication). These extracts were not found to 
stimulate activity when [4,5-3H] lysine labelled collagen was used as 
substrate. Attempts were made to isolate the activating factor, which is 
referred to as `Eclefin': Elastin cross -Linking Enhancer Factor. 
5.2 Purification of lysyl oxidase 
Lysyl oxidase was prepared from stillborn piglet skin (section 2.1) using 
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the method of Shackleton and Hulmes (1990a). The skins were minced 
and homogenised in PBS (9 mM Na2HPO4, 1mM NaH2PO4, 0.15M NaCI, 
pH 7.8), and then washed in PB (9 mM Na2HPO4, 1 mM NaH2PO4, pH 7.8) 
before extraction in 6M PBU (PB, 6 M urea, pH 7.8). (To reduce the 
accumulation of cyanate, all urea solutions were passed through a mixed 
bed deionizing resin before use, then stored at 0 °C and used within 2 -3 
days of preparation.) The filtered extract was loaded onto a DEAE - 
Sephacel fast flow ion exchange column (2.6 x 40 cm), pre -equilibrated 
with 6M PBU, pH 7.8. The lysyl oxidase fraction was eluted in 6M PBU, 0.5 
M NaCI and dialysed exhaustively against PB, pH 7.8. The protein was 
then loaded onto a Sephacryl S -400 column, pre -equilibrated with PB pH 
7.8. In the absence of urea, lysyl oxidase binds selectively to Sephacryl S- 
400 and can be eluted with PBU, pH 7.8, providing an almost 140 fold 
purification (Shackleton and Hulmes, 1990a). Fractions from the S -400 
column were analysed by SDS -PAGE (Fig. 3.1), and showed two major 
protein bands, lysyl oxidase (32 -33 kDa) and TRAMP (Tyrosine Rich Acidic 
Matrix Protein; 24 kDa). The amount of TRAMP was approximately 2 -4 fold 
greater than lysyl oxidase. 
To improve the separation of lysyl oxidase and TRAMP, the procedure 
was modified as described by Cronshaw et al. (1993). In brief, the initial 6M 
PBU extract was diluted with PB, pH 7.8 to a final urea concentration of 2 
M. The diluted extract was then loaded onto a DEAE -Sepharose column, 
pre -equilibrated with 2M PBU, pH 7.8 (2 M urea, PB, pH 7.8), and the 
column was washed in 2M PBU followed by PB. The column was eluted 
with PB, 0.3 M NaCI, pH 7.8 to remove the bulk of the protein, followed by 
3M PBU, 0.3 M NaCI, pH 7.8, which removes lysyl oxidase and a small 
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quantity of TRAMP. Finally, TRAMP was eluted from the column with 6M 
PBU, 0.5 M NaCI, pH 7.8. The lysyl oxidase fraction was then loaded onto 
a Sephadex G -25 gel filtration column (5.6cm x 100cm), pre -equilibrated 
with PB, pH 7.8 to remove urea and salt. Finally, this desalted lysyl oxidase 
fraction was loaded as before onto an Sephacryl S -400 column (2.6cm x 
40 cm), pre -equilibrated with PB pH 7.8, then washed with PB and finally 
eluted in 6M PBU, pH 7.8. 
5.3 Assay of lysyl oxidase activity 
Lysyl oxidase activity was assayed using the trituim release assay. 
Tritium was collected by ultrafiltration (protocol 1 a) or microdistillation 
(protocol 1 b) using 1000 of [4,5 -3H] lysine labelled elastin (3000 dpm /0), 
as substrate (Shackleton and Hulmes 1990b; section 2.4). Assays were 
regularly perfomed in duplicate, together with control assays in the 
presence of 0.2 mM ß- aminopropionitrile, a specific and irreversible 
inhibitor of lysyl oxidase activity (Siegel et al., 1970; Narayanan et al., 
1972). 
5.4 Definition of eclefin activity 
Control samples containing 1000 of [4,5 -3H] lysine labelled elastin, 
1000 of 6M PBU and 70011I of assay buffer were assayed to calculate 
background counts, and this was subtracted from all other assay results. 
The enhancement of lysyl oxidase activity produced by eclefin is defined 
as follows. Counts from assays containing lysyl oxidase in the absence of 
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eclefin, and from assays containing eclefin only (to correct for any 
endogenous lysyl oxidase activity) are subtracted from counts of assays 
containing lysyl oxidase in the presence of eclefin, to give counts 
attributable to enhancement only. To calculate the enhancement factor, 
enhancement counts were divided by counts from the assay of lysyl 
oxidase only. 
i.e. F = (A - B) - (C - B) - (D - B) A= Lysyl oxidase + Eclefin 
(C - B) B= Background 
C= Lysyl oxidase 
D= Eclefin 
5.5 Eclefin purification 
Eclefin was prepared from 6M PBU extracts of porcine skin by cation - 
exchange chromatography using a CM- Sepharose column (2.6 x 40 cm) 
pre -equilibrated with 6M PBU, and then eluted with 6M PBU, 1 M NaCI, pH 
7.8. No eclefin activity was observed in fractions that bind to DEAE- 
Sepharose at pH 7.8. After exhaustive dialysis of the pooled, protein 
containing fractions against PB, pH 7.8, the partially purified eclefin was 
loaded onto a Sephacryl S -400 column (2.6 x 40 cm) pre -equilibrated with 
PB, pH 7.8, and the eclefin containing fractions were eluted in 6M PBU, pH 
7.8 (Fig. 5.1). 
Analysis of the eclefin containing fractions on 12% SDS -PAGE under 
reducing conditions, followed by staining with Coomassie blue (Fig. 5.2), 
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Figure 5.1. Enhancing activity of eclefin fractions from 
Sephacryl S -400. Urea extracts of porcine skin were were loaded on to 
a CM- Sepharose ion exchange column and protein fractions were eluted 
with 6M PBU / 1 M NaCI. The fractions were dialysed against PB, pH 7.8 
and then loaded on to Sephacryl S -400 in the absence of urea. Eclefin 
was eluted in 6M PBU, and the fractions were measured for protein content 
at 280nm and assayed for enhancement of lysyl oxidase activity using [4,5- 












- 15000 - 14000 
Figure 5.2. Discontinuous SDS -PAGE of lysyl oxidase 
enhancing extracts eluting from Sephacryl S -400. The fraction 
showing the greatest enhancement factor from Fig. 5.1 was analysed on 
SDS -PAGE with a 12% separating gel, followed by Coomassie blue 
staining (right). Molecular mass was determined by a plot of migration 
distance vs log kDa, using protein standards as shown (left). 
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kDa, 62 kDa and 85 kDa. 
Inclusion of 1µg of the eclefin fraction in the tritium release assay with 
5011I (24) of lysyl oxidase and 10011I of [4,5 -3H] lysine labelled elastin 
produced an enhancement factor of up to 2.00 using the ultrafiltration 
assay (Table 5.1), and up to 1.79 using the microdistillation assay. 
Enhancement factor errors were calculated according to the following 
equation (D.J.S.Hulmes, personal communication) : 
8Y2 = 8a2 + (c -a)2 8b2 + 8c2 + (c -a)2 6d2 
(b -d)2 (b -d)4 (b -d)2 (b -d)4 
a = Eclefin + Lysyl oxidase 
b = Lysyl oxidase 
c = Eclef in 
d = Control 
Ultrafiltration and microdistillation were both used to isolate tritiated 
water from the reaction to determine whether enhancement was due to an 
artefact caused by the water isolation technique. The presence of 0.2 mM 
BAPN abolished all activity, indicating that lysyl oxidase was specifically 
responsible for all the activity observed (Table 5.2). Eclefin enhanced lysyl 
oxidase activity after exhaustive dialysis of both against PB, pH 7.8 to 
remove urea (not shown) 
5.6 Fast protein liquid chromatography 
Attempts were made to further purify and identify the molecular mass 
of eclefin using fast protein liquid chromatography (FPLC). An enhancing 
fraction (1 ml) containing 201.g of protein obtained from Sephacryl S -400 
was dialysed exhaustively against PBS, pH 7.8 and concentrated 10x 
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Table 5.1. Effect of eclefin on lysyl oxidase activity using [4,5- 
3H] lysine labelled elastin as substrate. 
Addition to assay cpm 
± S.E. 
(n =3) 






Control 2256 ± 152 100 ± 6.7 
Lysyl oxidase 3711 ± 187 164 ± 5.0 1 
Eclefin 2223 ± 39 100 11.7 
Eclefin + Lysyl oxidase 5170 ± 216 229 ± 4.2 2.00 ± 0.4 
Microdistillation 
Control 2537 226 100 11.0 
Lysyl oxidase 3706 ± 159 146 ± 4.3 1 
Eclefin 2631 ± 56 104 22.1 
Eclefin + Lysyl oxidase 4797 1135 189 ± 2.8 1.79 ± 0.28 
Lysyl oxidase (24), eclefin (14; section 5.5) and 1000 [4,5 -3H] lysine labelled 
elastin were incubated in assay buffer (0.1 M sodium borate, 0.15 M NaCI, pH 8.0) 
in a total volume of 9000 overnight at 370C. Control samples contained substrate 
alone with no lysyl oxidase or eclefin. 
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Table 5.2. Effect of 2 mM ß- aminopropionitrile on the 
enhancement of lysyl oxidase activity by eclefin. 
Addition to assay dpm 
+ S.E. 
activity % of control Enhancement 
factor 
± S.E. 
Experiment 1 (n =3) (n=3) 
Control 2279 ± 47 100 ± 2.1 
Lysyl oxidase 4099 ± 163 180 ±4.0 1.00 
Eclefin 2387 ± 112 105 ±4.7 
Eclefin + Lysyl oxidase 4602 ± 120 202 ± 2.6 1.28 ± 0.14 
Eclefin + Lysyl oxidase (BAPN) 1950 ± 66 86 ± 3.4 <1.00 
Experiment 2 (n =2) (n=2) 
Control 334 ± 12.5 100 ± 3.7 
Lysyl oxidase 773 ± 5 231 ± 0.6 1.00 
Eclefin 432 ± 39 129 ± 9.0 
Eclefin + Lysyl oxidase 1026 ± 24 307 ± 2.3 1.58 ± 0.11 
Eclefin + Lysyl oxidase (BAPN) 426 ± 38 127 ± 8.9 
Lysyl oxidase (24) was assayed with eclefin (14; section 5.5) and 1000 [4,5- 3H] 
lysine labelled elastin overnight at 37 °C in assay buffer (0.1 M sodium borate, 0.15 
M NaCI, pH 8.0) using the ultrafiltration method. 
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using an Amicon centricon filter unit with a molecular mass cut off point of 
10 kDa. A 100µI sample of the concentrate was then loaded onto a 
Pharmacia Superose 6 gel filtration column (1.6cm x 30 cm), pre - 
equilibrated in PBS, pH 7.8 , and eluted at 5000 / minute. Superose 6 
gives optimal separation of proteins in the range 5 - 5000 kDa. Fractions 
from the column were then assayed for lysyl oxidase enhancing activity 
using the ultrafiltration assay (section 2.4). Two fractions (8 and 19), eluting 
separately from the Superose 6 column, showed enhancing activity (Fig. 
5.3). When analysed by SDS -PAGE, followed by silver staining (section 
2.10.3; Fig. 5.4), a band at 14kDa was observed in fractions 17,18 and 19; 
and a 15kDa band was also observed in fraction 19. 
5.7 Peroxidase release- coupled fluorometric assay 
The activity of lysyl oxidase can be measured continuously by the 
hydrogen peroxide produced using artificial substrates such as 1,5- 
diaminopentane (Trackman et al., 1981; section 2.5). The reaction is 
carried out at an optimal temperature of 55 °C in the presence of horse 
radish peroxidase and a chromophore such as homovanillate. The 
peroxidase catalysed oxidation of the chromophore by H2O2 produces a 
fluorescent molecule that can be measured using excitation and emisson 
wavelengths of 315 nm and 425 nm respectively. 
The reaction was calibrated by adding known amounts of hydrogen 
peroxide to the reactants in the absence of lysyl oxidase, to give a standard 
curve (Fig. 5.5). The use of nonpeptidyl diamine substrates causes lysyl 
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Figure 5.3. Gel permeation of concentrated eclefin fractions in 
the absence of urea on FPLC. An eclefin fraction (201g ; section 5.5) 
was dialysed against PBS and concentrated 10 x using an Amicon 
Centricon filter unit (10kDa) and loaded on to a Superose 6 gel permeation 
column pre -equilibrated in PBS, pH 7.8. Fractions (1m1) were eluted at 
500111/ minute, and 500 of each fraction was assayed with lysyl oxidase 
















Figure 5.4. Discontinuous SDS -PAGE of concentrated eclefin 
fractions eluted from an FPLC gel permeation column in the 
absence of urea. An eclefin fraction (204 ; section 5.5) was dialysed 
against PBS, concentrated 10x using an Amicon Centricon filter unit (10 
kDa) and loaded on to a Superose 6 gel permeation column pre- 
equilibrated in PBS, pH 7.8. Fractions were eluted at 500pl/ minute, and 
100p of each fraction were analysed on SDS -PAGE with a 12% separating 
gel, followed by silver staining (section 2.10.3). 
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Figure 5.5. Standard curve of fluorescence versus hydrogen 
peroxide concentration in the peroxidase catalysed oxidation of 
homovanillate. Hydrogen peroxide was added in 200 pmole aliquots to 
1254 homovanillate, and 204 horse radish peroxidase in a total volume 
of 1 ml of assay buffer (0.1 M sodium borate, 0.15 M NaCI, pH 8.0), and 
incubated at 55 °C. Fluoresence was measured with an excitation 
wavelength of 315nm and an emission wavelength of 425nm. 
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(Trackman et al., 1981). As a result, the rate of release of H2O2fell to zero 
due to enzyme inactivation before substrate was exhausted. Subsequent 
addition of new lysyl oxidase restored hydrogen peroxide release to initial 
rates (Fig. 5.6). 
Inclusion of eclefin (1µg) in the reaction caused a slight reduction in 
release of hydrogen peroxide over a 45 minute period (Fig. 5.7). Hydrogen 
peroxide release was measured over the first 3 minutes of the assay at 
different substrate concentrations in the presence and absence of eclefin 
(1µg; Fig. 5.8). The apparent Km and V max values were calculated for these 
according to the Hanes equation (Hanes, 1932) by plotting substrate 
concentration / initial hydrogen peroxide release against substrate 
concentration (Fig. 5.9). The Hanes plot allows calculation of Km and Vmax 
from the intercept of the slope with the X -axis ( -Km) and the gradient of the 
slope (1 / V max ), respectively. The apparent Km with 2µg lysyl oxidase in 
the absence of eclefin was 9.93 x 10 -4 M which compares with the results 
of Trackman et al. (1981) who observed an apparent Km of 5 x 10 -4 M using 
4µg of purified lysyl oxidase. In the presence of eclefin (11.1g) the apparent 
Km was 7.27 x 10-4 M. The apparent Vmax in the absence of eclefin was 
69.4 pmoles min-1 and 65.4 pmoles min-1 in the presence of eclefin. These 
results indicate that eclefin probably has no enhancing activity on lysyl 
oxidase using 1,5- diaminopentane as substrate. 
5.8 Stability of eclefin 
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Figure 5.6. Lysyl oxidase inactivation using 1,5- 
diaminopentane as substrate. Lysyl oxidase (24) was added at t =0 
and t =52 minutes to the reaction containing 1,5- diaminopentane (1754), 
horse radish peroxidase (20µg), homovanillate (1254) and assay buffer 
(0.1M sodium borate, 0.15 M NaCI, pH 8.0), total volume 1 mi. The reaction 
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Figure 5.7. Hydrogen peroxide (pmoles) released from the 
fluoresence coupled lysyl oxidase assay in the presence and 
absence of eclefin. Lysyl oxidase (21.1g) was assayed for activity in the 
presence and absence of eclefin (14; section 5.5). Hydrogen peroxide 
was measured by the fluorescence produced as a result of the reaction 
between hydrogen peroxide and homovanillate (1254) in the presence of 
horse radish peroxidase (204), and 175 µg 1,5- diaminopentane as 
substrate at 55 °C. Fluoresence was measured with an excitation 
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Figure 5.8. Dependence of the initial rate of hydrogen peroxide 
release on the concentration of 1,5- diaminopentane in the 
peroxidase -coupled assay. Lysyl oxidase (2 µg) was assayed using 
the peroxidase coupled assay (section 2.5). Hydrogen peroxide release 
was measured over 3 minutes, and the mean rate of release per minute 














Figure 5.9. Hanes plots of the peroxidase -coupled lysyl 
oxidase assay. Concentration of 1,5- diaminopentane (µM) divided by the 
initial rate of release of hydrogen peroxide over three minutes (pmoles 
min -1) in a peroxidase coupled assay (section 2.5) using 24 lysyl oxidase 
vs concentration of 1,5- diaminopentane (µM) in the presence (a) and 
absence (b) of eclefin (14). 
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to enhance lysyl oxidase activity. However, subjecting eclefin to 
temperatures of 95 °C - 100 °C for 10 minutes abolished enhancing activity 
completely (Table 5.3). Eclefin is therefore relatively heat stable. 
Eclefin activity could be detected up to six months after purification 
when stored at 4 °C, but activity was lost completely after short term 
storage at -10 °C (not shown). 
5.9 Is eclefin a protein? 
Trypsin (E.C.3.4.21.4) is a mammalian serine protease that cleaves 
polypeptide chains at Lys / Arg -X sites, where X is non -specific. Trypsin is 
enzymatically fully active in urea solutions up to 6.5 M (Delaage and 
Lazdunski, 1968), and its optimal working pH range is 8.5 -8.8. To 
investigate whether eclefin was a protein, stimulating fractions were 
subjected to trypsin digestion, and subsequently assayed in a tritium 
release lysyl oxidase assay. 
An enhancing fraction from the Sephacryl S -400 column was 
incubated with trypsin (25 µg / ml) in 6M PBU, pH 7.8 for 5 hours at room 
temperature followed by incubation with soybean trypsin inhibitor (2 mg / 
ml) in 6M PBU, pH 7.8 for 20 minutes, also at room temperature, to inhibit 
trypsin activity. Controls without eclefin were also incubated with trypsin 
and soybean trypsin inhibitor. Eclefin (1µg) was then assayed for 
enhancing activity on lysyl oxidase by microdistillation, using [4,5 -3H] 
lysine labelled elastin (1000) as substrate. A control, containing inactivated 
trypsin incubated with lysyl oxidase alone showed that trypsin was totally 
inactivated by the soybean trypsin inhibitor, since lysyl oxidase remains 
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Table 5.3. Effect of prior heat treatment of eclefin on 
enhancement activity. 
Addition to assay cpm 
+ S.E. 
(n=2) 









Ecleptin + Lysyl oxidase 
2537 ± 261 
3706 ± 159 
2631 ± 56 










1.79 ± 0.28 
Eclefin heated at 800C 
Control 3048 ± 88.5 100 ± 2.9 
Lysyl oxidase 4332 ± 10.5 142 00.2 1.00 
Ecleptin 3104 ± 22.5 102 ± 0.7 
Ecleptin + Lysyl oxidase 5190 ± 0.5 170 ± 0.0 1.59 00.18 
Eclefin heated at 1000C 
Control 3004 ± 156 100 ± 5.2 
Lysyl oxidase 5400 ± 72 180 ± 1.3 1.00 
Ecleptin 3011 ± 149 100 ± 4.9 
Ecleptin + Lysyl oxidase 5458 ± 56 181 ± 1.0 1.02 ± 0.1 
(Top) Untreated eclefin (111g; section 5.5) assayed for activity with lysyl oxidase 
(24) and 100µI [4,5 -3H ] lysine labelled elastin using the ultrafiltration method. 
(Middle) Eclefin (111g) heated to 80 °C for 90 minutes before cooling and being 
assayed with lysyl oxidase (24). (Bottom) Eclefin (14) heated to 100 °C for 10 
minutes and then cooled before assaying with lysyl oxidase. 
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fully active. No stimulation was observed from eclefin fractions that had 
been pre- treated with trypsin followed by soybean trypsin inhibitor (Table 
5.4).This indicates that eclefin is probably a protein. 
5.10 Effect of substrate concentration 
Enhancement of tritiated water release was measured at different 
concentrations of [4,5 -3H] lysine labelled elastin, with eclefin (1µg) and 
lysyl oxidase (214). The results (Fig 5.10) show that enhancement was 
greater at low concentrations of radiolabelled elastin. This indicates that 
eclefin may increase the affinity between lysyl oxidase and elastin, or 
increase the number of lysine residues accessible to lysyl oxidase. 
5.11 Discussion 
Background radioactivity in the lysyl oxidase assay, using 10011I of 
[4,5 -3H] lysine labelled elastin can give a high signal -to -noise ratio, as 
observed in the assays shown in Table 5.1, where control samples show 
greater than 2000 dpm. During the lysyl oxidase assay using ultrafiltration, 
it is possible that small radiolabelled peptides generated from the elastin 
may filter through the 10kDa cut -off membrane used. Another contributing 
factor to the high background may be endogenous lysyl oxidase activity in 
the elastin substrate, which is not inhibited by the addition of BAPN (0.2 
mM) during preparation of the elastin (section 2.3). 
There is evidence from Superose -6 gel permeation FPLC that eclefin 
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Table 5.4. Effect of prior trypsin treatment on eclefin. 
Addition to assay cpm activity % of control Enhancement 
factor 
t S.E. ± S.E. 
(n=3) (n=3) 
Control 1253 ± 14 100 t 1.1 
Lysyl oxidase 1946 ± 4.5 155 ± 0.2 1.00 
Eclefin 1275 ± 144 102 111.3 
Eclefin + Lysyl oxidase 2228 ± 67 178 ± 3.0 1.41±0.23 
Eclefin (trypsin) +Lysyl oxidase 1961 ± 3 156 i 0.2 1.02± 0.21 
Control (trypsin) + Lysyl oxidase 2059 ± 59 164 ± 2.9 
Eclefin (1µg; section 5.5) was incubated with 254 / ml trypsin for 5 hours follow d 
by inactivation with 2mg / ml soybean trypsin inhibitor type I -S. Trypsin treated 
eclefin (14; 5011I) was then incubated with lysyl oxidase (24; 500) and [4,5 -3H] 
lysine labelled elastin (1001.I). Radiolabelled water produced in the reaction was 
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Figure 5.10. Effect of [4,5 -3H] lysine labelled elastin 
concentration on the enhancement of lysyl oxidase activity by 
eclefin. Lysyl oxidase (214) was incubated with increasing amounts of 
radiolabelled elastin in the presence of eclefin (14g) and assay buffer, at 
370C overnight in a total volume of 900u.I. 
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may aggregate in the absence of urea, since eclefin dialysed exhaustively 
against PBS and then run on a gel permeation column eluted in two 
separate fractions (8 and 19). 
The mechanism of lysyl oxidase enhancement by eclefin is unknown. 
However, studies carried out with cationic and anionic amphiphiles 
suggest that the affinity of pancreatic elastase and lysyl oxidase for elastin 
may be influenced by charge and hydrophobicity of the substrate. 
Susceptibility of elastin to digestion by pancreatic elastase has been 
shown to increase by incubation of elastin with anionic detergents e.g. 
sodium dodecyl sulphate (Kagan et al., 1972), sodium linolate (Kagan et 
aL, 1979b) or bile acids (Jordan et al., 1974). Susceptibility of elastin to 
elastase digestion is inhibited by incubation with the cationic detergent, 
dodecyltrimethylammonium chloride (Kagan et al., 1979b) and also by 
maleylation of elastase, which stops adsorption of elastase to elastin (Hall 
et al., 1 961; Gertler 1971). Changes in the circular dichroism spectrum of 
soluble elastin and stimulation of pancreatic elastase activity were 
observed when alkyl sulphate chains containing eight or more carbons 
were incubated with elastin (Jordan et aL, 1974). This suggests that ligand- 
induced conformational changes are responsible for stimulating effects. An 
anionic polar group was found to be necessary for stimulation, whereas 
neutral group or non -ionic detergents had no effect and cationic groups 
inhibited activity. 
The effects of cationic amphiphiles have also been studied on lysyl 
oxidase (Kagan et al., 1981). It was found that sodium dodecyl sulphate, 
bile salts and fatty acid salts are able to inhibit elastin oxidation by lysyl 
oxidase, whereas neutral detergents and non -hydrophobic molecules had 
no effect. Cationic amphiphiles such as dodecylamine hydrochloride could 
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stimulate lysyl oxidase activity up to five fold (Kagan et al., 1981). No 
effects on the oxidation of n- butylamine were observed when this substrate 
was treated with dodecylamine hydrochloride, which indicates that there is 
no direct effect on lysyl oxidase by these charged molecules. 
Studies on the effects of cationic amphiphiles may provide a model 
for the effect of eclefin on the oxidation of elastin by lysyl oxidase. Eclefin 
does not seem to enhance activity when radiolabelled collagen or 1 ,5- 
diaminopentane is used as substrate, consistent with an elastin specific 
interaction. Eclefin is extracted from porcine tissue in the presence of 6M 
urea, which indicates that it is probably hydrophobic, and requires the 
disruption of hydrogen bonds for solubilization. Also, unlike lysyl oxidase, 
eclefin binds to CM- Sepharose in the presence of 6M PBU, pH 7.8. 
It is possible that eclefin binds to elastin by hydrophobic interactions, 
and disrupts the structure of the substrate in such a way as to increase 
accessibility of potential lysine cross -linking sites to lysyl oxidase. 
Alternatively, eclefin may produce favourable electrostatic interactions 
between lysyl oxidase and localised areas of the elastin molecule, 
allowing lysyl oxidase to oxidise lysine residues in these areas. 
Evidence supporting a mechanism whereby more lysine residues 
become available for oxidation by the action of eclefin comes from 
observing enhancement at different elastin concentrations (section 5.10). 
At low elastin concentrations, stimulation appears to be greatest, which 
could indicate that eclefin is able to increase the number of potential cross - 
linkable lysine residues, thereby increasing the effective substrate 
concentration and increasing the reaction velocity towards Vmax. At higher 
elastin concentrations where the reaction velocity tends towards Vmax, the 
reaction appears to be stimulated less. Data regarding the Km and Vmax of 
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the lysyl oxidase reaction with elastin are difficult to obtain using the 
discontinuous trituim release assay because initial reaction velocities 
cannot be easily measured. Studies using the fluoresence- coupled assay 
(Trackman et al., 1983) will be necessary to establish the effect of eclefin 
on Km and Vmax in the lysyl oxidase reaction with elastin, although this 
substrate is poor in comparison to artificial substrates such as 1,5- 
diaminopentane when used in this assay. 
It is possible that eclefin is a regulatory enzyme of elastin turnover. 
Since cationic amphiphiles are capable of inhibiting the action of 
pancreatic elastase, and are able to stimulate lysyl oxidase activity, this is 
consistent with a system in which elastin degradation can be down - 
regulated and elastin synthesis increased when required. Eclefin, which is 
isolated from the same porcine tissue as lysyl oxidase and similarly 
hydrophobic, may be a naturally occurring lysyl oxidase enhancing 
enzyme involved in such an elastin regulating mechanism in vivo . Work is 
required to find out if eclefin is able to inhibit elastase activity, just as 







Part of the present study has been concerned with distribution of 
TRAMP in murine tissue, and its possible enzymatic role in tissue. It has 
been found previously that TRAMP is able to accelerate collagen fibril 
formation in vitro (MacBeath et al., 1993), and work here suggests that 
TRAMP may be a collagen specific lysyl oxidase. Further information on 
interactions between TRAMP and collagen may be obtained using the 
polyclonal antiserum raised against TRAMP, and immunogold localisation 
in the electron microscope. The studies presented here focus on collagen I, 
and therefore future work may be directed to demonstrate the effect of 
TRAMP on other collagen types, especially the fibrillar collagens. 
The interaction of TRAMP with other extracellular matrix components 
may also be determined using electron microscopy. It has been suggested 
that dermatan sulphate proteoglycans may bind to TRAMP, through the 
dermatan sulphate chain (Lewandowska et al., 1991). The same study 
reported TRAMP / cell surface binding to human and bovine dermal 
fibroblasts as well as Balb /c 3T3 cells in vitro, possibily mediated through 
the sequence Arg -Gly- Ala -Thr in TRAMP (Neame et al., 1989), which has 
potential integrin binding ability (Lewandowska etal., 1991). 
To determine more accurately the lysyl oxidase activity of TRAMP on 
collagen, it may be necessary to label collagen with [6 -3H] lysine instead of 
[4,5 -3H] lysine, because during the conversion of lysine to hydroxylysine, 
one tritium atom is lost from the 5- position (Popenoe et al., 1965), which 
means that there is less potential radioactivity in the exchangeable 5- 
position in highly hydroxylated collagen (Miller, 1972). 
TRAMP carries the sequence Asn / Tyr / Asp which has been reported 
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as a consensus sequence for the incorporation of topaquinone in copper 
containing amine oxidases. To determine whether TRAMP actually 
contains topaquinone, this can be detected by derivatizing the protein with 
phenylhydrazone and examining the spectrophotometric properties of the 
derivatives. At neutral pH, the derivatives of other copper dependent amine 
oxidases have a Xmax of 457 - 463 nm. When these are exposed to 2 M 
KOH the Amax shifts to 578 - 585nm. These maxima closely resemble those 
displayed by the p- nitrophenylhydrazone derivative of topaquinone 
hydantoin, which has a Xmax of 455nm and 575nm in neutral and basic 
solutions respectively (Janes et al., 1992). These spectral properties are 
thought to be unique to topaquinone, and can be utilised for detection in 
TRAMP. 
The publication of the human TRAMP cDNA sequence (Superti- 
Furga et al., 1993) allows the possibility of sequencing porcine TRAMP 
cDNA, and then expressing this in a yeast expression vector. Production of 
TRAMP will then be possible in the absence of urea, which denatures 
proteins and may cause carbamylation of a -amino and e -amino groups on 
the side chains of lysine residues. Expression of recombinant TRAMP 
cDNA altered by site directed mutagenesis will allow investigation of 
regions that are necessary for catalysis. 
6.2 Lysyl oxidase 
A construct for the expression of mature human lysyl oxidase in S. 
cerevisiae has been synthesised during this study from human placental 
cDNA amplified using the polymerase chain reaction. This construct has 
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been found to lack one adenine base at position 1205 compared with the 
human lysyl oxidase cDNA sequence published by Hamalainen et al. 
(1991), probably due to an error made by either the Taq DNA polymerase 
used to amplify VLO 2 or the vent DNA polymerase used to amplify ALO 2 . 
The missing base can be inserted using an oligonucleotide which 
will facilitate mutagenesis. In this method (Wallace et al., 1981; Zoller and 
Smith, 1982), an oligonucleotide is synthesised complementary to the DNA 
flanking the missing base. The oligonucleotide carries the extra base at the 
correct position for insertion and acts as a primer for a single stranded 
ALO2 i` vector template which is copied using DNA polymerase and then 
ligated at the ends, forming heteroduplex DNA. When transformed into E. 
coli, the heteroduplex denatures and both strands replicate, leading to 
double stranded wild -type and mutant DNA (i.e. with the extra base). There 
are ways to identify a mutant clone i.e. the mutant oligonucleotide used to 
introduce the mutation can be radiolabelled and hybridized to E.coli 
colony DNA. The temperature of the hybridization can be raised to a point 
at which the oligonucleotide will only bind mutant DNA, allowing its 
identification. 
Successful expression of the protein from this construct in yeast will 
depend on several factors which are currently being addressed. To detect 
the presence of the protein in the yeast medium, [14C] labelled BAPN is 
being prepared. This compound should be capable of irreversibly binding 
to and labelling lysyl oxidase secreted by yeast cells, therefore allowing 
identification of the enzyme in large volumes of medium. [ 14C] BAPN 
however requires the presence of the enzyme carbonyl containing cofactor 
before irreversible binding takes place (Tang etal., 1983) and currently it is 
not known whether S. cerevisiae will incorporate the correct cofactor into 
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the enzyme. 
To overcome problems of expression of active lysyl oxidase in yeast, 
it may be necessary to use a bacterial expression system. E.coli K -12 
produces an amine oxidase which catalyses oxidation of 2- 
phenylethylamine and contains copper and topaquinone cofactors 
(Cooper et al., 1992). Since there is no detectable glycosylation in lysyl 
oxidase, a bacterial cell may be able to produce active enzyme. 
Manipulation of the lysyl oxidase DNA by reverse genetic 
techniques may be used to study many aspects of the enzyme structure 
and functions such as the active site, cofactor binding domains, substrate 
binding domains. The nature of lysyl oxidase variants may also be 
elucidated by such techniques. 
Information regarding the effects of mutations in lysyl oxidase can 
then be used to address the causes of genetic diseases within connective 
tissue, and also may prove valuable in cancer therapies, since the rat lysyl 
oxidase gene has been found to be a homologue of the mouse ras recision 
gene Kenyon et al., (1991). In turn, mutation studies may also shed light on 
the possible link between an enzyme that initiates collagen and elastin 
cross -linking and the apparent ability to suppress tumours. 
Lysyl oxidase expression is down -regulated in H -ras transformed 
NIH 3T3 cells (Contente et al., 1990) and immortilized rat 208F fibroblasts 
(Hajnal et aL, 1993), but can be restored upon chemically induced 
reversion of these cell lines. Contente et aL, (1990) retransformed cell 
lines after transfecting NIH cells with an antisense rrg expression vector. 
This evidence suggests that lysyl oxidase is important in maintaining a 
non -transformed phenotype within certain cells. Genetic manipulation of 
lysyl oxidase cDNA is therefore also of great importance in identifying 
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causes of tumour susceptibility, as well as being able to express and study 
mutant enzymes unable to support the non -transformed phenotype. 
6.3 Eclefin 
Eclefin has been found to enhance activity of lysyl oxidase when 
[4,5 -3H] lysine labelled elastin is used as substrate. All activity is abolished 
in the presence of 0.2 mM BAPN. Eclefin activity is susceptible to trypsin 
activity, which indicates that it is probably a protein. Eclefin appears to 
enhance lysyl oxidase more in the presence of low elastin concentrations. 
The heat stability of eclefin may allow for the introduction of an 80 00 
heating step during its preparation since most other contaminating proteins 
are likely to denature at this temperature. Studies to determine the 
molecular weight of eclefin may be continued using FPLC gel permeation 
chromatogaphy, although the low yields of eclefin activity obtained usually 
result in the loss of all activity after further purification steps. 
Work should be carried out to determine whether eclefin will 
influence the binding of enzymes to elastin. Pancreatic elastase activity is 
inhibited by cationic amphiphiles such as dodecyltrimethylammonium 
chloride (Kagan et al., 1979b), whereas dodecyltrimethylammonium 
bromide stimulates the activity of lysyl oxidase (Kagan et al., 1981). The 
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